<html xmlns="http://www.w3.org/1999/xhtml" class=" js flexbox flexboxlegacy canvas canvastext webgl no-touch geolocation postmessage no-websqldatabase indexeddb hashchange history draganddrop websockets rgba hsla multiplebgs backgroundsize borderimage borderradius boxshadow textshadow opacity cssanimations csscolumns cssgradients no-cssreflections csstransforms csstransforms3d csstransitions fontface generatedcontent video audio localstorage sessionstorage webworkers applicationcache svg inlinesvg smil svgclippaths"><!--MODERNIZED PAGE--><head id="coid_website_head" profile="http://www.w3.org/2005/10/profile"><style type="text/css">@charset "UTF-8";[ng\:cloak],[ng-cloak],[data-ng-cloak],[x-ng-cloak],.ng-cloak,.x-ng-cloak,.ng-hide{display:none !important;}ng\:form{display:block;}.ng-animate-block-transitions{transition:0s all!important;-webkit-transition:0s all!important;}</style>
	<meta http-equiv="content-type" content="text/html; charset=UTF-8">
	<meta http-equiv="X-UA-Compatible" content="IE=edge">
	<meta name="description" content="View on Westlaw or start a FREE TRIAL today, King Pharmaceuticals, Inc. v. Eon Labs, Inc., Cases">







<script>
	

	(function () {
		window['$$errors'] = [];

		//handle js errors (it will be overwritten in GlobalPageHandlers.js. And any error will be processed when this script is loaded on the page.)
		window.onerror = function() {
			window['$$errors'].push(arguments);
		}
	})();
</script>




	<title>King Pharmaceuticals, Inc. v. Eon Labs, Inc. | Cases | Westlaw</title>

	
	



	
	
	



	




    
    <link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/utilities.css" type="text/css" rel="stylesheet">
<link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/core.css" type="text/css" rel="stylesheet">
<link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/components.css" type="text/css" rel="stylesheet">
<link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/features.css" type="text/css" rel="stylesheet">
<link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/document.css" type="text/css" rel="stylesheet">
<link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/print.css" type="text/css" rel="stylesheet" media="print">
<!--[if gte IE 6]>
<link href='https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/ie.css' type='text/css' rel='stylesheet' />
<![endif]-->


	<link rel="shortcut icon" type="image/vnd.microsoft.icon" href="https://ia.next.westlaw.com/favicon.ico">
	<link rel="apple-touch-icon" href="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v2/iphone-webclip-icon.png">
<script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="//ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/js/bundle.923c80f054c89ca796f84c4fbed803b0.dll.js"></script><script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="//ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/js/bundle.e94d5ee75e94c1087b529e979a552bed.dll.js"></script><script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="//ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/js/bundle.83634f9482d1ddf27e96c8f1d9498ac3.dll.js"></script><script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="//ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/js/bundle.82967e6fecb235c1f97c6591de01f9f7.dll.js"></script><script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="//ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/js/Website/Views/Document/DocumentTabView.bootstrap.js"></script><link id="Markman_MarkmanDisplayState"><link id="Markman"></head>



<body class="co_t2Left co_docDisplay">
	<div id="co_pageContainer" class="co_bodyToolbar">
		<div id="co_mainContainer">
			











<div id="co_headerWrapper" class="wlnv2 ">
	<div id="co_newHeader"><div id="co_privacyPolicyContainer"> 
	<p id="co_privacyPolicy">
		<b>We've updated our Privacy Statement.</b> Before you continue, please read our new <a id="coid_website_privacyPolicyLinkOut" href="javascript:void(0)">Privacy Statement</a> and familiarize yourself with the terms.
		<button type="button" id="coid_website_privacyPolicyAcknowledged" title="Close message to acknowledge privacy statement" class="co_absolute">
			<span class="icon25 icon_close_x"></span>
		</button>
	</p>
</div>
		<div id="co_headerContainer">
			<div id="co_newHeader_top" class="headerContent" role="banner">
					<div class="skipButtonContainer"><a href="javascript:void(0);" data-jumpto="co_docHeaderTitle" class="co_tbButton skipButton">Skip to Document</a><a href="javascript:void(0);" data-jumpto="co_footerLinks" class="co_tbButton skipButton">Skip to Footer</a></div>
						<ul id="co_mainNav" class="co_inlineList" role="navigation">
							
														<li id="co_kmFirmNameContainer"></li>


	<li id="co_clientIdContainer" class="navigation_link co_menuListFirst"><div id="co_clientID_title_0" class="co_dropdownTabCollapsed"><span class="co_clientID_label" id="co_clientID_label_0">Client ID:</span><span></span></div><div id="co_clientID_list_0" class="co_clientID_list co_hideState" aria-hidden="true">

<div class="co_dropdownBoxExpanded">
	<div class="co_dropdownBoxHeader">
		<span></span>
	</div>
	<div class="co_dropdownBoxContent">
		<button id="co_clientID_close_0" class="co_overlayBox_closeButton" type="button">Close</button>
		<div class="co_dropdownBoxContentRight" id="co_clientID_content_0"></div>
	</div>
	<div class="co_dropdownBoxFooter">
		<span></span>
	</div>
</div></div></li>
									<li id="co_recentHistoryContainer"><div id="tabIndicator" class="co_dropdownTabCollapsed"><div class="co_dropdownTab"><a href="javascript:void(0);" class="co_dropdownBoxanchorLabel"><span class="icon"></span>History</a><button class="co_hasTooltip co_dropdownArrowCollapsed" title="Recent History Menu"><span class="th_simple_icon icon_down_arrow reversed"></span><span class="co_accessibilityLabel" aria-hidden="true" id="coid_dropdownAriaLabel_1">History Menu</span> </button></div></div><div class="co_dropdownBoxCollapsed" aria-hidden="true" aria-labelledby="coid_dropdownAriaLabel_1"><span class="co_accessibilityLabel">Beginning of history window.</span><div class="co_dropdownBoxContent"><div class="co_recentResearch iac-a11y-header-redesign" id="co_recentResearch">
	<div class="co_recentDocuments co_floatLeft">
		<div class="co_globalNavDropdownBox_header">
			<h3 class="co_recentDocumentsHeader">Recent Documents</h3>
			<a class="co_floatRight co_recentDocumentsAll" href="javascript:void(0);" id="co_recentDocumentsLink">View all</a>
		</div>
		<div class="co_scrollWrapper">
			<ul class="co_recentDocumentsList" id="co_recentDocumentsList"></ul>
		</div>
	</div>
	<div class="co_recentSearches co_floatRight">
		<div class="co_globalNavDropdownBox_header">
			<h3 class="co_recentSearchesHeader">Recent Searches</h3>
			<a class="co_floatRight co_recentSearchesAll" href="javascript:void(0);" id="co_recentSearchesLink">View all</a>
		</div>
		<div class="co_scrollWrapper">
			<ul class="co_recentSearchesList" id="co_recentSearchesList"></ul>
		</div>
	</div>
	<div class="co_clear"></div>
</div></div><button class="co_overlayBox_closeButton" type="button" title="Close history menu">Close Recent History window</button><span class="co_accessibilityLabel">End of history window.</span></div></li>
								<li id="co_signOffContainer" class="">

									<div class="co_dropdownTabCollapsed">
										<div class="co_dropdownTab">
											<button id="coid_website_signOffRegion" class="co_dropdownBoxanchorLabel co_hasTooltip iac-a11y-header-redesign" title="Settings &amp; Sign Off">
												<span class="th_simple_icon icon_user reversed"></span>
												<span class="th_simple_icon icon_down_arrow reversed"></span>
												<span class="co_accessibilityLabel" aria-hidden="true">Settings &amp; Sign Off</span>
											</button>
										</div>
									</div>
									<div class="co_dropdownBoxCollapsed co_globalNavDropdownBox" aria-hidden="true" aria-labelledby="coid_dropdownAriaLabel_0"><span class="co_accessibilityLabel">Beginning of profile settings window.</span>
										<div class="co_globalNavDropdownBox_header">
											<h3 id="coid_dropdownAriaLabel_0">Profile Settings</h3>
										</div>
										<div class="co_globalNavDropdownBox_content">
											<div class="co_signOff_profile">
												<h4></h4>
												<ul>
													<li></li>
												</ul>
											</div>

											<div class="co_signOff_links">
												<ul>


	<li>
		<a id="coid_website_mycontent" href="/MyPlan/Show\?transitionType=Default&amp;contextData=(sc.Default)">My Content</a>
	</li>


													<li>
														<a id="coid_website_userSetting" href="javascript:void(0);">My Preferences</a>
													</li>
													<li>
														<a class="co_signOff_updateProfile" href="https://onepass.westlaw.com/v2/profile/general?productid=CBT&amp;viewproductid=&amp;returnto=1.next.westlaw.com">Update OnePass Profile</a>
													</li>
												</ul>

											</div>

											<div class="co_signOff_buttons">
												<div>
													<button type="button" class="co_primaryBtn js_website_signoff">Sign Off</button>
												</div>
											</div>
										</div>
									<button class="co_overlayBox_closeButton" type="button" title="Close profile menu">Close Profile Settings window</button><span class="co_accessibilityLabel">End of profile settings window.</span></div>

								</li>
						</ul>

			</div>
			<div id="co_newHeader_bottom" class="headerContent">







<div id="headerLogo" class="" data-compartment-start-page-id="">

	<a id="coid_website_logo" href="/?transitionType=Default&amp;contextData=(sc.Default)" tabindex="1" class="co_hasTooltip">
		<img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v2/logo.png" title="Westlaw Home">
		<span class="co_accessibilityLabel" aria-hidden="true">Westlaw Home</span>
	</a>
</div>







<div id="coid_website_searchWidget" style="display:none;"></div>
<div id="co_headerSearch" class="">
	<div id="co_searchWidgetInnerId" class="co_noAdvancedSearch">
		<form action="" onsubmit="return false;">
			<div id="co_searchFormLeft">
				<a href="javascript:void(0);" id="co_categorySearchButton">
					<span id="co_currentSelectedCategoryText">291 PATENTS</span>
					<span id="co_currentSelectedCategoryToggle" class="th_simple_icon icon_down_arrow co_hasTooltip">
						<span class="co_accessibilityLabel">Content Menu</span>
					</span>
				</a>
				<div class="co_dropdownBoxCollapsed" id="co_searchCategoryDropdown"><ul>  <li class="co_tabLeft" id="co_searchWidgetAllWestlawTab" title="Search All Content">    <div class="co_tabRight"><a href="#" onclick="return false;">All Content</a></div>  </li>  <li class="co_tabLeft co_hideState" id="co_searchWidgetCompartmentCustomTab" title="compartmentCustomTab">    <div id="compartmentCustomTabDivId" class="co_tabRight"><a title="Search " href="#" onclick="return false;">{compartmentCustomTabLinkText}</a></div>  </li>  <li class="co_tabActive co_tabLeft" id="co_searchWidgetCustomTab">    <div id="customTabDivId" class="co_tabRight"><a title="Search 291 PATENTS" href="#" onclick="return false;">291 PATENTS</a></div>  </li></ul>

				</div>
			</div>
			<div class="co_searchFormOuter">
				<div class="co_searchInputContainer" id="co_searchInputContainer">
					<div class="co_inputTop">
						<div class="co_inputTopRight"></div>
					</div>
					<div class="co_inputMidLeft">
						<div class="co_inputMidRight">
							<!-- Search text box -->
							<div class="co_textarea">
								<label id="searchInputIdLabel" for="searchInputId">Search:</label>
									<textarea style="" title="Search" name="searchInputId" aria-label="Westlaw Search. Search suggestions available after typing 3 characters. Use arrow keys to navigate suggestions." id="searchInputId" rows="1" spellcheck="false" autocorrect="off" autocapitalize="off" class="co_defaultInput"></textarea>
							</div>

							<!-- Medical litigator check box container -->
							<div id="co_medLitExpandedTerms" class="co_floatRight co_formInline"></div>



<!-- Recent search query toggle -->
<a id="co_searchLast10Link" class="th_simple_icon icon_down_arrow co_hasTooltip" href="#" onclick="return false;" title="Recent Searches Menu">
		<span class="co_accessibilityLabel">Recent Searches Menu</span>
</a>
						</div>
					</div>
					<div class="co_inputBottom">
						<div class="co_inputBottomRight"></div>
					</div>


<!-- Hold recent query drop down -->
<div id="co_recentQueryListBox" class="co_hideState">
	<ul class="co_searchSuggestionContainer" id="co_searchLast10List"></ul>
</div>
				<span role="application" id="searchBoxIndexSpan" style="display: none;"><p class="co_accessibilityLabel" id="co_resultsAvailable">Results are available, use up and down arrow keys to navigate</p><p class="co_accessibilityLabel" id="co_endOfList">End Of List</p><div id="co_typeAheadStatusAlert" aria-live="assertive" role="alert" aria-labelledby="co_resultsAvailable"></div><ul class="co_searchSuggestionContainer" aria-live="polite" aria-relevant="additions removals" id="co_searchSuggestion" style="display: none;" tabindex="-1"><li class="co_autoCompleteSection" id="coid_westlawanswers_elastic_westlawanswers_allcases" style="display:none"></li><li class="co_autoCompleteSection" id="coid_westlawanswers_elastic_westlawanswers" style="display:none"></li><li class="co_autoCompleteSection" id="coid_westlawanswers_elastic_westlawanswers" style="display:none"></li><li class="co_autoCompleteSection" id="coid_snapshotExactMatch_elastic_snapshots" style="display:none"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_categorypage"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_case"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_docket"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_statute"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_regulation"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_admindecision"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_analytical"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_pendingstatute"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_othercourtdocument"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_snapshots"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_westlawanswers"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_westlawanswers_static_questions"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_westlawanswers_static_questions_allcases"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_westlawanswers_it_depends_question"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_antitrust"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_arbitration"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_bankruptcy"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_capmarket_corpgovern"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_commtrans"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_corp_mna"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_empbenefits_excomp"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_fedcivilpract"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_finance"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_inhousecounsel"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_intelprop_tech"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_labor_emp"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_realestate"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_startup_smallbus"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_trust_estate"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointpicks_practicallaw"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointpicks_forms"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointpicks_secondarysrc"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepoint_rulebooks"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepoint_categorypage"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicallaw"></li></ul></span></div>
			</div>
			<div id="co_searchFormRight">
				<div id="co_searchFormRightWrapper">
					<!-- Jurisdiction selected -->
					<div id="co_jurisdictionWidgetContainer" class="">

<a class="co_jurisdictionSelectorDropDownArrowCollapsed" href="javascript:void(0);" id="jurisdictionId">
    <span id="jurisdictionIdInner">Federal Circuit</span>
</a>
</div>
					<!-- Search button -->
					<button title="Search" id="searchButton" class="co_hasTooltip" aria-label="Search 291 PATENTS">


						Search Westlaw
						<span class="co_accessibilityLabel">Search 291 PATENTS</span>
					</button>
					<!-- Advanced search -->
					<a href="#" onclick="return false;" class="co_hideState" id="co_search_advancedSearchLink" title="Advanced Search">Advanced</a>
					<!-- Holder jurisdiction pop up -->
					<div id="co_searchJurisdictionHoverContainer"></div>
				</div>
			</div>
			<!-- Search error container -->
			<div id="co_searchInputErrorMessageContainer" class="co_hideState"></div>
		</form>
	</div>
</div>
						<div id="coid_website_searchWidget" class="co_hideState"></div>
						<div id="co_researchAcceleratorWrapper">
							
						</div>
						<div class="co_skipToLink">
							<a id="coid_website_startContent" name="coid_website_startContent"></a>
						</div>

			</div><!--newHeader_bottom-->
		</div><!--headerContainer-->
	</div><!--newHeader-->
</div><!--co_headerWrapper-->




	
	
<!-- moved delivery toolbar to separate ascx control -->	








	<div id="co_body">
		<!-- BODY HEADER -->
		<div id="co_bodyHeader"></div>
		

	
	<!-- Reporting Name is "CTA" for document with guid "I5549a5e09f0f11df896a9debfa48a185". -->
	
	<!-- CENTER COLUMN -->  
	<div id="co_contentWrapper">
		<div id="co_contentColumn">
			<div class="co_innertube">










<div id="co_docHeaderContainer">
	<a class="co_skipToLink" href="#coid_website_errorsSummaryPlaceHolder">
		Skip Page Header
	</a>
	<div id="co_docHeader">
		<div id="co_docFixedHeader"><div id="co_docHeaderCitatorFlag"><span class="co_citatorFlag"><a href="https://1.next.westlaw.com/Link/RelatedInformation/Flag?documentGuid=I5549a5e09f0f11df896a9debfa48a185&amp;transitionType=Document&amp;originationContext=docHeaderFlag&amp;contextData=(sc.CustomDigest)"><img class="crsw_DocumentIndicator" alt="KeyCite Yellow Flag - Negative Treatment" src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v1/flag_yellow.png" title="KeyCite Yellow Flag - Negative Treatment"></a><span class="co_citatorFlagText">KeyCite Yellow Flag - Negative Treatment</span></span></div><div id="co_docHeaderTitle"><h2 id="co_docHeaderTitleLine" title="King Pharmaceuticals, Inc. v. Eon Labs, Inc."><span id="title"><a class="co_drag" href="https://1.next.westlaw.com/Document/I5549a5e09f0f11df896a9debfa48a185/View/FullText.html?listSource=Search&amp;navigationPath=Search%2fv1%2fresults%2fnavigation%2fi0ad62aef0000016306ea58342bf062c8%3fNav%3dCUSTOMDIGEST%26fragmentIdentifier%3dI5549a5e09f0f11df896a9debfa48a185%26startIndex%3d1%26contextData%3d%2528sc.CustomDigest%2529%26transitionType%3dCustomDigestItem&amp;list=CUSTOMDIGEST&amp;rank=142&amp;listPageSource=b1be020b4aba9e28af6c04f62c735c28&amp;originationContext=docHeader&amp;contextData=(sc.CustomDigest)&amp;transitionType=Document&amp;needToInjectTerms=False&amp;enableBestPortion=True&amp;docSource=6e919702fa1e42df8fd85176577733c3">King Pharmaceuticals, Inc. v. Eon Labs, Inc.</a></span></h2><ul id="co_documentStatusIcons" class="co_document_indicators"></ul><h3 id="co_docHeaderCitation" title="United States Court of Appeals, Federal Circuit. | August 2, 2010 | 616 F.3d 1267 | 95 U.S.P.Q.2d 1833&nbsp;(Approx. 23 pages)"><span id="courtline">United States Court of Appeals, Federal Circuit.</span><span id="filedate">August 2, 2010</span><span id="cite0">616 F.3d 1267</span><span id="cite1">95 U.S.P.Q.2d 1833</span><em>&nbsp;(Approx. 23 pages)</em></h3><h4 id="co_docHeaderNegativeTreatment"><span id="co_document_compositeHeader_citatorFlag" class="co_citatorFlag"></span></h4></div></div>
		<div class="co_clear"></div>
		<div id="co_docPrimaryTabNavigationContainer" class="co_docTabs">
				<a id="co_iPadKeyCiteMenuToggle">
					Toggle Menu
				</a>
			<ul id="co_docPrimaryTabNavigation" class="co_tabs">










<li id="DocumentTab" class="co_tabLeft co_tabActive co_dropdownTab">
	<h2 class="co_tabRight">
		<a id="coid_DocumentTab_link" class="co_tabLink" href="javascript:void(0);">
			<span>Document</span>
		</a>
				<div class="co_clear"></div> 
	</h2>
	</li>







<li id="riFilingsTab" class="co_tabLeft" countstatus="" categoryenum="riFilings">
	<h2 class="co_tabRight">
		<a id="coid_relatedInfo_riFilings_link" class="co_tabLink" href="/RelatedInformation/I5549a5e09f0f11df896a9debfa48a185/riFilings.html?originationContext=documentTab&amp;transitionType=Filings&amp;contextData=(sc.CustomDigest)&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;rulebookMode=false" hiddenhref="/RelatedInformation/I5549a5e09f0f11df896a9debfa48a185/riFilings.html?originationContext=documentTab&amp;transitionType=Filings&amp;contextData=(sc.CustomDigest)&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;rulebookMode=false">
			
			<span>
				Filings 
			 (36)</span>
		</a>
		<div class="co_clear"></div> 
	</h2>
</li>







<li id="kcNegativeTreatmentTab" class="co_tabLeft" countstatus="" categoryenum="kcNegativeTreatment">
	<h2 class="co_tabRight">
		<a id="coid_relatedInfo_kcNegativeTreatment_link" class="co_tabLink" href="/RelatedInformation/I5549a5e09f0f11df896a9debfa48a185/kcNegativeTreatment.html?originationContext=documentTab&amp;transitionType=NegativeTreatment&amp;contextData=(sc.CustomDigest)&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;rulebookMode=false" hiddenhref="/RelatedInformation/I5549a5e09f0f11df896a9debfa48a185/kcNegativeTreatment.html?originationContext=documentTab&amp;transitionType=NegativeTreatment&amp;contextData=(sc.CustomDigest)&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;rulebookMode=false">
			
			<span>
				Negative Treatment 
			 (3)</span>
		</a>
		<div class="co_clear"></div> 
	</h2>
</li>







<li id="kcJudicialHistoryTab" class="co_tabLeft" countstatus="" categoryenum="kcJudicialHistory">
	<h2 class="co_tabRight">
		<a id="coid_relatedInfo_kcJudicialHistory_link" class="co_tabLink" href="/RelatedInformation/I5549a5e09f0f11df896a9debfa48a185/kcJudicialHistory.html?originationContext=documentTab&amp;transitionType=History&amp;contextData=(sc.CustomDigest)&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;rulebookMode=false" hiddenhref="/RelatedInformation/I5549a5e09f0f11df896a9debfa48a185/kcJudicialHistory.html?originationContext=documentTab&amp;transitionType=History&amp;contextData=(sc.CustomDigest)&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;rulebookMode=false">
			
			<span>
				History 
			 (15)</span>
		</a>
		<div class="co_clear"></div> 
	</h2>
</li>







<li id="kcCitingReferencesTab" class="co_tabLeft co_dropdownTab" countstatus="" categoryenum="kcCitingReferences">
	<h2 class="co_tabRight">
		<a id="coid_relatedInfo_kcCitingReferences_link" class="co_tabLink" href="/RelatedInformation/I5549a5e09f0f11df896a9debfa48a185/kcCitingReferences.html?originationContext=documentTab&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;rulebookMode=false" hiddenhref="/RelatedInformation/I5549a5e09f0f11df896a9debfa48a185/kcCitingReferences.html?originationContext=documentTab&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;rulebookMode=false">
			
			<span>
				Citing References 
			 (1,191)</span>
		</a>





<span id="co_kcCitingReferencesNavAnchor" class="co_dropdownArrowCollapsed">Navigate Citing References</span>
		<div class="co_clear"></div> 
	</h2>
		<div id="co_kcCitingReferencesNavContent" class="co_dropdownBoxCollapsed" style="display:none;"></div>
</li>







<li id="kcTableOfAuthoritiesTab" class="co_tabLeft" countstatus="" categoryenum="kcTableOfAuthorities">
	<h2 class="co_tabRight">
		<a id="coid_relatedInfo_kcTableOfAuthorities_link" class="co_tabLink" href="/RelatedInformation/I5549a5e09f0f11df896a9debfa48a185/kcTableOfAuthorities.html?originationContext=documentTab&amp;transitionType=TableOfAuthorities&amp;contextData=(sc.CustomDigest)&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;rulebookMode=false" hiddenhref="/RelatedInformation/I5549a5e09f0f11df896a9debfa48a185/kcTableOfAuthorities.html?originationContext=documentTab&amp;transitionType=TableOfAuthorities&amp;contextData=(sc.CustomDigest)&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;rulebookMode=false">
			
			<span>
				Table of Authorities 
			</span>
		</a>
		<div class="co_clear"></div> 
	</h2>
</li>




<li id="co_powByKCContainer">
	<a id="co_powByKC" href="javascript:void(0)">
		Powered by KeyCite
	</a>
</li>

			</ul>
		</div>
		<div class="co_clear"></div>
		<div id="co_docToolbarContainer" class="">
			<div id="co_docToolbar"><div><ul id="co_docToolbarMenuLeft"><li id="co_docToolbarBackToResults"><div id="co_documentFooterBreadcrumb"><a class="co_tbButton" href="/Search/Results.html?jurisdiction=CTAF&amp;contentType=CUSTOMDIGEST&amp;querySubmissionGuid=i0ad62aef0000016306ea58342bf062c8&amp;tocGuid=I4aee2539c6f64c1812a4c2f3395c2607&amp;categoryPageUrl=Home%2FWestKeyNumberSystem&amp;searchId=i0ad62aef0000016306ea4650fbf37b75&amp;collectionSet=w_cs_cd_toc&amp;transitionType=ReturnToList&amp;contextData=%28sc.CustomDigest%29#I5549a5e09f0f11df896a9debfa48a185"><span class="icon25 icon_back_arrow btnOffset"></span>Return to list</a></div></li><li id="co_docToolbarDocumentNavigation"><div id="co_documentFooterResultsNavigation" class="co_prevNextNavigation"><button title="Previous Document" id="co_documentFooterResultsNavigationPrevious" class="co_prev co_tbButton">
	                <span class="icon25 icon_prev_arrow">Previous Document</span>
                </button>
                <span class="co_navigationText"><strong>142</strong> of <strong>718 results</strong></span>
                <button title="Next Document" id="co_documentFooterResultsNavigationNext" class="co_next co_tbButton">
                    <span class="icon25 icon_next_arrow">Next Document</span>
                </button></div></li></ul><ul id="co_docToolbarMenuRight"><li id="co_docToolbarMenuRightChildWidget0" class="co_hideState"></li><li id="co_docHeaderSearchGrading"></li><li id="co_docToolbarGoTo"><div class="co_dropdownTabCollapsed"><div class="co_dropdownTab"><a href="javascript:void(0);" class="co_dropdownBoxanchorLabel" role="button">Go to</a><a href="javascript:void(0);" role="button" class="co_dropdownArrowCollapsed">Open Skip to Menu</a></div></div><div id="co_docGoToWidget" class="co_dropdownBoxCollapsed"><div class="co_dropdownBoxContent" id="co_skipTo"><div class="co_dropdownBoxContentRight"><div><div><a href="#co_synopsis">Synopsis</a></div><div><a href="#co_headnoteHeader">West Headnotes</a></div><div><a href="#co_attorneysAndLawFirms">Attorneys and Law Firms</a></div><div><a href="#co_opinion">Opinion</a></div><div><a href="#co_allCitations">All Citations</a></div></div></div></div><div id="co_starPage" class="co_dropdownBoxContent"><div class="co_dropdownBoxContentRight"><label for="co_document_starPage_starPageNavInput">Page #</label><input id="co_document_starPage_starPageNavInput" maxlength="6" size="6" type="text"><span id="co_document_starPage_starPageNavGo" class="co_primaryBtn">Go</span><div id="co_document_starPage_starPageNavError"></div><div class="co_clear"></div></div></div></div></li><li id="co_docToolbarTocNavigation"></li><li id="co_docToolbarTocFlyout"></li><li id="co_docToolbarMenuRightChildWidget5"></li><li id="co_docToolbarMenuRightChildWidget6"></li><li id="co_docToolbarMenuRightChildWidget7" class="co_toolbarSeparator"></li><li id="co_docToolbarSearchWithinDocument"><div id="co_docSearchWithinContainer"><a role="button" href="javascript:void(0);" class="co_dropdownTitle" title="Search text in this document">Search Within this Document</a>
<div id="co_docSearchWithinDropdownContainer">
	<div id="co_docSearchWithinDropdownContainerInner">
		<div id="co_docSearchWithinDropdownContainerInnerContent" class="co_dropdownBoxCollapsed">
			<!-- toggle between co_dropDownBoxCollapsed and co_dropdownBoxExpanded to show/hide -->
			<div class="co_dropdownBoxHeader">
				<span></span>
			</div>
			<div class="co_dropdownBoxContent">
				<div class="co_dropdownBoxContentRight">
					<div id="co_docSearchWithin_input">
						
<div id="co_docSearchWithin_searchInputContainer_withRecentSearch">
	<a id="co_searchLast10Link" class="co_recentSearchesLink" href="javascript:void(0);" title="Recent Searches">
		Last 10 Searches
	</a>
	<div class="co_textarea">
		<textarea id="co_docSearchWithin_searchInput_withRecentSearch" rows="1" autocorrect="off" autocapitalize="off" role="textbox" aria-label="Enter term to search for in current document"></textarea>
	</div>
	<div id="co_documentRecentQueryListBox" class="co_hideState"><ul class="co_searchSuggestionContainer" id="co_documentSearchLast10List"></ul></div>
</div>

						<input id="co_docSearchWithin_searchButton" class="co_secondaryBtn" value="Search" role="button" aria-label="Search Within this Document" type="button">
					</div>
					<div class="co_prevNextNavigation co_hideState">
						<button title="Previous Term" class="co_prev co_tbButton">
							<span class="icon25 icon_prev_arrow">Previous Term</span>
						</button>
						<button title="Next Term" class="co_next co_tbButton">
							<span class="icon25 icon_next_arrow">Next Term</span>
						</button>
						<span class="co_navigationText co_hideState"></span>
					</div>
					<button id="co_docSearchWithin_help" class="co_helpLink">Terms &amp;amp; Connectors</button>
					<button id="co_docSearchWithinCloseButton" class="co_widget_closeIcon">Close</button>
					<div id="co_docSearchWithinMessage"></div>
					<div class="co_clear"></div>
				</div>
				<div id="searchWithinTncContainer" class="co_hideState"><div id="co_search_advancedSearch_tncLegendBox">  <h2 id="co_search_advancedSearch_tncHelpTitle">Connectors and Expanders</h2>  <a id="co_search_advancedSearch_tncHelpLink" href="#" class="co_hideState">Help</a>  <dl id="co_search_advancedSearch_tncLegendList">    <dt>&amp;</dt><dd>AND</dd>    <dt>/s</dt><dd>In same sentence</dd>    <dt>or</dt><dd>OR</dd>    <dt>+s</dt><dd>Preceding within sentence</dd>    <dt>/p</dt><dd>In same paragraph</dd>    <dt>""</dt><dd>Phrase</dd>    <dt>+p</dt><dd>Preceding within paragraph</dd>    <dt>%</dt><dd>But not</dd>    <dt>/n</dt><dd>Within n terms of</dd>    <dt>!</dt><dd>Root expander</dd>    <dt>+n</dt><dd>Preceding within n terms of</dd>    <dt>*</dt><dd>Universal character</dd>    <dt>#</dt><dd>Prefix to turn off plurals and equivalents</dd>  </dl></div></div>
			</div>
			<div class="co_dropdownBoxFooter">
				<span></span>
			</div>
		</div>
	</div>
</div></div></li><li id="co_docToolbarDisplayOptions"><a role="button" id="co_displayOptionsLink" class="co_tbButton" href="javascript:void(0);" title="Display Options"><span class="icon25 icon_text_resize">Display Options</span></a></li><li id="co_docToolbarDeliveryWidget"><div id="deliveryWidget1" class="co_dropDownMenu collapsed"><div class="co_dropDownButton"><a role="button" id="deliveryLink1" title="Email" class="co_tbButton" href="javascript:void(0);"><span class="icon25 icon_email">Email</span></a><a href="javascript:void(0);" class="co_tbButton co_dropDownAnchor" role="button" id="deliveryDropButton1" aria-label="Delivery menu" title="Delivery menu" aria-describedby="navigation1"><span class="icon25 icon_down_blue_arrow"></span></a><span id="navigation1" class="co_accessibilityLabel">Enter to open, tab to navigate, enter to select</span></div><div id="deliveryWidgetMenu1" class="co_dropDownMenuContent" role="document"><ul class="co_dropDownMenuList checkmarks icons" role="listbox" aria-multiselectable="true" aria-hidden="false" aria-expanded="true"><li id="deliveryRow1Email" name="Email" role="presentation" class="checked"><a title="Email" id="deliveryLinkRow1Email" role="option" aria-posinset="1" aria-setsize="3" class="co_deliveryLinkOptions" tabindex="0" aria-selected="true"><span class="icon25 icon_email"></span>Email</a></li><li id="deliveryRow1Print" name="Print" role="presentation"><a title="Print" id="deliveryLinkRow1Print" role="option" aria-posinset="2" aria-setsize="3" class="co_deliveryLinkOptions" tabindex="0" aria-selected="false"><span class="icon25 icon_print"></span>Print</a></li><li id="deliveryRow1Download" name="Download" role="presentation"><a title="Download" id="deliveryLinkRow1Download" role="option" aria-posinset="3" aria-setsize="3" class="co_deliveryLinkOptions" tabindex="0" aria-selected="false"><span class="icon25 icon_download"></span>Download</a></li></ul><div class="co_deliveryWidgetMenuFooter"></div></div><div id="co_deliveryWidget_Message1"></div></div></li><li id="co_docToolbarReadingModeWidget"><a role="button" id="co_fullscreenModeLink" class="co_tbButton" href="javascript:void(0);" title="Fullscreen Mode"><span class="icon25 icon_fullscreen">Fullscreen Mode</span></a></li></ul></div></div> 
			<div class="co_clear"></div>
		</div>
	</div>
</div>

				<div id="coid_website_errorsSummaryPlaceHolder"><div class="co_infoBox failure" style="display: none;"><div class="co_infoBox_container"><div class="co_infoBox_outer"><div class="co_infoBox_inner"><a id="co_website_errorSumarryCloseLink" class="co_infoBox_closeButton">Close</a><div class="co_infoBox_message" tabindex="-1">Sorry, there was an error on this page.<a href="javascript:void(0);" id="co_website_errorSummaryToggleLink">More info</a><a href="javascript:void(0);" id="co_website_errorSummaryToggleLinkLessInfo" style="display: none; margin-left: 6px;">Less info</a><ul class="co_website_errorsSummaryList" style="display: none;"></ul></div></div></div></div></div></div>
				<div id="coid_website_messagePlaceholder"></div>







				<div id="test_hplink"></div>
				<div class="co_scrollWrapper">





							<div id="coid_website_documentWidgetDiv" class=" co_khSpeedReadExpandAll">
<div id="co_briefItDiv" class="co_excludeAnnotations"><button id="co_briefItButton" class="co_primaryBtn co_floatRight">Brief It</button><div class="undefined"></div></div><div id="co_document" class="co_addFocusCorrection"><div id="co_document_0" class="co_document co_caselawNRS"><div id="co_readingModeKC" class="co_keyCiteFlagWidgetContainer co_excludeAnnotations"><div id="co_readingModeCitatorFlag"><span class="co_citatorFlag"><a href="https://1.next.westlaw.com/Link/RelatedInformation/Flag?documentGuid=I5549a5e09f0f11df896a9debfa48a185&amp;transitionType=Document&amp;originationContext=docHeaderSntTitleFlag&amp;contextData=(sc.CustomDigest)"><img class="crsw_DocumentIndicator" alt="KeyCite Yellow Flag - Negative Treatment" src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v1/flag_yellow.png" title="KeyCite Yellow Flag - Negative Treatment"></a><span class="co_citatorFlagText">KeyCite Yellow Flag - Negative Treatment</span></span></div><div id="co_readingModeNegativeTreatment"><span id="NegativeTreatmentWidget_I5549a5e09f0f11df896a9debfa48a185"><span class="co_snt_treatmentPhrase">Distinguished by </span><a href="https://1.next.westlaw.com/Document/I5b9cab20c43e11e79c8f8bb0457c507d/View/FullText.html?navigationPath=RelatedInfo%2Fv4%2Fkeycite%2Fnav%2F%3Fguid%3DI5b9cab20c43e11e79c8f8bb0457c507d%26ss%3D2022669341%26ds%3D2043119539&amp;listSource=RelatedInfo&amp;list=NegativeCitingReferences&amp;rank=0&amp;originationContext=docHeader&amp;transitionType=NegativeTreatment&amp;contextData=%28sc.CustomDigest%29">Industrial Models, Inc. v. SNF, Inc.</a><span>, </span><span class="co_snt_courtLine">Fed.Cir.(Tex.), </span><span class="co_snt_dateFiled">November 7, 2017</span></span></div></div><input id="co_keyCiteFlagPlaceHolder" type="hidden"><input id="co_document_starPageMetadata" value="{ &quot;citations&quot;: { &quot;Sad93c832d14b11dfb5fdfcf739be147c&quot;:&quot;616 F.3d 1267&quot; }, &quot;pubs&quot;: { &quot;Sad93c832d14b11dfb5fdfcf739be147c&quot;:&quot;506&quot; } }" alt="metadata" type="hidden"><div><a href="https://1.next.westlaw.com/Link/Document/Blob/I256301F01DD211B2A83CC60072092446/616_F.3d_1267.pdf?targetType=NRS&amp;originationContext=pagepdflink&amp;transitionType=DocumentImage&amp;uniqueId=f2eafe66-b533-4373-bd00-a9b3d4ba90d5&amp;contextData=(sc.CustomDigest)" class="co_blobLink" type="application/pdf"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v1/co_pdf-icon.gif" class="co_pdfIcon" alt="PDF">​Original Image of 616 F.3d 1267 (PDF)</a></div><div class="co_cites">616 F.3d 1267</div><input id="co_document_paraNumbersSourceCiteMetadata" value="{ &quot;paraNumbersSourceCite&quot;: &quot;616 F.3d 1267&quot;, &quot;publicationNumber&quot;: &quot;506&quot; }" alt="metadata" type="hidden"><div class="co_contentBlock co_briefItState co_courtBlock"><div><div class="co_hAlign2">United States Court of Appeals,</div>Federal Circuit.</div></div><div class="co_title"><div class="co_suit"><div class="co_partyLine">KING PHARMACEUTICALS, INC., and King Pharmaceuticals Research and Development, Inc, Plaintiffs–Appellants,</div><div>v.</div><div class="co_partyLine">EON LABS, INC., Defendant–Appellee,</div><div>v.</div><div class="co_partyLine">Elan Pharmaceuticals, Inc., Counterclaim Defendant–Appellant.</div></div></div><div class="co_docketDate"><div class="co_contentBlock co_briefItState co_docketBlock"><span>Nos. 2009–1437, 2009–1438.</span></div><div class="co_date"><span>Aug. 2, 2010.</span><span>Rehearing and Rehearing En Banc Denied Oct. 14, 2010.</span></div></div><div class="co_contentBlock co_briefItState co_synopsis"><h2 id="co_synopsis" class="co_printHeading">Synopsis</h2><div><div class="co_paragraph"><div class="co_paragraphText"><strong>Background:</strong> Patent holder filed action against competitor alleging infringement of patents directed toward methods of informing patients about and administering muscle relaxant metaxalone. Competitor asserted affirmative defenses and counterclaims for invalidity, fraud, and unclean hands. The United States District Court for the Eastern District of New York, <a id="co_link_I84f0151822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0198307001&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">David G. Trager</a>, Senior District Judge, <a id="co_link_I84f0151922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;pubNum=0004637&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">593 F.Supp.2d 501</a>, invalidated patents. Plaintiff appealed.</div></div></div><div class="co_contentBlock co_briefItState co_synopsisHolding"><div class="co_paragraph"><div class="co_paragraphText"><strong>Holdings:</strong> The Court of Appeals, Gajarsa, Circuit Judge, held that:</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F42022669341" class="co_internalLink co_excludeAnnotations co_disableHighlightFeatures">1</a> claim directed toward methods of informing patients about and administering muscle relaxant metaxalone was invalid due to anticipation;</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F52022669341" class="co_internalLink co_excludeAnnotations co_disableHighlightFeatures">2</a> broad terms used in patent's claims could not be limited to specific food conditions disclosed in written description;</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F82022669341" class="co_internalLink co_excludeAnnotations co_disableHighlightFeatures">3</a> claims limiting time frame in which patient had to ingest metaxalone had been anticipated by prior;</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F102022669341" class="co_internalLink co_excludeAnnotations co_disableHighlightFeatures">4</a> instructional limitation, that taking drug with food increased bioavailability of drug, had been anticipated;</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F132022669341" class="co_internalLink co_excludeAnnotations co_disableHighlightFeatures">5</a> printed label claim had been anticipated;</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F142022669341" class="co_internalLink co_excludeAnnotations co_disableHighlightFeatures">6</a> commercial success of patented product was not objective indication of nonobviousness;</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F152022669341" class="co_internalLink co_excludeAnnotations co_disableHighlightFeatures">7</a> patent claim directed toward methods of informing patients about and administering muscle relaxant metaxalone was obvious; and</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F162022669341" class="co_internalLink co_excludeAnnotations co_disableHighlightFeatures">8</a> actual case or controversy did not exist between competitor and corporation after corporation sold all its interests in asserted patents to another entity.</div></div></div><div class="co_paragraph"><div class="co_paragraphText">Affirmed and vacated in part.</div></div></div><div id="co_headnotes" class="co_headnotes co_fancyHeadnotes"><h2 id="co_headnoteHeader" class="co_headnoteHeader co_printHeading"><span class="co_headnoteHeaderSpan">West Headnotes (20)</span><a id="co_headnoteExpandCollapseLink" class="co_accLink co_excludeAnnotations co_disableHighlightFeatures" href="javascript:void(0);" role="button">Collapse West Headnotes</a></h2><div class="co_headnotesContentContainer"><div id="co_expandedHeadnotes"><div id="co_headnoteTools"><a id="co_headnotesShowOrHideFancy" href="javascript:void(0);" class="co_fancyHeadnotesShowHide co_excludeAnnotations co_disableHighlightFeatures">Change View</a></div><div class="co_headnoteRow" id="co_anchor_2022669341001"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F12022669341"><span class="co_headnoteNumber" id="co_anchor_headNote_1"><a href="#co_anchor_B12022669341" class="co_internalLink">1</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0ECKAC" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EQMAC" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k489(2)/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Single reference disclosing every element or limitation of claim</a></span></div><div class="co_secondaryHeadnoteNodes"> <span class="co_hiddenKeyText"><strong><a id="co_link_ID0EFNAC" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EFPAC" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k490/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Inherent anticipation</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">A patent claim is anticipated if each and every limitation is found either expressly or inherently in a single prior art reference. <a id="co_link_I84f0152922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C.A. § 102</a>.</div></div><div id="co_headnoteId_202266934100120180308023334" class="co_headnoteCitedCaseRef"><a id="co_link_ID0E1PAC" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;headnoteId=202266934100120180308023334&amp;originationContext=document&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 1"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">24 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0151c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0151d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0151e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)</a></span><span class="co_headnoteTopicKey">Novelty;  Anticipation</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0151f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)1/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)1</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0152022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k483/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k483</a></span><span class="co_headnoteTopicKey">Prior Art and Relation of Claimed Invention Thereto</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0152122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k489/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k489</a></span><span class="co_headnoteTopicKey">Number of Prior Art References;  Combinations</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0152222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k489(2)/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k489(2)</a></span><span class="co_headnoteTopicKey">Single reference disclosing every element or limitation of claim</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k72(1))</span></span></div></div></div></div></div><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0152322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0152422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0152522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)</a></span><span class="co_headnoteTopicKey">Novelty;  Anticipation</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0152622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)1/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)1</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0152722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k483/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k483</a></span><span class="co_headnoteTopicKey">Prior Art and Relation of Claimed Invention Thereto</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0152822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k490/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k490</a></span><span class="co_headnoteTopicKey">Inherent anticipation</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k72(1))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2022669341002"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F22022669341"><span class="co_headnoteNumber" id="co_anchor_headNote_2"><a href="#co_anchor_B22022669341" class="co_internalLink">2</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EWAAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EWCAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k490/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Inherent anticipation</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Anticipation by inherent disclosure is appropriate only when the reference discloses prior art that must necessarily include the unstated patent limitation. <a id="co_link_I84f0153022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C.A. § 102</a>.</div></div><div id="co_headnoteId_202266934100220180308023334" class="co_headnoteCitedCaseRef"><a id="co_link_ID0ELDAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;headnoteId=202266934100220180308023334&amp;originationContext=document&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 2"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">22 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0152a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0152b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0152c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)</a></span><span class="co_headnoteTopicKey">Novelty;  Anticipation</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0152d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)1/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)1</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0152e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k483/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k483</a></span><span class="co_headnoteTopicKey">Prior Art and Relation of Claimed Invention Thereto</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0152f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k490/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k490</a></span><span class="co_headnoteTopicKey">Inherent anticipation</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k65)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2022669341003"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F32022669341"><span class="co_headnoteNumber" id="co_anchor_headNote_3"><a href="#co_anchor_B32022669341" class="co_internalLink">3</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EGEAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EOFAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k455/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Use or operation of machine or apparatus as affecting process;  “machine or transformation” test</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">A process may be patentable if (1) it is tied to a particular machine or apparatus, or if (2) it transforms a particular article into a different state or thing. <a id="co_link_I84f0153522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS101&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C.A. § 101</a>.</div></div><div id="co_headnoteId_202266934100320180308023334" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EDGAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;headnoteId=202266934100320180308023334&amp;originationContext=document&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 3"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">3 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0153122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0153222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0153322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(B)/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(B)</a></span><span class="co_headnoteTopicKey">Eligible Subject Matter</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0153422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k455/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k455</a></span><span class="co_headnoteTopicKey">Use or operation of machine or apparatus as affecting process;  “machine or transformation” test<input id="co_docMarker_0" type="hidden"></span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k7.11)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2022669341004"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F42022669341"><span class="co_headnoteNumber" id="co_anchor_headNote_4"><a href="#co_anchor_B42022669341" class="co_internalLink">4</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0E5GAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E5IAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k548/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Drugs and medicines</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Claim in patent directed toward methods of informing patients about and administering muscle relaxant metaxalone, that had been based on discovery of naturally occurring side effect of increased bioavailability to known practice of administering metaxalone with food to decrease nausea, was invalid due to anticipation; although disclosure of taking metaxalone with food would not inherently disclose increasing bioavailability of metaxalone, increase in bioavailability of metaxalone was inherent property of taking metaxalone with food to treat musculoskeletal conditions which had been disclosed in prior art. <a id="co_link_I84f0153c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C.A. § 102</a>.</div></div><div id="co_headnoteId_202266934100420180308023334" class="co_headnoteCitedCaseRef"><a id="co_link_ID0ETJAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;headnoteId=202266934100420180308023334&amp;originationContext=document&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 4"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">3 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0153622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0153722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0153822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)</a></span><span class="co_headnoteTopicKey">Novelty;  Anticipation</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0153922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)2/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)2</a></span><span class="co_headnoteTopicKey">Particular Fields of Invention</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0153a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k546/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k546</a></span><span class="co_headnoteTopicKey">Health Care and Medical Products</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0153b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k548/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k548</a></span><span class="co_headnoteTopicKey">Drugs and medicines</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k66(1.24))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2022669341005"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F52022669341"><span class="co_headnoteNumber" id="co_anchor_headNote_5"><a href="#co_anchor_B52022669341" class="co_internalLink">5</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0ETKAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EJMAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1408/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Drugs and medicines</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Written description which taught that claimed increase in metaxalone's bioavailability could be achieved through consumption of “meal, such as breakfast, lunch or dinner” did not identify any additional conditions that had to be present for the food effect to occur, and thus broad terms used in patent's claims could not be limited to specific food conditions disclosed in written description; although written description had disclosed specific conditions for food consumption, it did not suggest that specific food conditions disclosed were necessary for increasing metaxalone's bioavailability. <a id="co_link_I84f0154222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C.A. § 102</a>.</div></div><div id="co_headnoteId_202266934100520180308023334" class="co_headnoteCitedCaseRef"><a id="co_link_ID0E5MAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;headnoteId=202266934100520180308023334&amp;originationContext=document&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 5"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">1 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0153d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0153e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291V/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291V</a></span><span class="co_headnoteTopicKey">Construction and Operation of Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0153f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291V(C)/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291V(C)</a></span><span class="co_headnoteTopicKey">Particular Fields of Invention</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0154022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1406/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1406</a></span><span class="co_headnoteTopicKey">Health Care and Medical Products</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0154122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1408/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1408</a></span><span class="co_headnoteTopicKey">Drugs and medicines</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k101(4))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2022669341006"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F62022669341"><span class="co_headnoteNumber" id="co_anchor_headNote_6"><a href="#co_anchor_B62022669341" class="co_internalLink">6</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EZNAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EZPAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k490/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Inherent anticipation</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">While inherent anticipation of a patent may not be established by probabilities or possibilities, if the prior art's disclosure is sufficient to show that the natural result flowing from the operation as taught would result in the performance of the questioned function, the disclosure should be regarded as sufficient. <a id="co_link_I84f0154922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C.A. § 102</a>.</div></div><div id="co_headnoteId_202266934100620180308023334" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EOQAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;headnoteId=202266934100620180308023334&amp;originationContext=document&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 6"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">2 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0154322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0154422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0154522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)</a></span><span class="co_headnoteTopicKey">Novelty;  Anticipation</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0154622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)1/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)1</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0154722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k483/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k483</a></span><span class="co_headnoteTopicKey">Prior Art and Relation of Claimed Invention Thereto</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0154822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k490/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k490</a></span><span class="co_headnoteTopicKey">Inherent anticipation</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k65)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2022669341007"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F72022669341"><span class="co_headnoteNumber" id="co_anchor_headNote_7"><a href="#co_anchor_B72022669341" class="co_internalLink">7</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EJRAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EJTAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k490/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Inherent anticipation</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">To anticipate, the prior art need only meet the inherently disclosed limitation to the extent the patented method does. <a id="co_link_I84f0155022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C.A. § 102</a>.</div></div><div id="co_headnoteId_202266934100720180308023334" class="co_headnoteCitedCaseRef"><a id="co_link_ID0E5TAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;headnoteId=202266934100720180308023334&amp;originationContext=document&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 7"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">16 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0154a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0154b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0154c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)</a></span><span class="co_headnoteTopicKey">Novelty;  Anticipation</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0154d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)1/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)1</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0154e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k483/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k483</a></span><span class="co_headnoteTopicKey">Prior Art and Relation of Claimed Invention Thereto</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0154f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k490/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k490</a></span><span class="co_headnoteTopicKey">Inherent anticipation</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k72(1))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2022669341008"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F82022669341"><span class="co_headnoteNumber" id="co_anchor_headNote_8"><a href="#co_anchor_B82022669341" class="co_internalLink">8</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EZUAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EZWAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k548/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Drugs and medicines</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Process patent claims limiting time frame in which patient had to ingest metaxalone in relation to consuming food to “30 minutes prior to 2 hours after consumption of the food,” to “substantially at the same time,” or to “immediately after the consumption of food up to 1 hour after” had been anticipated by prior art which disclosed administering metaxalone “with food,” “with meals,” and “with food or milk,” since common-sense definition of “with food” could mean taking metaxalone “1 hour prior to up to about 2 hours after eating.”</div></div><div id="co_headnoteId_202266934100820180308023334" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EOXAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;headnoteId=202266934100820180308023334&amp;originationContext=document&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 8"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">1 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0155122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0155222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0155322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)</a></span><span class="co_headnoteTopicKey">Novelty;  Anticipation</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0155422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)2/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)2</a></span><span class="co_headnoteTopicKey">Particular Fields of Invention</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0155522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k546/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k546</a></span><span class="co_headnoteTopicKey">Health Care and Medical Products</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0155622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k548/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k548</a></span><span class="co_headnoteTopicKey">Drugs and medicines<input id="co_docMarker_1" type="hidden"></span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k66(1.24))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2022669341009"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F92022669341" tabindex="0"><span class="co_headnoteNumber" id="co_anchor_headNote_9"><a href="#co_anchor_B92022669341" class="co_internalLink">9</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EAYAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EWZAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k444/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Processes or methods</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Patentability analysis had to be directed to process claim as a whole, not individual limitations of claim. <a id="co_link_I84f0155c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS101&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C.A. § 101</a>.</div></div><div id="co_headnoteId_202266934100920180308023334" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EL1AE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;headnoteId=202266934100920180308023334&amp;originationContext=document&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 9"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">2 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0155722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0155822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0155922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(B)/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(B)</a></span><span class="co_headnoteTopicKey">Eligible Subject Matter</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0155a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k442/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k442</a></span><span class="co_headnoteTopicKey">Classes of Invention or Discovery;  Statutory Subject Matter</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0155b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k444/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k444</a></span><span class="co_headnoteTopicKey">Processes or methods</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k7)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2022669341010"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F102022669341"><span class="co_headnoteNumber" id="co_anchor_headNote_10"><a href="#co_anchor_B102022669341" class="co_internalLink">10</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EG2AE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EG4AE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k548/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Drugs and medicines</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Instructional limitation which taught method of treating patients with metaxalone, whereby patient was administered metaxalone with food and informed that such treatment increased bioavailability of drug, had been anticipated, since limitation was not functionally related to otherwise anticipated method of administering metaxalone with food that had been known in art. <a id="co_link_I84f0156322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C.A. § 102</a>.</div></div><div id="co_headnoteId_202266934101020180308023334" class="co_headnoteCitedCaseRef"><a id="co_link_ID0E24AE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;headnoteId=202266934101020180308023334&amp;originationContext=document&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 10"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">2 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0155d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0155e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0155f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)</a></span><span class="co_headnoteTopicKey">Novelty;  Anticipation</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0156022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)2/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)2</a></span><span class="co_headnoteTopicKey">Particular Fields of Invention</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0156122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k546/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k546</a></span><span class="co_headnoteTopicKey">Health Care and Medical Products</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0156222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k548/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k548</a></span><span class="co_headnoteTopicKey">Drugs and medicines</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k66(1.24))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2022669341011"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F112022669341"><span class="co_headnoteNumber" id="co_anchor_headNote_11"><a href="#co_anchor_B112022669341" class="co_internalLink">11</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EW5AE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EJAAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1965/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Scope, Standard, and Extent of Review</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">An appellate court is not limited to a district court's stated reasons for invalidating patent claims and can affirm a grant of summary judgment on any ground supported by the record and adequately raised below. <a id="co_link_I84f0156a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C.A. § 102</a>; <a id="co_link_I84f0156b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000600&amp;cite=USFRCPR56&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Fed.Rules Civ.Proc.Rule 56, 28 U.S.C.A</a>.</div></div><div id="co_headnoteId_202266934101120180308023334" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EMBAG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;headnoteId=202266934101120180308023334&amp;originationContext=document&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 11"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">2 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0156422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0156522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0156622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(C)/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(C)</a></span><span class="co_headnoteTopicKey">Actions</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0156722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(C)7/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(C)7</a></span><span class="co_headnoteTopicKey">Appellate Review</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0156822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1965/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1965</a></span><span class="co_headnoteTopicKey">Scope, Standard, and Extent of Review</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0156922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1966/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1966</a></span><span class="co_headnoteTopicKey">In general</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k324.5)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2022669341012"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F122022669341"><span class="co_headnoteNumber" id="co_anchor_headNote_12"><a href="#co_anchor_B122022669341" class="co_internalLink">12</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EPCAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EPEAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k691/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">New use or application</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">It is not invention to perceive that the product which others had discovered had qualities they failed to detect. <a id="co_link_I84f0157222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS101&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C.A. § 101</a>.</div></div><div id="co_headnoteId_202266934101220180308023334" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EEFAG" class="co_link co_excludeAnnotations co_disableHighlightFeatures co_hideState" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;headnoteId=202266934101220180308023334&amp;originationContext=document&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 12"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">0 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0156c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0156d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0156e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(E)/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(E)</a></span><span class="co_headnoteTopicKey">Obviousness;  Lack of Invention</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0156f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(E)2/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(E)2</a></span><span class="co_headnoteTopicKey">Factors Considered</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0157022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k682/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k682</a></span><span class="co_headnoteTopicKey">Prior Art and Relation of Claimed Invention Thereto</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0157122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k691/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k691</a></span><span class="co_headnoteTopicKey">New use or application</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k27(1))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2022669341013"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F132022669341"><span class="co_headnoteNumber" id="co_anchor_headNote_13"><a href="#co_anchor_B132022669341" class="co_internalLink">13</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0E6FAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E6HAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k548/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Drugs and medicines</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Claim relating to printed label on product, “advising that administration with food results in an increase in the maximal plasma concentration (Cmax) and extent of absorption (AUC(last)) of metaxalone compared to administration without food,” had been anticipated, since method of administering metaxalone with food was known in art and label was not functionally related to either product within method claim or method claim as a whole. <a id="co_link_I84f0157922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C.A. § 102</a>.</div></div><div id="co_headnoteId_202266934101320180308023334" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EUIAG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;headnoteId=202266934101320180308023334&amp;originationContext=document&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 13"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">2 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0157322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0157422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0157522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)</a></span><span class="co_headnoteTopicKey">Novelty;  Anticipation</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0157622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)2/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)2</a></span><span class="co_headnoteTopicKey">Particular Fields of Invention</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0157722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k546/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k546</a></span><span class="co_headnoteTopicKey">Health Care and Medical Products</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0157822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k548/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k548</a></span><span class="co_headnoteTopicKey">Drugs and medicines</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k66(1.24))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2022669341014"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F142022669341"><span class="co_headnoteNumber" id="co_anchor_headNote_14"><a href="#co_anchor_B142022669341" class="co_internalLink">14</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EUJAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0ECMAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k709(6)/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Success attributable to other causes</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Commercial success of patented product was not objective indication of nonobviousness, since commercial success existed prior to study leading to patents and nexus did not exist between drug's alleged commercial success and specific invention claimed. <a id="co_link_I84f0158122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS103&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C.A. § 103</a>.</div></div><div id="co_headnoteId_202266934101420180308023334" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EXMAG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;headnoteId=202266934101420180308023334&amp;originationContext=document&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 14"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">2 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0157a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0157b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0157c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(E)/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(E)</a></span><span class="co_headnoteTopicKey">Obviousness;  Lack of Invention</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0157d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(E)2/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(E)2</a></span><span class="co_headnoteTopicKey">Factors Considered</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0157e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k700/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k700</a></span><span class="co_headnoteTopicKey">Secondary Factors or Considerations;  Objective Indicia or Evidence</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0157f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k709/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k709</a></span><span class="co_headnoteTopicKey">Commercial Success</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0158022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k709(6)/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k709(6)</a></span><span class="co_headnoteTopicKey">Success attributable to other causes</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k36.2(4))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2022669341015"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F152022669341"><span class="co_headnoteNumber" id="co_anchor_headNote_15"><a href="#co_anchor_B152022669341" class="co_internalLink">15</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0ESNAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0ESPAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k768/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Drugs and medicines</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Person of ordinary skill in the art, confronted with teaching of one prior art to take one 400 mg tablet of metaxalone four times daily and suggestion of other prior art to take metaxalone with food, would have seen benefit to administering 400 mg tablet of metaxalone at mealtimes, and thus patent claim directed toward methods of informing patients about and administering muscle relaxant metaxalone was obvious. <input id="co_docMarker_2" type="hidden"><a id="co_link_I84f0158822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS103&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C.A. § 103</a>.</div></div><div id="co_headnoteId_202266934101520180308023334" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EHQAG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;headnoteId=202266934101520180308023334&amp;originationContext=document&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 15"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">1 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0158222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0158322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0158422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(E)/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(E)</a></span><span class="co_headnoteTopicKey">Obviousness;  Lack of Invention</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0158522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(E)3/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(E)3</a></span><span class="co_headnoteTopicKey">Particular Fields of Invention</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0158622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k766/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k766</a></span><span class="co_headnoteTopicKey">Health Care and Medical Products</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0158722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k768/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k768</a></span><span class="co_headnoteTopicKey">Drugs and medicines</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k16.25)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2022669341016"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F162022669341"><span class="co_headnoteNumber" id="co_anchor_headNote_16"><a href="#co_anchor_B162022669341" class="co_internalLink">16</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0ECRAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/118A/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Declaratory Judgment</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EYSAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/118Ak232/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Validity of patents</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Actual case or controversy did not exist between competitor and corporation that had brought suit against competitor alleging infringement, and competitor filed declaratory counterclaim of invalidity, after corporation sold all its interests in asserted patents to another entity.</div></div><div id="co_headnoteId_202266934101620180308023334" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EHTAG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;headnoteId=202266934101620180308023334&amp;originationContext=document&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 16"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">2 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0158922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/118A/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">118A</a></span><span class="co_headnoteTopicKey">Declaratory Judgment</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0158a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/118AII/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">118AII</a></span><span class="co_headnoteTopicKey">Subjects of Declaratory Relief</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0158b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/118AII(L)/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">118AII(L)</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0158c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/118Ak231/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">118Ak231</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0158d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/118Ak232/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">118Ak232</a></span><span class="co_headnoteTopicKey">Validity of patents</span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2022669341017"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F172022669341"><span class="co_headnoteNumber" id="co_anchor_headNote_17"><a href="#co_anchor_B172022669341" class="co_internalLink">17</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EZTAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170B/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Federal Courts</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EZVAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170Bk3581/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Jurisdiction</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Whether an actual case or controversy exists is reviewed de novo.</div></div><div id="co_headnoteId_202266934101720180308023334" class="co_headnoteCitedCaseRef"><a id="co_link_ID0E3WAG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;headnoteId=202266934101720180308023334&amp;originationContext=document&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 17"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">8 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0158e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170B/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170B</a></span><span class="co_headnoteTopicKey">Federal Courts</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0158f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170BXVII/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170BXVII</a></span><span class="co_headnoteTopicKey">Courts of Appeals</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0159022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170BXVII(K)/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170BXVII(K)</a></span><span class="co_headnoteTopicKey">Scope and Extent of Review</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0159122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170BXVII(K)2/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170BXVII(K)2</a></span><span class="co_headnoteTopicKey">Standard of Review</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0159222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170Bk3576/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170Bk3576</a></span><span class="co_headnoteTopicKey">Procedural Matters</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0159322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170Bk3581/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170Bk3581</a></span><span class="co_headnoteTopicKey">Jurisdiction</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0159422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170Bk3581(1)/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170Bk3581(1)</a></span><span class="co_headnoteTopicKey">In general</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 170Bk776)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2022669341018"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F182022669341"><span class="co_headnoteNumber" id="co_anchor_headNote_18"><a href="#co_anchor_B182022669341" class="co_internalLink">18</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EOXAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/118A/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Declaratory Judgment</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EWYAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/118Ak62/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Nature and elements in general</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">A case or controversy exists when the facts alleged, under all the circumstances, show that there is a substantial controversy, between parties having adverse legal interests, of sufficient immediacy and reality to warrant the issuance of a declaratory judgment. <a id="co_link_I84f0159922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000583&amp;cite=USCOARTIIIS1&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">U.S.C.A. Const. Art. 3, § 1</a> et seq.</div></div><div id="co_headnoteId_202266934101820180308023334" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EFZAG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;headnoteId=202266934101820180308023334&amp;originationContext=document&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 18"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">9 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0159522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/118A/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">118A</a></span><span class="co_headnoteTopicKey">Declaratory Judgment</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0159622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/118AI/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">118AI</a></span><span class="co_headnoteTopicKey">Nature and Grounds in General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0159722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/118AI(D)/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">118AI(D)</a></span><span class="co_headnoteTopicKey">Actual or Justiciable Controversy</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0159822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/118Ak62/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">118Ak62</a></span><span class="co_headnoteTopicKey">Nature and elements in general</span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2022669341501"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_2022669341"><span class="co_headnoteNumber" id="co_anchor_headNote_19">19</span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0E5ZAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E31AG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k2091/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">In general;  utility</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText"><a id="co_link_I84f0159d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1962071596&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=I9488a380722811d7a5a58ae19b0bc350&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">US Patent 3,062,827</a>. Cited.</div></div><div id="co_headnoteId_202266934150120180308023334" class="co_headnoteCitedCaseRef"><a id="co_link_ID0ER2AG" class="co_link co_excludeAnnotations co_disableHighlightFeatures co_hideState" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;headnoteId=202266934150120180308023334&amp;originationContext=document&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 19"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">0 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0159a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0159b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291X/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291X</a></span><span class="co_headnoteTopicKey">Patents Enumerated</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0159c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k2091/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k2091</a></span><span class="co_headnoteTopicKey">In general;  utility</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k328(2))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2022669341502"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_2022669341_0"><span class="co_headnoteNumber" id="co_anchor_headNote_20">20</span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EK3AG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EI4AG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k2091/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">In general;  utility</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText"><a id="co_link_I84f015a122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">US Patent 6,407,128</a>, <a id="co_link_I84f015a222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004090134&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ibfe574a051a111d89e91fb27c9eb3845&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">US Patent 6,683,102</a>. Invalid.</div></div><div id="co_headnoteId_202266934150220180308023334" class="co_headnoteCitedCaseRef"><a id="co_link_ID0E44AG" class="co_link co_excludeAnnotations co_disableHighlightFeatures co_hideState" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;headnoteId=202266934150220180308023334&amp;originationContext=document&amp;docSource=6e919702fa1e42df8fd85176577733c3&amp;rank=142&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 20"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">0 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0159e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f0159f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291X/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291X</a></span><span class="co_headnoteTopicKey">Patents Enumerated</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I84f015a022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k2091/View.html?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k2091</a></span><span class="co_headnoteTopicKey">In general;  utility</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k328(2))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div></div></div><div> </div></div><a id="co_headnotesEnd"></a><h2 class="co_attorneyBlockLabel co_printHeading co_briefItState" id="co_attorneysAndLawFirms">Attorneys and Law Firms</h2><div class="co_contentBlock co_briefItState co_attorneyBlock"><div> <span class="co_starPage" id="co_pp_sp_506_1269"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sad93c832d14b11dfb5fdfcf739be147c&quot;, &quot;pageNumber&quot;: &quot;1269&quot; }" alt="metadata" type="hidden">*1269</span> <a id="co_link_I84f015a322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0177077901&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Gregory A. Castanias</a>, <a id="co_link_I84f015a422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0177049701&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Jones Day</a>, of Washington, DC, argued for plaintiffs-appellants. With him on the brief were <a id="co_link_I84f015a522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0206089001&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">F. Dominic Cerrito</a>, <a id="co_link_I84f015a622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0241051501&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Daniel L. Malone</a> and <a id="co_link_I84f015a722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0325032201&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Eric C. Stops</a>, of New York, NY. Of counsel was <a id="co_link_I84f015a822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0325031701&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Evangeline Shih</a>.</div><div><a id="co_link_I84f015a922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0151574101&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Martin B. Pavane</a>, Cohen Pontani Lieberman &amp; Pavane LLP, of New York, NY, argued for defendant-appellee. With him on the brief were <a id="co_link_I84f015aa22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0293252501&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Alfred H. Hemingway, Jr.</a> and <a id="co_link_I84f015ab22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0342345901&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Marilyn Neiman</a>.</div><div><a id="co_link_I84f015ac22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0231721701&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">James B. Monroe</a>, Finnegan, Henderson, Farabow, Garrett &amp; Dunner, LLP, of Washington, DC, argued for counterclaim defendant-appellant. With him on the brief were <a id="co_link_I84f015ad22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0325753701&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Paul W. Browning</a> and Kakoli Caprihan. Of counsel were <a id="co_link_I84f015ae22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0335800801&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Justin J. Hasford</a> and <a id="co_link_I84f015af22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0358176801&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Lawrence L. Ilag</a>.</div></div><div class="co_contentBlock co_briefItState co_panelBlock"><div>Before <a id="co_link_I84f015b022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0112582701&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">BRYSON</a>, GAJARSA, and <a id="co_link_I84f015b222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0324402101&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">PROST</a>, Circuit Judges.</div></div><div class="co_contentBlock co_briefItState co_opinionBlock"><h2 id="co_opinion" class="co_printHeading">Opinion</h2><div class="co_docDelivery_dottedLine"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/co_docDelivery_dottedLine.png" alt=""></div><div class="co_contentBlock x_opinionBlockBody"><div class="co_contentBlock x_opinionLead"><div class="co_contentBlock x_leadAuthorLineBlock"><div class="co_contentBlock x_leadAuthorLine">GAJARSA, Circuit Judge.</div></div><div class="co_contentBlock x_opinionBody"><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I4a74754522b911e89bf099c0ee06c731"><div class="co_paragraph"><div class="co_paragraphText">King Pharmaceuticals, Inc. and King Pharmaceuticals Research and Development, Inc. (“King”) appeal the U.S. District Court for the Eastern District of New York's grant of Eon Labs, Inc.'s (“Eon”) motion for summary judgment that all claims of <a id="co_link_I84f015b422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">U.S. Patent Nos. 6,407,128 (the “ ′128 patent”)</a> and <a id="co_link_I84f015b522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004090134&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ibfe574a051a111d89e91fb27c9eb3845&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">6,683,102 (the “ ′102 patent”)</a> are invalid. <em>See </em><a id="co_link_I84f015b622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;pubNum=0004637&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>King Pharms., Inc. v. Eon Labs, Inc.,</em> 593 F.Supp.2d 501 (E.D.N.Y.2009)</a>. In granting Eon's motion, the district court held four claims invalid under <a id="co_link_I84f015b722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS101&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C. § 101</a>, three claims invalid under <a id="co_link_I84f015b822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS103&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C. § 103</a>, and the remaining claims invalid under <a id="co_link_I84f015b922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C. § 102</a>. <em>See </em><a id="co_link_I84f015ba22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em> at 506–15.</a></div></div><div class="co_paragraph"><div class="co_paragraphText"> <span class="co_starPage" id="co_pp_sp_506_1270"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sad93c832d14b11dfb5fdfcf739be147c&quot;, &quot;pageNumber&quot;: &quot;1270&quot; }" alt="metadata" type="hidden">*1270</span> Following the summary judgment order, the district court entered a final judgment against both King and Elan Pharmaceuticals, Inc. (“Elan”), a prior owner of one of the asserted patents and a third-party, counterclaim defendant. Elan filed a “cautionary” notice of appeal on July 2, 2009 contending that the district court lacked jurisdiction to enter a final judgment against it. Elan then moved to be dismissed as a party from this appeal for lack of subject matter jurisdiction and to vacate the district court's judgment as to Elan. A Federal Circuit motions panel denied the motion because the jurisdictional facts went to the merits of the case. Elan reasserts its jurisdictional arguments in the present appeal.<input id="co_docMarker_3" type="hidden"></div></div><div class="co_paragraph"><div class="co_paragraphText">For the reasons stated below, we affirm the district court's grant of summary judgment of invalidity. We vacate the district court's invalidity order against Elan because the district court lacked subject matter jurisdiction to adjudicate the invalidity counterclaim.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I4a74754622b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">Background</span></div><div class="co_paragraph"><div class="co_paragraphText">King markets and sells a name brand version of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a">metaxalone</a> called <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I37b9d419475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I37b9d419475111db9765f9243f53508a">Skelaxin</a>. <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_0">Metaxalone</a> is a muscle relaxant that is used to treat “discomforts associated with acute, painful musculosketal conditions.” <a id="co_link_I84f015be22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">′128 patent</a> col.1 ll.21–23. <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_1">Metaxalone</a> was first discovered in the 1960s, and the first patent claiming the method of producing the compound, <a id="co_link_I84f015c022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1962071596&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=I9488a380722811d7a5a58ae19b0bc350&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">U.S. Patent No. 3,062,827</a>, issued in 1962 to A.H. Robins Company, Inc. A.H. Robins began selling <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_2">metaxalone</a> under the brand name <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I37b9d419475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I37b9d419475111db9765f9243f53508a_0">Skelaxin</a> in 1962. Elan eventually acquired the rights to <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I37b9d419475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I37b9d419475111db9765f9243f53508a_1">Skelaxin</a> and sold those rights in 2003 to King, which now markets and sells <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I37b9d419475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I37b9d419475111db9765f9243f53508a_2">Skelaxin</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">On August 31, 2004, Eon filed an Abbreviated New Drug Application (“ANDA”) for a generic 800 mg metaxalone tablet. Eon filed with the ANDA a patent certification pursuant to <a id="co_link_I84f015c522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=21USCAS355&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RB&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_0123000089ab5">21 U.S.C. § 355(j)(2)(A)(vii)(IV)</a> (“Paragraph IV Certification”), which alleged that none of the claims of the ′<a id="co_link_I84f015c622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a> would be infringed by the manufacture, use, or sale of Eon's generic 800 mg metaxalone tablet, and that all the claims of the ′<a id="co_link_I84f015c722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a> are invalid. In response to the ANDA and Paragraph IV Certification, King filed suit against Eon under the Hatch–Waxman Act (the “800 mg Action”). The complaint accused Eon of infringing the ′128 and ′<a id="co_link_I84f015c822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004090134&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ibfe574a051a111d89e91fb27c9eb3845&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">102 patents</a>. King's action was consolidated with an earlier, related action, <em>Elan Pharmaceuticals, Inc. v. Eon Labs, Inc.,</em> No. 03–0006 (E.D.N.Y.) (the “<em>400 mg Action</em>”), that Elan filed in 2001 against Eon after Eon filed an ANDA for a generic 400 mg metaxalone tablet. Elan asserted the ′<a id="co_link_I84f015ca22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a> in the <em>400 mg Action</em>, but the case was dismissed after Eon withdrew its 400 mg ANDA. The district court then severed Eon's claims for attorneys fees against King and Elan and consolidated those claims with the 800 mg Action.</div></div><div class="co_paragraph"><div class="co_paragraphText">The ′<a id="co_link_I84f015cb22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a>, titled “Method for Increasing the Bioavailability of Metaxalone,” issued on June 18, 2002 and was initially assigned to Elan. Elan subsequently assigned the ′<a id="co_link_I84f015cc22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a> to King in 2003. The patent discloses a method of “increasing the bioavailability of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_3">metaxalone</a> by administration of an oral dosage form with food.” <a id="co_link_I84f015ce22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">′128 patent</a> [Abstract]. The claimed invention is the result of “the unexpected finding that administration of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_4">metaxalone</a> with food increases both the rate and extent of absorption via the oral dosage form in human subjects.” <a id="co_link_I84f015d022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> at col.2 ll.6–9.</div></div><div class="co_paragraph"><div class="co_paragraphText">The ′<a id="co_link_I84f015d122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a> has three independent claims, claims 1, 9, and 17. Claim 1 claims “a method of increasing the oral bioavailability of metaxalone” by “administering to the patient a therapeutically effective amount of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_5">metaxalone</a> in a pharmaceutical composition with food.” Claim 9 claims a  <span class="co_starPage" id="co_pp_sp_506_1271"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sad93c832d14b11dfb5fdfcf739be147c&quot;, &quot;pageNumber&quot;: &quot;1271&quot; }" alt="metadata" type="hidden">*1271</span> method for increasing “the rate and extent of absorption ... of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_6">metaxalone</a> ... in the blood stream” by “administering to the patient a therapeutically effective amount of metaxalone in a pharmaceutical composition with food.” Claim 17 claims a method similar to claim 1, but limits the effective amount of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_7">metaxalone</a> to between 400 and 800 mg and defines an increase in bioavailability as “an increase in the maximal plasma concentration (Cmax) and extent of absorption (AUC(last)) of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_8">metaxalone</a> compared to administration without food.”</div></div><div class="co_paragraph"><div class="co_paragraphText">Dependent claims 2, 3, 10, and 11 specify that the “therapeutically effective amount” of metaxalone is “200 mg to 900 mg” (claims 2 and 10) or “400 mg to 800 mg” (claims 3 and 11). Dependent claims 4–6, 12–14, and 18–20 specify specific times for administering the metaxalone relative to the consumption of food, either thirty minutes prior to two hours after consumption of food (claims 4, 12 and 18), “substantially at the same time” as consumption of food (claims 5, 13 and 19), or up to one hour after consumption of food (claims 6, 14 and 20). Dependent claims 7 and 15 limit the dosage to a tablet form, and dependent claims 8 and 16 limit the dosage to a “unit dosage form.” Dependent claim 21 claims the method of claim 1 with the additional limitation of “informing” the patient that taking metaxalone with food will increase the drug's bioavailability, and dependent claim 22 claims the method of claim 1 with the additional limitation that <input id="co_docMarker_4" type="hidden">“the metaxalone is from a container with printed labeling advising” that taking metaxalone with food will increase the drug's bioavailability.</div></div><div class="co_paragraph"><div class="co_paragraphText">The ′<a id="co_link_I84f015d622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004090134&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ibfe574a051a111d89e91fb27c9eb3845&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">102 patent</a> issued on January 27, 2004 and is titled “Methods of Using Metaxalone in the Treatment of Musculoskeletal Conditions.” Elan assigned the application that resulted in the ′<a id="co_link_I84f015d722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004090134&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ibfe574a051a111d89e91fb27c9eb3845&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">102 patent</a> to King in 2003. Like the ′<a id="co_link_I84f015d822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"> 128 patent</a>, the ′<a id="co_link_I84f015d922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004090134&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ibfe574a051a111d89e91fb27c9eb3845&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">102 patent</a> discloses a method of “increasing the bioavailability of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_9">metaxalone</a> by administration of an oral dosage form with food.” <a id="co_link_I84f015db22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004090134&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ibfe574a051a111d89e91fb27c9eb3845&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">′102 patent</a> [Abstract]. Independent claim 1 claims a method for using <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_10">metaxalone</a> in the treatment of musculosketal conditions comprising both “providing” a patient with a “therapeutically effective amount of metaxalone” and “informing” the patient that taking <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_11">metaxalone</a> with food increases the bioavailability of the drug. Claims 2 through 5 depend from claim 1 and either specify the “therapeutically effective amount” as 200 mg to 900 mg (claim 2) or 400 mg to 800 mg (claim 3), or limit the dosage to a tablet form (claim 4) or a “unit dosage form” (claim 5).</div></div><div class="co_paragraph"><div class="co_paragraphText">Independent claim 6 claims a “method of using metaxalone in the treatment of musculosketal conditions” consisting of “informing a patient” that taking <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_12">metaxalone</a> with food increases the bioavailability of the drug compared to taking <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_13">metaxalone</a> without food. Independent claim 7 claims a “method of using <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_14">metaxalone</a> in the treatment of musculosketal conditions” by “obtaining <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_15">metaxalone</a> from a container providing information that administration of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_16">metaxalone</a> with food” increases the drug's bioavailability and “ingesting the <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_17">metaxalone</a> with food.”</div></div><div class="co_paragraph"><div class="co_paragraphText">Independent claim 8 claims a “method of using metaxalone in the treatment of musculosketal conditions” comprising both administering metaxalone with food and informing the patient that such administration increases the bioavailability of the drug. Dependent claims 9 through 11 limit claim 8 to <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_18">metaxalone</a> from a container with printed information concerning the increased bioavailability of the drug (claim 9), metaxalone in a tablet form (claim 10), and 400 mg of metaxalone (claim 11). Claims 12, 13, and 14 depend from claim 9 and limit the printed label to stating certain percentage increases in the  <span class="co_starPage" id="co_pp_sp_506_1272"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sad93c832d14b11dfb5fdfcf739be147c&quot;, &quot;pageNumber&quot;: &quot;1272&quot; }" alt="metadata" type="hidden">*1272</span> bioavailability of metaxalone. Finally, claim 15 depends from claim 8 and limits the metaxalone to a 400 mg tablet with a printed label that states certain percentage increases in the bioavailability of the metaxalone.</div></div><div class="co_paragraph"><div class="co_paragraphText">Before the district court, Eon presented six prior art references it contended invalidated the ′128 and ′<a id="co_link_I84f015e522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004090134&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ibfe574a051a111d89e91fb27c9eb3845&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">102 patents</a>. <em>See </em><a id="co_link_I84f015e622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;pubNum=4637&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_4637_504&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_504"><em>King Pharms., Inc.,</em> 593 F.Supp.2d at 504–06.</a> In granting Eon's motion for summary judgment, the district court relied only upon three references: <span class="co_smallCaps">Kazem Fathie,</span> <em><a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=disease&amp;entityId=Iafb0674e475411db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_Iafb0674e475411db9765f9243f53508a">Musculoskeletal Disorders</a> and Their Management with a New Relaxant,</em> <span class="co_smallCaps">Clinical Medicine</span> 678 (April 1965) (“Fathie II”); <span class="co_smallCaps">Joseph A. Albanese, Nurses' Drug Reference</span> 427 (2 ed. 1982) (“Albanese”); and <span class="co_smallCaps">Anne C. Abrams, Clinical Drug Therapy</span> 145 (1995) (“Abrams”). <em>See </em><a id="co_link_I84f015e822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em> at 506–15.</a></div></div><div class="co_paragraph"><div class="co_paragraphText">Fathie II describes a clinical study in which patients were given 800 mg of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_19">metaxalone</a> to be taken three to five times a day. The article notes that several patients complained of nausea and that “[n]ausea might have been less prominent if the medication had been taken with food.” J.A.3054.</div></div><div class="co_paragraph"><div class="co_paragraphText">Albanese is a reference guide for registered nurses. The guide discloses that <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_20">metaxalone</a> is available in 400 mg tablets and recommends a dosage range of 800 mg three to four times daily. The guide also notes that <input id="co_docMarker_5" type="hidden">“[a]dministration with meals will help reduce gastric upset.” J.A.3065.</div></div><div class="co_paragraph"><div class="co_paragraphText">Abrams is another reference guide for registered nurses. The reference guide discloses providing patients with 800 mg of metaxalone three or four times daily for not more than ten consecutive days. The reference guide also instructs nurses to give metaxalone “with milk or food” in order to “decrease gastrointestinal distress.” J.A.3072.</div></div><div class="co_paragraph"><div class="co_paragraphText">Eon moved for summary judgment of invalidity. Eon's motion asserted that all claims of the ′128 and ′<a id="co_link_I84f015eb22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004090134&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ibfe574a051a111d89e91fb27c9eb3845&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">102 patents</a> were either anticipated by or obvious in light of the prior art. The district court granted Eon's motion. <em>See </em><a id="co_link_I84f015ec22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;pubNum=0004637&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>King Pharms., Inc.,</em> 593 F.Supp.2d 501</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">Starting with independent claim 1 of the ′<a id="co_link_I84f015ed22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a>, the district court found the claim's preamble—“[a] method of increasing the oral bioavailability of metaxalone to a patient receiving metaxalone therapy”—inherently anticipated because “an increase in the bioavailability of metaxalone is inherent when the drug is taken with food.” <a id="co_link_I84f015ee22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 508.</a> The district court then concluded that “because the ′<a id="co_link_I84f015ef22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a> teaches nothing more than administering metaxalone with food to increase its bioavailability and because Fathie II, Albanese and Abrams all teach administering metaxalone with food—which inherently increases metaxalone's bioavailability—claim 1 is anticipated.” <a id="co_link_I84f015f022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 509.</a></div></div><div class="co_paragraph"><div class="co_paragraphText">Turning to the ′<a id="co_link_I84f015f122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a>'s dependent claims, the district court found claims 2 and 3 anticipated because the prior art references disclosed dosage amounts within the claimed “therapeutically effective” range. <em>See </em><a id="co_link_I84f015f222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em> at 510.</a> Claims 4 through 7 were also found anticipated because the prior art disclosed taking metaxalone with food within the various time frames claimed. <em>See</em> <a id="co_link_I84f015f322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em></a> As for claim 8, the district court found that no reference disclosed taking a single tablet of metaxalone with food, but held the claim obvious in light of a prior art reference, 18 <span class="co_smallCaps">R.W. Dent, Jr. and Dorothy K. Ervin,</span> <em>A Study of Metaxalone (Skelaxin) vs. Placebo in Acute Musculoskeletal Disorders: A Cooperative Study,</em> <span class="co_smallCaps">Current Therapeutic Research</span> (1975) (“Dent”), which discloses a single tablet dosage and Albanese, which discloses taking dosages with food. <em>See </em><a id="co_link_I84f015f422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em> at 510–11.</a></div></div><div class="co_paragraph"><div class="co_paragraphText">The district court then found claims 9 through 16 mirrored claims 1 through 7,  <span class="co_starPage" id="co_pp_sp_506_1273"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sad93c832d14b11dfb5fdfcf739be147c&quot;, &quot;pageNumber&quot;: &quot;1273&quot; }" alt="metadata" type="hidden">*1273</span> and found the claims anticipated for the earlier stated reasons. <em>See </em><a id="co_link_I84f015f522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em> at 512.</a> Claim 17 was also found anticipated because the claim's “wherein the administration [of metaxalone] results in an increase in [bioavailability]” language, like claim 1's preamble, is an inherent property of the prior art. <em>See</em> <a id="co_link_I84f015f622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em></a> Claims 18 through 20, which depend from claim 17, include the same timing limitations as claims 4 through 6, and were anticipated for the same reasons. <em>See</em> <a id="co_link_I84f015f722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em></a> The district court then found claim 21 invalid under <a id="co_link_I84f015f822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS101&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C. § 101</a> because the claim's “informing” limitation did not “transform the metaxalone into a different state or thing.” <em>Id.</em> at 513 (citing <a id="co_link_I84f015fa22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017388082&amp;pubNum=0000506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>In re Bilski,</em> 545 F.3d 943 (Fed.Cir.2008)</a>, <em>aff'd sub nom, </em><a id="co_link_I84f015fb22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2022394590&amp;pubNum=0000708&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Bilski v. Kappos,</em> ––– U.S. ––––, 130 S.Ct. 3218, 177 L.Ed.2d 792 (2010)</a>). Finally, the district court held claim 22 anticipated because the inclusion of an instruction sheet with a known compound did not make the claim patentably distinct from the prior art. <em>See</em> <a id="co_link_I84f015fc22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em></a> (citing <a id="co_link_I84f015fd22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004469000&amp;pubNum=0000506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>In re Ngai,</em> 367 F.3d 1336 (Fed.Cir.2004)</a> (per curiam)).</div></div><div class="co_paragraph"><div class="co_paragraphText">The district court next addressed the ′<a id="co_link_I84f015fe22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004090134&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ibfe574a051a111d89e91fb27c9eb3845&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">102 patent</a>, reading claim 1 to “require[ ] giving a patient metaxalone and informing the patient about an inherent property of the drug.”<input id="co_docMarker_6" type="hidden"> <em>Id.</em> at 514 (alteration added). In analyzing claim 1, the district court held that administering metaxalone to a patient was disclosed in the prior art, the “informing” limitation was not patentable for the same reasons as claim 21 of the ′<a id="co_link_I84f0160022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a>, and the entire claim was invalid under <a id="co_link_I84f0160122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS101&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 101</a>. <em>See</em> <a id="co_link_I84f0160222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em></a> Claims 2 through 4 contained dosage limitations similar to the limitations disclosed in anticipated claims 2, 3, and 7 of the ′<a id="co_link_I84f0160322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a>, and the district court found the claims to be similarly anticipated under <a id="co_link_I84f0160422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 102</a>. <em>See</em> <a id="co_link_I84f0160522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em></a> Claim 5 was similar to claim 8 of the ′<a id="co_link_I84f0160622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a> and was obvious for the same reasons. <em>See <a id="co_link_I84f0160722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">id.</a></em></div></div><div class="co_paragraph"><div class="co_paragraphText">The district court found claim 6 claimed solely the “informing” limitation and invalidated it under <a id="co_link_I84f0160822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS101&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 101</a>.<sup id="co_footnoteReference_B00112022669341_ID0EKTAI"><a href="#co_footnote_B00112022669341" class="co_footnoteReference">1</a></sup> <em>See</em> <a id="co_link_I84f0160922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em></a> The district court then found claims 7 and 9 invalid for the same reasons as claim 22 of the ′<a id="co_link_I84f0160a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a>, and claim 8 invalid for the same reasons as claim 21 of the ′<a id="co_link_I84f0160b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a>. <em>See </em><a id="co_link_I84f0160c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em> at 514–15.</a> Claims 10 and 11 were found invalid for the same reasons as claim 7 of the ′<a id="co_link_I84f0160d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a>. <em>See </em><a id="co_link_I84f0160e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em> at 515.</a> Finally, claims 12 through 15, which “differ from the prior art only in the content of the written material that accompanies the metaxalone,” were, like claim 22 of the ′<a id="co_link_I84f0160f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a>, anticipated because “a variation in written material that is not functionally related to the invention does not render a known product patentable.” <a id="co_link_I84f0161022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a></div></div><div class="co_paragraph"><div class="co_paragraphText">In light of its invalidity determination, the district court granted King's motion to dismiss Eon's counterclaims for fraud and unclean hands as moot. <em>See </em><a id="co_link_I84f0161122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em> at 516.</a> The district court, however, permitted Eon to brief its argument that the case was exceptional under <a id="co_link_I84f0161222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS285&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C. § 285</a>. <em>See </em><a id="co_link_I84f0161322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em> at 515.</a> The district court then entered its invalidity judgment against not only King, but also Elan, which had not participated in the summary judgment proceeding.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I4a74754722b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">Discussion</span></div><div class="co_headtext co_hAlign2">A. Legal Standards</div><div class="co_paragraph"><div class="co_paragraphText">We review the district court's grant of summary judgment de novo. <em>See </em><a id="co_link_I84f0161422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018333471&amp;pubNum=0000506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_506_1374&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1374"><em>ICU Med., Inc. v. Alaris Med. Sys., Inc.,</em> 558 F.3d 1368, 1374 (Fed.Cir.2009)</a>. Summary judgment is appropriate when, drawing all justifiable inferences in the non-movant's favor, there exists no genuine issue of material fact and the movant is entitled to judgment as a matter of law. <em>See</em> <a id="co_link_I84f0161522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000600&amp;cite=USFRCPR56&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RB&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_4b24000003ba5">Fed.R.Civ.P. 56(c)</a>; <a id="co_link_I84f0161622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1986132674&amp;pubNum=0000708&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Anderson v. Liberty Lobby, Inc.,</em> 477 U.S. 242, 255, 106 S.Ct. 2505, 91 L.Ed.2d 202 (1986)</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText"> <span class="co_starPage" id="co_pp_sp_506_1274"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sad93c832d14b11dfb5fdfcf739be147c&quot;, &quot;pageNumber&quot;: &quot;1274&quot; }" alt="metadata" type="hidden">*1274</span> <a href="#co_anchor_F12022669341" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF1">1</a><a id="co_anchor_B12022669341"></a><a href="#co_anchor_F22022669341" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF2">2</a><a id="co_anchor_B22022669341"></a> Under <a id="co_link_I84f0161722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C. § 102</a> a claim is anticipated “if each and every limitation is found either expressly or inherently in a single prior art reference.” <a id="co_link_I84f0161822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998151585&amp;pubNum=0000506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_506_1360&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1360"><em>Celeritas Techs. Ltd. v. Rockwell Int'l Corp.,</em> 150 F.3d 1354, 1360 (Fed.Cir.1998)</a>. “[A]nticipation by inherent disclosure is appropriate only when the reference discloses prior art that must <em>necessarily</em> include the unstated limitation....” <a id="co_link_I84f0161922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002315963&amp;pubNum=0000506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_506_1373&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1373"><em>Transclean Corp. v. Bridgewood Servs., Inc.,</em> 290 F.3d 1364, 1373 (Fed.Cir.2002)</a> (emphasis in original). A claim is obvious when “the differences between the subject matter sought to be patented and the prior art are such that the subject matter as a whole would have been obvious at the time the invention was made to a person having ordinary skill in the art to which said subject matter pertains.” <a id="co_link_I84f0161a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS103&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C. § 103</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F32022669341" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF3">3</a><a id="co_anchor_B32022669341"></a> Moreover, “[t]he laws of nature, physical phenomena, and abstract ideas have been held not patentable.” <a id="co_link_I84f0161b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1980116775&amp;pubNum=0000708&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Diamond v. Chakrabarty,</em> 447 U.S. 303, 309, 100 S.Ct. 2204, 65 L.Ed.2d 144 (1980)</a>. While a process may be patentable if “(1) it is tied to a particular machine or apparatus, or (2) it transforms a particular article into a different state or thing,” <a id="co_link_I84f0161c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017388082&amp;pubNum=506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_506_954&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_954"><em>In re Bilski,<input id="co_docMarker_7" type="hidden"></em> 545 F.3d at 954,</a> there is no exclusive test for determining patentability under <a id="co_link_I84f0161d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS101&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 101</a>, <a id="co_link_I84f0161e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2022394590&amp;pubNum=0000708&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_708_3226&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_708_3226"><em>Bilski,</em> 130 S.Ct. at 3226–27</a>.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I4a74754822b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign2">B. Analysis</div><div class="co_paragraph"><div class="co_paragraphText">The district court considered and invalidated all thirty-seven claims of the ′128 and ′<a id="co_link_I84f0161f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004090134&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ibfe574a051a111d89e91fb27c9eb3845&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">102 patents</a>, and King appeals thirty-six of those findings. We begin, as the district court did, with the ′<a id="co_link_I84f0162022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a> and then turn to the ′<a id="co_link_I84f0162122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004090134&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ibfe574a051a111d89e91fb27c9eb3845&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">102 patent</a>.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I4a74754922b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign2">I. The ′<a id="co_link_I84f0162222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 Patent</a></div><div class="co_headtext co_hAlign2">a. Claim 1</div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F42022669341" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF4">4</a><a id="co_anchor_B42022669341"></a> Claim 1 is an independent claim requiring the administration of “a therapeutically effective amount of metaxalone in a pharmaceutical composition with food.” Claim 1 contains a preamble, which King argues is the claim's source of novelty. The preamble reads, “[a] method of increasing the bioavailability of metaxalone to a patient receiving metaxalone therapy.” According to King, while the prior art may disclose taking metaxalone with food, it does not disclose increasing the bioavailability of the drug.</div></div><div class="co_paragraph"><div class="co_paragraphText">In its summary judgment opinion, the district court rejected King's argument and found claim 1's preamble inherently anticipated. <em>See </em><a id="co_link_I84f0162322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;pubNum=4637&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_4637_507&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_507"><em>King Pharms., Inc.,</em> 593 F.Supp.2d at 507–09.</a> According to the district court, an increase in the bioavailability of metaxalone is an inherent property of taking metaxalone with food, which is disclosed in each of Fathie II, Albanese, and Abrams. <em>See</em> <em>id.</em></div></div><div class="co_paragraph"><div class="co_paragraphText">On appeal, King argues the district court erred because Eon did not provide any evidence or expert testimony that the prior art would <em>necessarily</em> result in an increase in metaxalone's bioavailability. King argues that the prior art's disclosure (taking metaxalone with food to reduce gastric discomfort) is vague as to the conditions under which the food was administered such that it was improper for the district court to assume that an increase in bioavailability was necessarily disclosed. Specifically, King contrasts the precise conditions on food consumption disclosed in the ′<a id="co_link_I84f0162522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a> with the vague conditions disclosed in Fathie II, Albanese, and Abrams.<sup id="co_footnoteReference_B00222022669341_ID0EBIBI"><a href="#co_footnote_B00222022669341" class="co_footnoteReference">2</a></sup> For further support, King cites  <span class="co_starPage" id="co_pp_sp_506_1275"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sad93c832d14b11dfb5fdfcf739be147c&quot;, &quot;pageNumber&quot;: &quot;1275&quot; }" alt="metadata" type="hidden">*1275</span> its own expert reports which conclude that “even a disclosure of taking metaxalone with food would not inherently disclose increasing the bioavailability of metaxalone.”</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F52022669341" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF5">5</a><a id="co_anchor_B52022669341"></a> As an initial matter, King's attempt to link an increase in metaxalone's bioavailability to specific food conditions is untenable. While the ′<a id="co_link_I84f0162722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a>'s written description discloses specific conditions for food consumption, its claims only recite taking metaxalone “with food.” It would be improper to limit the broad terms used in the ′<a id="co_link_I84f0162822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a>'s claims to the specific food conditions disclosed in the written description. <em>See </em><a id="co_link_I84f0162922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2019871664&amp;pubNum=0000506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_506_1348&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1348"><em>Kara Tech. Inc. v. Stamps.com Inc.,</em> 582 F.3d 1341, 1348 (Fed.Cir.2009)</a> (“The claims, not specification embodiments, define the scope of patent protection. The patentee is entitled to the full scope of his claims, and we will not limit him to his preferred embodiment or import a limitation from the specification into the claims.”). Moreover, the written description in no way suggests that the specific food conditions disclosed were necessary for increasing metaxalone's bioavailability. Rather, the written description teaches that the claimed increase in metaxalone's bioavailability can be achieved through the consumption of “a meal, such as breakfast, lunch or dinner.” <a id="co_link_I84f0162a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">′128 patent</a> col.2 ll.37–38. The district court was therefore correct in finding that “the ′<a id="co_link_I84f0162b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"> 128 patent</a> does not identify any additional conditions that must be present for the food effect to occur. Rather, it occurs naturally in most people when they take metaxalone with food.”<input id="co_docMarker_8" type="hidden"> <a id="co_link_I84f0162c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;pubNum=4637&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_4637_508&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_508"><em>King Pharms., Inc.,</em> 593 F.Supp.2d at 508;</a> <em>see also </em><a id="co_link_I84f0162d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987033992&amp;pubNum=0000350&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_350_632&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_632"><em>Verdegaal Bros., Inc. v. Union Oil Co. of California,</em> 814 F.2d 628, 632 (Fed.Cir.1987)</a> (holding reliance on non-claimed distinction between prior art method and claimed method “inappropriate” and insufficient to save the claim from inherent anticipation).</div></div><div class="co_paragraph"><div class="co_paragraphText">As for the merits of King's argument, we first note that Fathie II, Albanese, and Abrams each disclose administering metaxalone “with food” or “with meals” to treat musculoskeletal conditions. Fathie II, published thirty-six years prior to the filing of the ′<a id="co_link_I84f0162e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a>, teaches administering <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_21">metaxalone</a> “with food” to reduce nausea. J.A.3054. Albanese, published nineteen years prior to the filing of the ′<a id="co_link_I84f0163022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a>, teaches administering metaxalone “with meals” to “reduce gastric upset.” J.A.3065. And, Abrams, published six years prior to the filing of the ′<a id="co_link_I84f0163122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a>, teaches administering <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_22">metaxalone</a> “with milk or food” to “decrease gastrointestinal distress.” J.A.3072.</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F62022669341" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF6">6</a><a id="co_anchor_B62022669341"></a> We have held that “[i]t is a general rule that merely discovering and claiming a new benefit of an old process cannot render the process again patentable.” <a id="co_link_I84f0163322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990167350&amp;pubNum=0000350&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_350_1578&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1578"><em>In re Woodruff,</em> 919 F.2d 1575, 1578 (Fed.Cir.1990)</a>. Such newly discovered benefits are not patentable because they are inherent in the prior art. <em>See </em><a id="co_link_I84f0163422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2001324901&amp;pubNum=0000506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_506_1376&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1376"><em>Bristol–Myers Squibb Co. v. Ben Venue Labs., Inc.,</em> 246 F.3d 1368, 1376 (Fed.Cir.2001)</a>. While inherent anticipation “may not be established by probabilities or possibilities,” <a id="co_link_I84f0163522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1981151399&amp;pubNum=0000350&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_350_581&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_581"><em>In re Oelrich,</em> 666 F.2d 578, 581 (CCPA 1981)</a>, if “the [prior art's] disclosure is sufficient to show that the natural result flowing from the operation as taught would result in the performance of the questioned function, it seems to be well-settled that the disclosure should be regarded as sufficient,” <em>id.</em> (alterations added).</div></div><div class="co_paragraph"><div class="co_paragraphText">According to the ′<a id="co_link_I84f0163722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a>, the natural result of taking metaxalone with food is an increase in the bioavailability of the drug. The prior art discloses taking metaxalone with food, but not the natural result of this process. However, because the prior art methods in their “normal and usual operation ... perform the function which [King] claims in [the ′<a id="co_link_I84f0163822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a>], then such [patent] <span class="co_starPage" id="co_pp_sp_506_1276"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sad93c832d14b11dfb5fdfcf739be147c&quot;, &quot;pageNumber&quot;: &quot;1276&quot; }" alt="metadata" type="hidden">*1276</span>  will be considered, to have been anticipated by the [prior art].” <a id="co_link_I84f0163922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1931129020&amp;pubNum=0000350&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_350_439&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_439"><em>In re Ackenbach,</em> 18 C.C.P.A. 769, 45 F.2d 437, 439 (1930)</a> (alterations added). As taught by the ′<a id="co_link_I84f0163a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a>, the only steps required to increase metaxalone's bioavailability are (1) ingesting metaxalone (2) with food. These steps are undeniably disclosed by the prior art. An increase in metaxalone's bioavailability is, therefore, an inherent aspect of the prior art. In other words, the increase in metaxalone's bioavailability is the “ ‘natural result’ flowing from the [prior art's] explicitly explicated limitations.” <a id="co_link_I84f0163b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2001454897&amp;pubNum=0000506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_506_970&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_970"><em>Eli Lilly &amp; Co. v. Barr Labs., Inc.,</em> 251 F.3d 955, 970 (Fed.Cir.2001)</a> (alterations added); <em>see also </em><a id="co_link_I84f0163c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999224124&amp;pubNum=0000506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_506_1366&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1366"><em>MEHL/Biophile Int'l Corp. v. Milgraum,</em> 192 F.3d 1362, 1366 (Fed.Cir.1999)</a> (“[T]o the extent the embodiment in the patent achieves [the limitation], so does the [prior art].”) (alterations added). Accordingly, claim 1's preamble is inherently anticipated.</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F72022669341" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF7">7</a><a id="co_anchor_B72022669341"></a> King's experts' opinions that “even a disclosure of taking metaxalone with food would not inherently disclose increasing the bioavailability of metaxalone,” do not undermine our analysis. To anticipate, the prior art need only meet the inherently disclosed limitation to the extent the patented method does. <em>See </em><a id="co_link_I84f0163d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2003545068&amp;pubNum=0000506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_506_1326&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1326"><em>Hewlett–Packard Co. v. Mustek Systems, Inc.,</em> 340 F.3d 1314, 1326 (Fed.Cir.2003)<input id="co_docMarker_9" type="hidden"></a> (“[A] prior art product that sometimes, but not always, embodies a claimed method nonetheless teaches that aspect of the invention.”). Because the ′<a id="co_link_I84f0163e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a> discloses no more than taking metaxalone with food, to the extent such a method increases the bioavailability of metaxalone, the identical prior art method does as well. As the district court aptly stated, “to inherently anticipate, the prior art need only give the same results as the patent, not better.” <a id="co_link_I84f0163f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;pubNum=0004637&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_4637_509&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_509"><em>King Pharms., Inc.,</em> 593 F.Supp.2d at 509</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">For the foregoing reasons, the district court's inherent anticipation analysis was proper. The preamble to claim 1 is inherently anticipated. To hold otherwise would remove from the public a method of treating muscle pain that has been performed for decades. <em>See </em><a id="co_link_I84f0164022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999205673&amp;pubNum=0000506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_506_1348&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1348"><em>Atlas Powder Co. v. Ireco, Inc.,</em> 190 F.3d 1342, 1348 (Fed.Cir.1999)</a> (“The public remains free to make, use, or sell prior art compositions or processes, regardless of whether or not they understand their complete makeup or the underlying scientific principles which allow them to operate. The doctrine of anticipation by inherency, among other doctrines, enforces that basic principle.”). Accordingly, the district court's finding that claim 1 is anticipated is affirmed.</div></div><div class="co_paragraph"><div class="co_paragraphText">Because we reject King's argument that claim 1's preamble is novel, we also affirm the district court's findings of invalidity as to claims 2, 3, 8–11, and 15–17. For these claims, King's sole argument on appeal was that their incorporation of claim 1's preamble (claims 2, 3, 7, and 8) or their recitation of a similar preamble (claims 9–11 and 15–17) made the claims novel. Like claim 1, these claims are anticipated because their sole source of novelty is inherently disclosed by the prior art.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I4a74754a22b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign2">b. Claims 4–6, 12–14, and 18–20.</div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F82022669341" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF8">8</a><a id="co_anchor_B82022669341"></a> Claims 4–6 depend from claim 1. The claims limit the time frame in which the patient must ingest the metaxalone in relation to consuming food. Claim 4 limits the time frame to “30 minutes prior to 2 hours after consumption of the food,” claim 5 limits it to “substantially at the same time,” and claim 6 limits it to “immediately after the consumption of food up to 1 hour after.” Fathie II, Albanese, and Abrams respectively disclose administering metaxalone “with food,” “with meals,” and “with food or milk.” J.A.3054, 3065, 3072.</div></div><div class="co_paragraph"><div class="co_paragraphText">On appeal, King argues that none of the claims' specific timeframe requirements is disclosed in Fathie II, Albanese, or  <span class="co_starPage" id="co_pp_sp_506_1277"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sad93c832d14b11dfb5fdfcf739be147c&quot;, &quot;pageNumber&quot;: &quot;1277&quot; }" alt="metadata" type="hidden">*1277</span> Abrams. Yet, according to King's own experts, “with food” could mean taking metaxalone “1 hour prior to up to about 2 hours after eating.” J.A.3221 (Decl. of Dr. Elia). Under this common-sense definition of “with food,” the prior art discloses a timeframe for ingesting metaxalone in relation to consuming food that falls within the timeframes claimed by claims 4–6. The district court's finding that claims 4–6 are anticipated is therefore affirmed. <em>See </em><a id="co_link_I84f0164122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1985154699&amp;pubNum=0000350&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_350_782&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_782"><em>Titanium Metals Corp. of America v. Banner,</em> 778 F.2d 775, 782 (Fed.Cir.1985)</a> (“[It is] an elementary principle of patent law that when, as by a recitation of ranges or otherwise, a claim covers several compositions, the claim is ‘anticipated’ if one of them is in the prior art.”); <a id="co_link_I84f0164222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2019781329&amp;pubNum=0000506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_506_1298&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1298"><em>Fresenius USA, Inc. v. Baxter Int'l, Inc.,</em> 582 F.3d 1288, 1298 (Fed.Cir.2009)</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">Claims 12–14 and 18–20 contain identical timeframe requirements. The district court invalidated these claims for the same reasons it invalidated claims 4–6. We therefore affirm the district court's invalidation of these claims for the same reasons we affirmed its invalidation of claims 4–6.<input id="co_docMarker_10" type="hidden"></div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I4a74754b22b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign2">c. Claim 21</div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F92022669341" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF9">9</a><a id="co_anchor_B92022669341"></a><a href="#co_anchor_F102022669341" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF10">10</a><a id="co_anchor_B102022669341"></a> Claim 21 depends from claim 1 and adds the limitation “informing the patient that administration of a therapeutically effective amount of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_23">metaxalone</a> in a pharmaceutical composition with food results in an increase in the maximal plasma concentration (Cmax) and extent of absorption (AUC(last)) of metaxalone compared to administration without food.” The district court invalidated claim 21 pursuant to <a id="co_link_I84f0164422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS101&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C. § 101</a>. In invalidating claim 21, the district court cited this court's opinion in <em>In re Bilski</em> and held that “the act of informing another person of the food effect of metaxalone does not transform metaxalone into a different state or thing.” <a id="co_link_I84f0164622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;pubNum=0004637&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_4637_513&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_513"><em>King Pharms., Inc.,</em> 593 F.Supp.2d at 513</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">On appeal, King contends it was legal error for the district court to focus solely on the “informing” limitation in invalidating the claim. Instead, according to King, the district court should have examined the claim as a whole to determine whether it recited patent eligible subject matter. King is correct.</div></div><div class="co_paragraph"><div class="co_paragraphText">The Supreme Court has stated that a <a id="co_link_I84f0164722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS101&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 101</a> patentability analysis is directed to the claim as a whole, not individual limitations. <em>See </em><a id="co_link_I84f0164822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1978139495&amp;pubNum=0000708&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Parker v. Flook,</em> 437 U.S. 584, 590, 98 S.Ct. 2522, 57 L.Ed.2d 451 (1978)</a> (“[A] process is not unpatentable simply because it contains a law of nature or a mathematical algorithm.” (alterations added)); <em>see also </em><a id="co_link_I84f0164922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017388082&amp;pubNum=0000506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_506_958&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_958"><em>In re Bilski,</em> 545 F.3d at 958</a> (“[T]he [Supreme] Court has made clear that it is inappropriate to determine the patent-eligibility of a claim as a whole based on whether selected limitations constitute patent-eligible subject matter.” (alterations added)). Contrary to the Supreme Court's instructions, the district court ignored the claim as a whole and improperly focused on one limitation, the “informing” limitation, in invalidating the claim under <a id="co_link_I84f0164a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS101&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 101</a>. Such an analysis is improper.</div></div><div class="co_paragraph"><div class="co_paragraphText">Reviewed as a whole, claim 21 teaches a method of treating patients with metaxalone, whereby the patient is administered <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_24">metaxalone</a> with food and informed that such treatment increases the bioavailability of the drug. Prior to the Supreme Court's decision in <em>Bilski,</em> this court held that such medical treatment methods were patentable processes under <a id="co_link_I84f0164d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS101&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 101</a> because they fell squarely within the machine-or-transformation test applied in <em>In re Bilski.</em> Specifically, we held that methods of treatment “are always transformative when a defined group of drugs is administered to the body to ameliorate the effects of an undesired condition,” because such methods transform the human body. <a id="co_link_I84f0164f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2019816892&amp;pubNum=0000506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_506_1346&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1346"><em>Prometheus <span class="co_starPage" id="co_pp_sp_506_1278"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sad93c832d14b11dfb5fdfcf739be147c&quot;, &quot;pageNumber&quot;: &quot;1278&quot; }" alt="metadata" type="hidden">*1278</span>  Labs., Inc. v. Mayo Collaborative Serv.,</em> 581 F.3d 1336, 1346 (Fed.Cir.2009)</a>, <em>cert. granted and vacated,</em> <a id="co_link_I84f0165022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2020224316&amp;pubNum=708&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">––– U.S. ––––, 130 S.Ct. 3543, 177 L.Ed.2d 1120 (2010)</a>. While the Supreme Court in <em>Bilski</em> made clear that our machine-or-transformation test is not the exclusive test for patentability, <a id="co_link_I84f0165222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2022394590&amp;pubNum=708&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_708_3226&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_708_3226"><em>Bilski,</em> 130 S.Ct. at 3226–27,</a> it also made clear that the test “is a useful and important clue, an investigative tool, for determining whether some claimed inventions are processes under <a id="co_link_I84f0165322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS101&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 101</a>,” <a id="co_link_I84f0165422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2022394590&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em> at 3227.</a> We therefore understand the Supreme Court to have rejected the exclusive nature of our test, but not necessarily the wisdom behind it.</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F112022669341" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF11">11</a><a id="co_anchor_B112022669341"></a> The present case, however, does not present the proper vehicle for determining whether claims covering medical treatment methods are eligible for patenting under <a id="co_link_I84f0165522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS101&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 101</a> because even if claim 21 recites patent eligible subject matter, that subject matter is anticipated for the reasons discussed below. As an appellate court, we are not limited to a district court's stated reasons for invalidating claims and can affirm a grant of summary judgment on any ground supported by the record and adequately raised below. <input id="co_docMarker_11" type="hidden"><em>See </em><a id="co_link_I84f0165622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998175912&amp;pubNum=0000506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_506_1371&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1371"><em>Glaxo, Inc. v. TorPharm, Inc.,</em> 153 F.3d 1366, 1371 (Fed.Cir.1998)</a>; <a id="co_link_I84f0165722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1957102193&amp;pubNum=0000708&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Jaffke v. Dunham,</em> 352 U.S. 280, 281, 77 S.Ct. 307, 1 L.Ed.2d 314 (1957)</a> (per curiam). In moving for summary judgment, Eon argued that claim 21, as well as the other claims the district court invalidated under <a id="co_link_I84f0165822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS101&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 101</a>, was invalid under <a id="co_link_I84f0165922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 102</a>, not <a id="co_link_I84f0165a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS101&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 101</a>. Accordingly, the novelty of claim 21 was an issue presented to the district court and an alternative ground upon which the district court's invalidation of the claim can be affirmed. <em>See </em><a id="co_link_I84f038f022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998102974&amp;pubNum=0000506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_506_1480&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1480"><em>Hester Indus., Inc. v. Stein, Inc.,</em> 142 F.3d 1472, 1480 (Fed.Cir.1998)</a> (affirming summary judgment of invalidity on ground advanced by defendant in summary judgment motion but not adopted by district court).</div></div><div class="co_paragraph"><div class="co_paragraphText">Because we have already determined that independent claim 1 is anticipated, dependent claim 21's sole potential source of novelty is the “informing” limitation. King argues that the district court committed legal error because it never found the “informing” limitation disclosed in the prior art, which it was required to do. <em>See </em><a id="co_link_I84f038f122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2008742849&amp;pubNum=0000506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_506_999&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_999"><em>Atofina v. Great Lakes Chem. Corp.,</em> 441 F.3d 991, 999 (Fed.Cir.2006)</a> (“Anticipation requires a showing that each limitation of a claim is found in a single reference, either expressly or inherently.”). Eon tacitly concedes that the district court never expressly found the “informing” limitation disclosed in the prior art, but contends such a finding was unnecessary because the nonpatentable “informing” limitation cannot breathe novelty into an otherwise anticipated method.</div></div><div class="co_paragraph"><div class="co_paragraphText">The specific question before us is whether an otherwise anticipated method claim becomes patentable because it includes a step of “informing” someone about the existence of an inherent property of that method. We hold it does not. The “informing” limitation adds no novelty to the method, which is otherwise anticipated by the prior art. In other words, in light of our holding that the method of taking metaxalone with food to increase the drug's bioavailability, as recited in claim 1, is not patentable, it readily follows that claim 21, which recites the same method with the sole additional step of informing the patient about this increase in bioavailability, is not patentable.</div></div><div class="co_paragraph"><div class="co_paragraphText">In an analogous context, we have held that “[w]here the printed matter is not functionally related to the substrate, the printed matter will not distinguish the invention from the prior art in terms of patentability.” <a id="co_link_I84f038f222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1983115564&amp;pubNum=0000350&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_350_1385&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1385"><em>In re Gulack,</em> 703 F.2d 1381, 1385 (Fed.Cir.1983)</a> (alterations added). In such cases, we have recognized that the printed matter is not independently <span class="co_starPage" id="co_pp_sp_506_1279"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sad93c832d14b11dfb5fdfcf739be147c&quot;, &quot;pageNumber&quot;: &quot;1279&quot; }" alt="metadata" type="hidden">*1279</span>  patentable, but have cautioned that the limitation must not be excised from the claim. <em>See </em><a id="co_link_I84f038f322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1983115564&amp;pubNum=0000350&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_350_1385&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1385"><em>id.</em> at 1385</a> (“[T]he board cannot dissect a claim, excise the printed matter from it, and declare the remaining portion of the mutilated claim to be unpatentable. The claim must be read as a whole.”) (alterations added). Instead, the relevant question is whether “there exists any new and unobvious functional relationship between the printed matter and the substrate.” <a id="co_link_I84f038f422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1983115564&amp;pubNum=0000350&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_350_1386&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1386"><em>Id.</em> at 1386</a> (citing <a id="co_link_I84f038f522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1970104055&amp;pubNum=350&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_350_1396&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1396"><em>In re Miller,</em> 57 C.C.P.A. 809, 418 F.2d 1392, 1396 (1969)</a>). The rationale behind this line of cases is preventing the indefinite patenting of known products by the simple inclusion of novel, yet functionally unrelated limitations. <em>See </em><a id="co_link_I84f038f622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004469000&amp;pubNum=0000506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_506_1339&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1339"><em>In re Ngai,</em> 367 F.3d at 1339</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">Although these “printed matter” cases involved the addition of printed matter, such as written instructions, to a known product, we see no principled reason for limiting their reasoning to that specific factual context. <input id="co_docMarker_12" type="hidden"><em>See </em><a id="co_link_I84f038f722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004469000&amp;pubNum=506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_506_1338&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1338"><em>In re Ngai,</em> 367 F.3d at 1338–39;</a> <a id="co_link_I84f038f822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1983115564&amp;pubNum=350&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_350_1385&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1385"><em>In re Gulack,</em> 703 F.2d at 1385–87.</a> Rather, we believe that the rationale underlying these cases extends to the situation presented in this case, wherein an instructional limitation is added to a method, as opposed to a product, known in the art. Thus, the relevant inquiry here is whether the additional instructional limitation of claim 21 has a “new and unobvious functional relationship” with the known method of administering metaxalone with food. <em>See </em><a id="co_link_I84f038f922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004469000&amp;pubNum=0000506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_506_1338&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1338"><em>In re Ngai,</em> 367 F.3d at 1338</a> (quoting <a id="co_link_I84f038fa22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1983115564&amp;pubNum=350&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_350_1386&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1386"><em>In re Gulack,</em> 703 F.2d at 1386).</a></div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F122022669341" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF12">12</a><a id="co_anchor_B122022669341"></a> King contends that there is a functional relationship between the “informing” limitation and the method. Specifically, at oral argument, King's counsel argued that the “informing” limitation increases the likelihood that the patient will take metaxalone with food, thereby increasing the efficiency of the method. <em>See</em> Oral Arg. at 7:30–8:26. This relationship, however, is not functional. Informing a patient about the benefits of a drug in no way transforms the process of taking the drug with food. Irrespective of whether the patient is informed about the benefits, the actual method, taking metaxalone with food, is the same. In other words, the “informing” limitation “in no way depends on the [method], and the [method] does not depend on the [‘informing’ limitation].” <a id="co_link_I84f038fb22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004469000&amp;pubNum=0000506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_506_1339&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1339"><em>In re Ngai,</em> 367 F.3d at 1339</a> (alterations added). “It is not invention to perceive that the product which others had discovered had qualities they failed to detect.” <a id="co_link_I84f038fc22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1945114606&amp;pubNum=0000708&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Gen. Elec. Co. v. Jewel Incandescent Lamp Co.,</em> 326 U.S. 242, 249, 66 S.Ct. 81, 90 L.Ed. 43 (1945)</a>. Accordingly, we affirm the district court's finding that claim 21 is invalid, but on the alternative ground that the claim is anticipated by the prior art.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I4a74754c22b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign2">d. Claim 22</div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F132022669341" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF13">13</a><a id="co_anchor_B132022669341"></a> Claim 22 is closely related to claim 21. Claim 22 depends from claim 1 and limits claim 1's method to situations “wherein the metaxalone is from a container with printed labeling advising that administration with food results in an increase in the maximal plasma concentration (Cmax) and extent of absorption (AUC(last)) of metaxalone compared to administration without food.” The district court, relying on this court's printed matter precedent as articulated in <em>In re Ngai,</em> found the claim anticipated by Fathie II, Albanese, and Abrams. <em>See </em><a id="co_link_I84f038fe22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;pubNum=0004637&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_4637_513&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_513"><em>King Pharms., Inc.,</em> 593 F.Supp.2d at 513</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">Because it depends from claim 1, the printed label limitation is claim 22's only potential source of novelty. However, as the district court correctly found, the printed label limitation falls squarely within our printed matter cases discussed above with respect to claim 21. While ostensibly a method claim, the potentially novel aspect of claim 22 concerns a printed  <span class="co_starPage" id="co_pp_sp_506_1280"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sad93c832d14b11dfb5fdfcf739be147c&quot;, &quot;pageNumber&quot;: &quot;1280&quot; }" alt="metadata" type="hidden">*1280</span> label on a product. Like claim 21's “informing” limitation, the printed label is not functionally related to either the product within the method claim or the method claim as a whole. Therefore, the district court was correct in finding the claim anticipated. <em>See </em><a id="co_link_I84f038ff22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004469000&amp;pubNum=0000506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_506_1339&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1339"><em>In re Ngai,</em> 367 F.3d at 1339</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">King attempts to avoid <em>In re Ngai</em> by limiting that case to product claims. According to King, because claim 22 is a method claim, <em>In re Ngai,</em> which addressed a product claim, is not applicable. During our discussion of claim 21, we rejected the notion that <em>In re Ngai's</em> holding should be limited solely to product claims. Accordingly, we reject King's argument and affirm the district court's finding that claim 22 is anticipated.</div></div><div class="co_paragraph"><div class="co_paragraphText">We also affirm the district court's invalidation of claims 7, 9, and 12–15 of the ′<input id="co_docMarker_13" type="hidden"><a id="co_link_I84f0390322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004090134&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ibfe574a051a111d89e91fb27c9eb3845&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">102 patent</a>, which are nearly identical to claim 22 of the ′<a id="co_link_I84f0390422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a>. The district court invalidated these claims for the same reasons it invalidated claim 22. On appeal, King argues claims 7, 9, and 12–15 of ′<a id="co_link_I84f0390522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004090134&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ibfe574a051a111d89e91fb27c9eb3845&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">102 patent</a> are novel for the same reasons claim 22 was allegedly novel, i.e., their incorporation of a printed label limitation. For the reasons discussed above, we reject this argument and affirm the district court's invalidation of claims 7, 9, and 12–15 of ′<a id="co_link_I84f0390622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004090134&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ibfe574a051a111d89e91fb27c9eb3845&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">102 patent</a>.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I4a74754d22b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign2">II. The ′<a id="co_link_I84f0390722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004090134&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ibfe574a051a111d89e91fb27c9eb3845&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">102 Patent</a></div><div class="co_headtext co_hAlign2">a. Claim 1</div><div class="co_paragraph"><div class="co_paragraphText">Claim 1 of the ′<a id="co_link_I84f0390822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004090134&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ibfe574a051a111d89e91fb27c9eb3845&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">102 patent</a> is an independent claim, which claims a “method of using <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_25">metaxalone</a> in the treatment of musculoskeletal conditions” comprising both “providing the patient with a therapeutically effective amount of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_26">metaxalone</a>” and “informing the patient that administration with food results in an increase in the maximal plasma concentration (Cmax) and extent of absorption (AUC(last)) of metaxalone compared to administration without food.” The district court held the claim was invalid under <a id="co_link_I84f0390b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS101&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 101</a> for the same reasons it invalidated claim 21 of the ′<a id="co_link_I84f0390c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a>. <em>See </em><a id="co_link_I84f0390d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;pubNum=4637&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_4637_514&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_514"><em>King Pharms., Inc.,</em> 593 F.Supp.2d at 514.</a> King contends the district court erred because it failed to consider the claim as a whole.</div></div><div class="co_paragraph"><div class="co_paragraphText">As we discussed with respect to claim 21 of the ′<a id="co_link_I84f0390e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a>, we agree with King that the district court's invalidation of claim 1 under <a id="co_link_I84f0390f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS101&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 101</a> is improper because it ignored the claim as a whole and focused on one limitation. Yet, also like claim 21, claim 1's sole source of novelty is the “informing” limitation. Because this limitation is not functionally related to the otherwise anticipated method, the claim is anticipated. Accordingly, we affirm the district court's finding that claim 1 is invalid, but on the alternative ground that the claim is anticipated by the prior art.</div></div><div class="co_paragraph"><div class="co_paragraphText">Because we reject King's argument that claim 1's “informing” limitation is novel, we also affirm the district court's finding of invalidity as to dependent claims 2 through 4 and independent claim 8 and its dependent claims 10 and 11. For these claims, King argued on appeal that their incorporation of the “informing” limitation (claims 2–4) or their recitation of a similar limitation (claims 8, 10, and 11) made the claims novel. For the reasons discussed above, we reject King's argument and find the claims anticipated by the prior art.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I4a74754e22b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign2">b. Claim 5</div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F142022669341" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF14">14</a><a id="co_anchor_B142022669341"></a> Claim 5 depends from claim 1 and limits the metaxalone to a “unit dosage form.” Like claim 8 of the ′<a id="co_link_I84f0391022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a>, the district court found claim 5 obvious over Albanese in light of Dent. <em>See </em><a id="co_link_I84f0391122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;pubNum=0004637&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_4637_514&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_514"><em>King Pharms., Inc.,</em> 593 F.Supp.2d at 514</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">In addition to arguing that the “informing” limit provides the claim with novelty, King argues that the district court improperly disregarded King's evidence of secondary <span class="co_starPage" id="co_pp_sp_506_1281"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sad93c832d14b11dfb5fdfcf739be147c&quot;, &quot;pageNumber&quot;: &quot;1281&quot; }" alt="metadata" type="hidden">*1281</span>  indicia of non-obviousness. King's secondary-considerations evidence consisted primarily of an expert report concerning sales of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I37b9d419475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I37b9d419475111db9765f9243f53508a_3">Skelaxin</a> from 1998 to 2003. As the district court found, however, a significant portion of the increase in <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I37b9d419475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I37b9d419475111db9765f9243f53508a_4">Skelaxin</a> sales occurred prior to the determination that ingesting metaxalone with food increases the drug's bioavailability and well before the patents issued. Moreover, King has not shown any nexus between the drug's alleged commercial success and the specific invention claimed in claim 5. <a id="co_link_I84f0391422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2000571512&amp;pubNum=0000506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_506_1130&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1130"><em>Brown &amp; Williamson Tobacco Corp. v. Philip Morris Inc.,</em> 229 F.3d 1120, 1130 (Fed.Cir.2000)</a> (“A nexus between commercial success and the claimed features is required.”). With respect to claim 5, the claimed invention is the administration of <input id="co_docMarker_14" type="hidden"><a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_27">metaxalone</a> in a tablet that constitutes a “unit dosage form.” King has not shown any connection between administering <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3ba629c5475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3ba629c5475111db9765f9243f53508a_28">metaxalone</a> in a “unit dosage form” and the alleged commercial success.</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F152022669341" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF15">15</a><a id="co_anchor_B152022669341"></a> Turning to the district court's obviousness analysis, the district court held that a prior art reference, Dent, disclosed taking metaxalone in a single 400 mg tablet four times a day. <a id="co_link_I84f0391722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017911057&amp;pubNum=4637&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_4637_511&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_511"><em>King Pharms., Inc.,</em> 593 F.Supp.2d at 511.</a> Dent does make such a disclosure. It would be obvious to a person of ordinary skill in the art to combine Dent's teaching of taking a tablet dosage of metaxalone four times a day with Albanese's teaching of administering metaxalone with food. <em>See </em><a id="co_link_I84f0391822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012126122&amp;pubNum=0000708&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>KSR Int'l Co. v. Teleflex Inc.,</em> 550 U.S. 398, 421, 127 S.Ct. 1727, 167 L.Ed.2d 705 (2007)</a> (“A person of ordinary skill is also a person of ordinary creativity, not an automaton.”). Accordingly, the district court's determination that claim 5 is obvious is affirmed.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I4a74754f22b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign2">III. Jurisdiction Over Elan</div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F162022669341" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF16">16</a><a id="co_anchor_B162022669341"></a> In January 2003, after Eon filed an ANDA with the Food and Drug Administration (“FDA”) for a generic 400 mg metaxalone tablet, it was sued by Elan for infringement of the ′<a id="co_link_I84f0391922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a>, the <em>400 mg Action</em>. While that suit was pending, Elan entered into a sale agreement with King in which Elan transferred to King all of Elan's rights to <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I37b9d419475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I37b9d419475111db9765f9243f53508a_5">Skelaxin</a>, including the ′<a id="co_link_I84f0391b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a> and the application that would yield the ′<a id="co_link_I84f0391c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004090134&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ibfe574a051a111d89e91fb27c9eb3845&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">102 patent</a>. The sale occurred on June 12, 2003, and a month later Elan recorded a patent assignment agreement with the Patent and Trademark Office assigning both the ′<a id="co_link_I84f0391d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a> and the application that would lead to the ′<a id="co_link_I84f0391e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004090134&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ibfe574a051a111d89e91fb27c9eb3845&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">102 patent</a> to King.</div></div><div class="co_paragraph"><div class="co_paragraphText">Following the sale, Elan attempted to extricate itself from the 400 mg Action by moving to (1) substitute King as a plaintiff and (2) dismiss itself from the suit. In addition to its motion, Elan represented to the district court in several letters that it no longer possessed any rights in the ′128 and ′<a id="co_link_I84f0391f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004090134&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ibfe574a051a111d89e91fb27c9eb3845&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">102 patents</a> and that it was willing to enter into a stipulation to that effect. While Elan's motion to substitute King as the plaintiff in the 400 mg Action was pending, King filed suit against Eon when Eon filed an ANDA with the FDA for a generic 800 mg metaxalone tablet, the 800 mg Action. In this second action, Eon filed several declaratory counterclaims against Elan, including a counterclaim of invalidity. The district court initially consolidated the 400 and 800 mg Actions, but eventually dismissed the 400 mg Action when Eon withdrew its 400 mg metaxalone ANDA. However, despite the dismissal of the 400 mg Action, the district court denied Elan's motion to substitute King as a plaintiff and dismiss Elan from the consolidated litigation. Instead, the district court dismissed various anticompetitive counterclaims Eon had asserted against Elan, but maintained Eon's various invalidity counterclaims against Elan.</div></div><div class="co_paragraph"><div class="co_paragraphText">Despite not being formally removed from the litigation, Elan did not participate  <span class="co_starPage" id="co_pp_sp_506_1282"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sad93c832d14b11dfb5fdfcf739be147c&quot;, &quot;pageNumber&quot;: &quot;1282&quot; }" alt="metadata" type="hidden">*1282</span> in the merits proceedings of the litigation. Indeed, Elan did not submit briefing in conjunction with Eon's motion for summary judgment of invalidity, and Eon stated in a letter to the district court that its motion was “directed at King, not Elan.” J.A.9700. Nonetheless, when issuing its final order declaring the ′128 and ′<a id="co_link_I84f0392022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004090134&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ibfe574a051a111d89e91fb27c9eb3845&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">102 patents</a> invalid, the district court entered the order against both King and Elan.</div></div><div class="co_paragraph"><div class="co_paragraphText">On appeal, Elan argues that the district court lacked jurisdiction to enter an invalidity order against it. According to Elan, it sold all its rights to the ′128 and ′<input id="co_docMarker_15" type="hidden"><a id="co_link_I84f0392122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004090134&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ibfe574a051a111d89e91fb27c9eb3845&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">102 patents</a> prior to King filing suit, and therefore the district court lacked jurisdiction to adjudicate the counterclaim.</div></div><div class="co_paragraph"><div class="co_paragraphText">In granting summary judgment of invalidity, the district court did not address whether it had jurisdiction over Elan. This court, however, must address the issue. <em>See </em><a id="co_link_I84f0392222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1969133009&amp;pubNum=0000708&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Jenkins v. McKeithen,</em> 395 U.S. 411, 421, 89 S.Ct. 1843, 23 L.Ed.2d 404 (1969)</a> (“[S]ince the question of standing goes to this Court's jurisdiction, we must decide the issue even though the court below passed over it without comment.” (citation omitted)).</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F172022669341" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF17">17</a><a id="co_anchor_B172022669341"></a><a href="#co_anchor_F182022669341" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF18">18</a><a id="co_anchor_B182022669341"></a> Whether an actual case or controversy exists is reviewed de novo. <em>See </em><a id="co_link_I84f0392322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2016901484&amp;pubNum=0000506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_506_1359&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1359"><em>Janssen Pharmaceutica, N.V. v. Apotex, Inc.,</em> 540 F.3d 1353, 1359 (Fed.Cir.2008)</a>. A case or controversy exists when “the facts alleged, under all the circumstances, show that there is a substantial controversy, between parties having adverse legal interests, of sufficient immediacy and reality to warrant the issuance of a declaratory judgment.” <a id="co_link_I84f0392422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2011142967&amp;pubNum=0000708&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>MedImmune, Inc. v. Genentech, Inc.,</em> 549 U.S. 118, 127, 127 S.Ct. 764, 166 L.Ed.2d 604 (2007)</a> (quoting <a id="co_link_I84f0392522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1941124592&amp;pubNum=0000708&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Maryland Casualty Co. v. Pacific Coal &amp; Oil Co.,</em> 312 U.S. 270, 273, 61 S.Ct. 510, 85 L.Ed. 826 (1941)</a>). Eon has the burden of demonstrating an actual case or controversy. <em>See </em><a id="co_link_I84f0392622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012748317&amp;pubNum=0000506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_506_1344&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1344"><em>Benitec Australia, Ltd. v. Nucleonics, Inc.,</em> 495 F.3d 1340, 1344 (Fed.Cir.2007)</a> (“The burden is on the party claiming declaratory judgment jurisdiction to establish that such jurisdiction existed at the time the claim for declaratory relief was filed and that it has continued since.”).</div></div><div class="co_paragraph"><div class="co_paragraphText">Eon has not met its burden of demonstrating the existence of an actual case or controversy between it and Elan. The acquisition documents between Elan and King demonstrate quite clearly that Elan sold all its interests in the asserted patents to King. For example, the Asset Purchase Agreement transferred “all <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I37b9d419475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I37b9d419475111db9765f9243f53508a_6">Skelaxin</a> Patent Rights” from Elan to King. Elan also produced the Patent Assignment agreement which unambiguously assigns “an undivided right, title, and interest in and to the Patent Rights” to King. J.A.9653–54. The “Patent Rights” include both the ′<a id="co_link_I84f0392822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a> and the application (<a id="co_link_I84f0392922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2003861527&amp;pubNum=0006769&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ic97c66601c8911d88eb8c1cb27893554&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">U.S. Patent Application No. 10/104,044</a>) that issued as the ′<a id="co_link_I84f0392a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004090134&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ibfe574a051a111d89e91fb27c9eb3845&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">102 patent</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">Moreover, in a letter to the district court, Elan stated it “will waive any rights it may have, if any, separate and apart from any rights it has transferred to the new patent owners, to pursue any damages or relief from Eon ... based on Elan's past ownership of the ′<a id="co_link_I84f0392b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patent</a>.” J.A.7408. Once the ′<a id="co_link_I84f0392c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004090134&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ibfe574a051a111d89e91fb27c9eb3845&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">102 patent</a> issued, Elan wrote Eon's counsel and made a similar proposal concerning that patent. Elan reiterated its proposals in several pleadings before the district court and made a similar representation during oral argument, which Eon's counsel found sufficient. <em>See</em> Oral Arg. at 24:32–25:30 (representation), 25:43–25:48 (acceptance by Eon's counsel).</div></div><div class="co_paragraph"><div class="co_paragraphText">Elan's broad and unrestricted covenants not to sue Eon for infringement of the ′102 or ′<a id="co_link_I84f0392d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">128 patents</a>, remove any case or controversy that may have existed between the parties at one point. <em>See </em><a id="co_link_I84f0392e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2008683916&amp;pubNum=0000506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_506_943&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_943"><em>Microchip Technology Inc. v. Chamberlain Group, Inc.,</em> 441 F.3d 936, 943 (Fed.Cir.2006)</a> (vacating district court's summary judgment  <span class="co_starPage" id="co_pp_sp_506_1283"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sad93c832d14b11dfb5fdfcf739be147c&quot;, &quot;pageNumber&quot;: &quot;1283&quot; }" alt="metadata" type="hidden">*1283</span> of invalidity because the declaratory judgment plaintiff could “not identif[y] a single legal claim that it believes [the defendant] could have brought against it in the absence of [the] declaratory judgment action”); <a id="co_link_I84f0392f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012748317&amp;pubNum=0000506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_506_1347&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1347"><em>Benitec Australia, Ltd.,</em> 495 F.3d at 1347–48</a> (finding no case or controversy where patentee withdrew its infringement claims and covenanted not to sue the defendant for future acts). Had Elan retained the right to sue Eon in some instances, then an actual case or controversy may exist. <input id="co_docMarker_16" type="hidden"><em>See </em><a id="co_link_I84f0393022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018138951&amp;pubNum=0000506&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=RP&amp;fi=co_pp_sp_506_1298&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1298"><em>Revolution Eyewear, Inc. v. Aspex Eyewear, Inc.,</em> 556 F.3d 1294, 1298 (Fed.Cir.2009)</a> (holding that covenant not to sue did not divest district court of declaratory judgment jurisdiction because the covenant did not cover future products). Elan, however, did not retain any such rights, and its covenants not to sue confirm that there is no case or controversy between it and Eon. Accordingly, we vacate the district court's order of invalidity as entered against Elan.</div></div><div class="co_paragraph"><div class="co_paragraphText">In summary, while the district court erred in invalidating several of the claims as unpatentable under <a id="co_link_I84f0393122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS101&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 101</a>, all the claims of the ′128 and ′<a id="co_link_I84f0393222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004090134&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ibfe574a051a111d89e91fb27c9eb3845&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">102 patents</a> are ultimately anticipated under <a id="co_link_I84f0393322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C. § 102</a> or obvious under <a id="co_link_I84f0393422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS103&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C. § 103</a> in light of the prior art. Additionally, the district court erred in entering a judgment of invalidity against Elan because no case or controversy currently exists between Elan and Eon.<sup id="co_footnoteReference_B00332022669341_ID0ET3DI"><a href="#co_footnote_B00332022669341" class="co_footnoteReference">3</a></sup></div></div><div class="co_paragraph"><div class="co_paragraphText"><strong>AFFIRMED and VACATED–IN–PART</strong></div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I4a74755022b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">Costs</span></div><div class="co_paragraph"><div class="co_paragraphText">No costs.</div></div></div></div></div></div></div><div class="co_parallelCites"><h2 id="co_allCitations" class="co_parallelCitesBlockLabel co_printHeading">All Citations</h2>616 F.3d 1267, 95 U.S.P.Q.2d 1833</div><div id="co_footnoteSection" class="co_footnoteSection co_briefItState"><h2 class="co_footnoteSectionTitle co_printHeading">Footnotes</h2><div><div class="co_footnoteNumber"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sad93c832d14b11dfb5fdfcf739be147c&quot;, &quot;pageNumber&quot;: &quot;1273&quot; }" alt="metadata" type="hidden"><span id="co_footnote_B00112022669341"><a href="#co_footnoteReference_B00112022669341_ID0EKTAI">1</a></span></div><div class="co_footnoteBody"><div class="co_paragraph"><div class="co_paragraphText">King does not appeal this finding of invalidity of claim 6.</div></div></div></div><div><div class="co_footnoteNumber"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sad93c832d14b11dfb5fdfcf739be147c&quot;, &quot;pageNumber&quot;: &quot;1275&quot; }" alt="metadata" type="hidden"><span id="co_footnote_B00222022669341"><a href="#co_footnoteReference_B00222022669341_ID0EBIBI">2</a></span></div><div class="co_footnoteBody"><div class="co_paragraph"><div class="co_paragraphText">Participants in the study were given fifteen minutes to eat the following before administration of the metaxalone: two eggs (fried in butter), two strips of bacon, two slices of toast with butter, four ounces of hash brown potatoes, and one glass whole milk (eight ounces). <em>See</em> ′ <a id="co_link_I84f0162622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002376456&amp;pubNum=0004074&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=PA&amp;docFamilyGuid=Ifd8b8760725711d7ab54daa4035d65fa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"> 128 patent</a> col.3 ll.14–25.</div></div></div></div><div><div class="co_footnoteNumber"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sad93c832d14b11dfb5fdfcf739be147c&quot;, &quot;pageNumber&quot;: &quot;1283&quot; }" alt="metadata" type="hidden"><span id="co_footnote_B00332022669341"><a href="#co_footnoteReference_B00332022669341_ID0ET3DI">3</a></span></div><div class="co_footnoteBody"><div class="co_paragraph"><div class="co_paragraphText">We take no position as to whether the district court possesses jurisdiction to hear any claim by Eon against Elan for attorneys fees under <a id="co_link_I84f0393522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS285&amp;originatingDoc=I5549a5e09f0f11df896a9debfa48a185&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C. § 285</a>.</div></div></div></div></div><table id="co_endOfDocument"><tbody><tr><td>End of Document</td><td class="co_endOfDocCopyright">© 2018 Thomson Reuters. No claim to original U.S. Government Works.</td></tr></tbody></table></div><input class="co_chunkNumber" value="0" type="hidden"><input id="co_finalChunkMarker" type="hidden"></div><input id="co_document_metaInfo_I5549a5e09f0f11df896a9debfa48a185" value="{&quot;FirstLineCite&quot;:null,&quot;PU&quot;:null,&quot;accessControl&quot;:null,&quot;accessionNumber&quot;:&quot;&quot;,&quot;acquirerCompany&quot;:null,&quot;activeDate&quot;:null,&quot;additionalLinks&quot;:null,&quot;agreementDisplayDate&quot;:null,&quot;announcementDate&quot;:null,&quot;articleTitle&quot;:null,&quot;borrower&quot;:null,&quot;caseRequired&quot;:null,&quot;ciCompany&quot;:null,&quot;cicOfficer&quot;:null,&quot;cipOfficer&quot;:null,&quot;cite&quot;:&quot;616 F.3d 1267&quot;,&quot;citeAbbreviation&quot;:null,&quot;citePrimary&quot;:null,&quot;city&quot;:null,&quot;collection&quot;:&quot;w_cs_fed1&quot;,&quot;compoundTitle&quot;:null,&quot;containerId&quot;:null,&quot;containerType&quot;:null,&quot;contentType&quot;:&quot;Cases&quot;,&quot;contentTypeId&quot;:&quot;1&quot;,&quot;correlationIds&quot;:null,&quot;country&quot;:null,&quot;countryDocumentCountry&quot;:null,&quot;countryDocumentGuid&quot;:null,&quot;court&quot;:&quot;C.A.Fed. (N.Y.)&quot;,&quot;courtDocumentType&quot;:null,&quot;courtNumber&quot;:&quot;4242&quot;,&quot;courtYear&quot;:&quot;C.A.Fed. (N.Y.),2010.&quot;,&quot;date&quot;:&quot;August 02, 2010&quot;,&quot;dateFile&quot;:&quot;August 02, 2010&quot;,&quot;dealDate&quot;:null,&quot;dealTrackPublishDate&quot;:null,&quot;dealType&quot;:null,&quot;dealValue&quot;:null,&quot;description&quot;:null,&quot;docFamilyGuid&quot;:&quot;I5549a5e19f0f11df896a9debfa48a185&quot;,&quot;docGuid&quot;:&quot;I5549a5e09f0f11df896a9debfa48a185&quot;,&quot;docLink&quot;:&quot;https://1.next.westlaw.com/Document/I5549a5e09f0f11df896a9debfa48a185/View/FullText.html?originationContext=document&amp;contextData=(sc.CustomDigest)&amp;needToInjectTerms=False&quot;,&quot;documentTitle&quot;:null,&quot;edgarFileNumber&quot;:null,&quot;entityId&quot;:null,&quot;expertType&quot;:null,&quot;fileName&quot;:null,&quot;fileNumber&quot;:&quot;&quot;,&quot;fileSize&quot;:0,&quot;fileType&quot;:null,&quot;filerCik&quot;:null,&quot;filerName&quot;:null,&quot;filingDate&quot;:null,&quot;filingYear&quot;:null,&quot;firmName&quot;:null,&quot;formNumber&quot;:null,&quot;formSubType&quot;:null,&quot;formType&quot;:null,&quot;formTypeDisplay&quot;:null,&quot;formVolume&quot;:null,&quot;functionalCite&quot;:&quot;616 F.3d 1267&quot;,&quot;fundFirmCompoundTitle&quot;:null,&quot;fundLocation&quot;:null,&quot;fundName&quot;:null,&quot;fundTargetSize&quot;:null,&quot;fundType&quot;:null,&quot;fundYear&quot;:null,&quot;fundraisingStatus&quot;:null,&quot;getTocData&quot;:false,&quot;hasDraftingNotes&quot;:null,&quot;hasVideoContent&quot;:null,&quot;impersonationKey&quot;:null,&quot;inlineKeyCiteFlagsIncluded&quot;:false,&quot;inlineKeyCiteFlagsResolutionStatus&quot;:null,&quot;insiderName&quot;:null,&quot;ip_assignmentsAction&quot;:null,&quot;ip_citeParallel&quot;:null,&quot;ip_derwentPublishedDate&quot;:null,&quot;ip_docket&quot;:null,&quot;ip_documentDate&quot;:&quot;August 02, 2010&quot;,&quot;ip_issuedDate&quot;:null,&quot;ip_litAlertAttorney&quot;:null,&quot;ip_patStatCode&quot;:null,&quot;ip_patentOwner&quot;:null,&quot;ip_publishedDate&quot;:null,&quot;ip_shortTitle&quot;:null,&quot;isDisplayMiniReport&quot;:false,&quot;isGatewayDocument&quot;:false,&quot;isLargeDocument&quot;:false,&quot;isPersistedContent&quot;:false,&quot;isPublicRecordsBlockedByPermissibleUse&quot;:false,&quot;isPublicRecordsBlockedBySocialSecurityAdmin&quot;:false,&quot;isPublicRecordsDocument&quot;:false,&quot;isRefsAndAnnos&quot;:false,&quot;isRegChangeDocument&quot;:false,&quot;isSearchable&quot;:null,&quot;isSecureContent&quot;:false,&quot;issueDate&quot;:null,&quot;issuerName&quot;:null,&quot;jobDescription&quot;:null,&quot;judge&quot;:&quot;GAJARSA, Circuit Judge.&quot;,&quot;jurisAbbrev&quot;:null,&quot;jurisdiction&quot;:&quot;NY&quot;,&quot;jurisdictionFacet&quot;:&quot;Federal|**|Cts. of Appeals|**|Federal Cir.&quot;,&quot;jurisdictionText&quot;:&quot;New York&quot;,&quot;knos&quot;:null,&quot;lastRoundExitComb&quot;:null,&quot;legacyId&quot;:&quot;2022669341&quot;,&quot;letterType&quot;:null,&quot;locationOfIncorporation&quot;:null,&quot;maxOfferingPrice&quot;:null,&quot;natureOfTransaction&quot;:null,&quot;newsImageHrefLarge&quot;:null,&quot;newsImageHrefSmall&quot;:null,&quot;normalizedDocType&quot;:null,&quot;normalizedFormType&quot;:null,&quot;offeringType&quot;:null,&quot;organizationName&quot;:null,&quot;originatingDoc&quot;:null,&quot;pageCount&quot;:null,&quot;persistedDocGuid&quot;:null,&quot;plcFirmStyleAvailable&quot;:false,&quot;plcResourceName&quot;:&quot;&quot;,&quot;portfolioCompanyLocation&quot;:null,&quot;portfolioCompanyName&quot;:null,&quot;prMetaInfo1&quot;:null,&quot;prMetaInfo2&quot;:null,&quot;prMetaInfo3&quot;:null,&quot;prMetaInfo4&quot;:null,&quot;prMetaInfo5&quot;:null,&quot;primaryEditorialService&quot;:null,&quot;profileType&quot;:null,&quot;pubSeries&quot;:null,&quot;publishDate&quot;:null,&quot;questionText&quot;:null,&quot;redlined&quot;:false,&quot;registrationDate&quot;:null,&quot;renditionId&quot;:&quot;I256301F01DD211B2A83CC60072092446&quot;,&quot;royaltyId&quot;:&quot;0&quot;,&quot;rulebookNViews&quot;:null,&quot;serialNumber&quot;:&quot;2022669341&quot;,&quot;status&quot;:null,&quot;subContentType&quot;:&quot;Caselaw - NRS&quot;,&quot;subContentTypeId&quot;:&quot;27&quot;,&quot;subTitle&quot;:null,&quot;targetCompany&quot;:null,&quot;testimonyType&quot;:null,&quot;titleHtml&quot;:&quot;King Pharmaceuticals, Inc. v. Eon Labs, Inc.&quot;,&quot;titleText&quot;:&quot;King Pharmaceuticals, Inc. v. Eon Labs, Inc.&quot;,&quot;totalAmountIssuedWithCurrency&quot;:null,&quot;totalPages&quot;:&quot;&quot;,&quot;trademarkStatus&quot;:null,&quot;transactionAmountWithCurrency&quot;:null,&quot;transactionValue&quot;:null,&quot;valuationComb&quot;:null,&quot;viewExpressions&quot;:&quot;EZ5|E3I|P3D|000&quot;,&quot;westlawDatabaseIdentifier&quot;:&quot;AWFED2&quot;,&quot;westlawDocumentNumber&quot;:&quot;1485249&quot;}" type="hidden"><input id="co_document_documentNavigation_Search_Search-v1-results-navigation-i0ad62aef0000016306ea58342bf062c8-Nav-CUSTOMDIGEST-fragmentIdentifier-I5549a5e09f0f11df896a9debfa48a185-startIndex-1-contextData--28sc.CustomDigest-29-transitionType-CustomDigestItem_CUSTOMDIGEST_142" value="{&quot;AnswerSnippetId&quot;:null,&quot;CurrentDocumentGuid&quot;:&quot;I5549a5e09f0f11df896a9debfa48a185&quot;,&quot;CurrentPosition&quot;:142,&quot;CurrentWatsonAnswerText&quot;:null,&quot;EnableConceptCounts&quot;:false,&quot;HighlightPoints&quot;:null,&quot;HighlightTerms&quot;:null,&quot;InPlanUrl&quot;:null,&quot;IsSnapSnippet&quot;:false,&quot;ListCount&quot;:718,&quot;Message&quot;:null,&quot;NextDocument&quot;:{&quot;SkipLinkOutDoc&quot;:false,&quot;Title&quot;:&quot;Prometheus Laboratories, Inc. v. Mayo Collaborative Services&quot;,&quot;Url&quot;:&quot;/Document/I7b101bb3a2e411deabdfd03f2b83b8a4/View/FullText.html?navigationPath=Search%2Fv1%2Fresults%2Fnavigation%2Fi0ad62aef0000016306ea58342bf062c8%3FNav%3DCUSTOMDIGEST%26fragmentIdentifier%3DI7b101bb3a2e411deabdfd03f2b83b8a4%26startIndex%3D1%26contextData%3D%2528sc.CustomDigest%2529%26transitionType%3DCustomDigestItem&amp;listSource=Search&amp;list=CUSTOMDIGEST&amp;rank=143&amp;grading=na&amp;sessionScopeId=8ddfa247da5ec522372afb44cc5a905f27604688c70f518919c93bafe2056482&amp;originationContext=Custom%20Digest&amp;transitionType=CustomDigestItem&amp;contextData=%28sc.CustomDigest%29&amp;listPageSource=b1be020b4aba9e28af6c04f62c735c28#co_anchor_F92019816892&quot;},&quot;NovusQueryType&quot;:null,&quot;NovusSearchResult&quot;:null,&quot;NumberOfSnips&quot;:0,&quot;ParagraphId&quot;:null,&quot;PreviousDocument&quot;:{&quot;SkipLinkOutDoc&quot;:false,&quot;Title&quot;:&quot;Prometheus Laboratories, Inc. v. Mayo Collaborative Services&quot;,&quot;Url&quot;:&quot;/Document/I715675b20ddd11e0852cd4369a8093f1/View/FullText.html?navigationPath=Search%2Fv1%2Fresults%2Fnavigation%2Fi0ad62aef0000016306ea58342bf062c8%3FNav%3DCUSTOMDIGEST%26fragmentIdentifier%3DI715675b20ddd11e0852cd4369a8093f1%26startIndex%3D1%26contextData%3D%2528sc.CustomDigest%2529%26transitionType%3DCustomDigestItem&amp;listSource=Search&amp;list=CUSTOMDIGEST&amp;rank=141&amp;grading=na&amp;sessionScopeId=8ddfa247da5ec522372afb44cc5a905f27604688c70f518919c93bafe2056482&amp;originationContext=Custom%20Digest&amp;transitionType=CustomDigestItem&amp;contextData=%28sc.CustomDigest%29&amp;listPageSource=b1be020b4aba9e28af6c04f62c735c28#co_anchor_F72024172308&quot;},&quot;ReturnTo&quot;:{&quot;SkipLinkOutDoc&quot;:false,&quot;Title&quot;:&quot;list&quot;,&quot;Url&quot;:&quot;/Search/Results.html?jurisdiction=CTAF&amp;contentType=CUSTOMDIGEST&amp;querySubmissionGuid=i0ad62aef0000016306ea58342bf062c8&amp;tocGuid=I4aee2539c6f64c1812a4c2f3395c2607&amp;categoryPageUrl=Home%2FWestKeyNumberSystem&amp;searchId=i0ad62aef0000016306ea4650fbf37b75&amp;collectionSet=w_cs_cd_toc&amp;transitionType=ReturnToList&amp;contextData=%28sc.CustomDigest%29#I5549a5e09f0f11df896a9debfa48a185&quot;},&quot;SearchQuery&quot;:null,&quot;SearchQueryType&quot;:null,&quot;SearchWithinQuery&quot;:null,&quot;SecondaryHighlightTerms&quot;:null,&quot;ShowSkipOutOfPlanOption&quot;:false}" type="hidden"><div id="co_nrsOutline" class="co_hideState"></div><input id="co_documentContentCacheKey" value="WestlawNext|none|I5549a5e09f0f11df896a9debfa48a185|||||||Search|Search/v1/results/navigation/i0ad62aef0000016306ea58342bf062c8?Nav=CUSTOMDIGEST&amp;fragmentIdentifier=I5549a5e09f0f11df896a9debfa48a185&amp;startIndex=1&amp;contextData=%28sc.CustomDigest%29&amp;transitionType=CustomDigestItem|CUSTOMDIGEST|142|False|True|{&quot;HighlightPoints&quot;:null,&quot;HighlightTerms&quot;:null,&quot;SearchWithinQuery&quot;:null,&quot;SecondaryHighlightTerms&quot;:null}|False|||False|False|||True|S|False|Core|||001|False|False|False|False|False|" type="hidden"><input id="co_documentFlagInfo" value="{&quot;docGuid&quot;:&quot;I5549a5e09f0f11df896a9debfa48a185&quot;,&quot;flags&quot;:[{&quot;categoryId&quot;:&quot;kcJudicialHistory&quot;,&quot;id&quot;:&quot;negative.indirect.history.mild&quot;,&quot;link&quot;:&quot;https://1.next.westlaw.com/Link/RelatedInformation/Flag?docGuid=I5549a5e09f0f11df896a9debfa48a185&amp;originationContext=docHeaderFlag&amp;transitionType=Document&amp;contextData=%28sc.CustomDigest%29&quot;,&quot;metadata&quot;:{&quot;citation&quot;:&quot;2017-2 Trade Cases  P 80,186&quot;,&quot;court&quot;:&quot;Fed.Cir.(Tex.)&quot;,&quot;docFamilyGuid&quot;:&quot;I5d4f3d20c43e11e789b88f29e3360977&quot;,&quot;docGuid&quot;:&quot;I5b9cab20c43e11e79c8f8bb0457c507d&quot;,&quot;liveDate&quot;:&quot;November 7, 2017&quot;,&quot;title&quot;:&quot;Industrial Models, Inc. v. SNF, Inc.&quot;,&quot;titleLink&quot;:&quot;https://1.next.westlaw.com/Document/I5b9cab20c43e11e79c8f8bb0457c507d/View/FullText.html?navigationPath=RelatedInfo%2Fv4%2Fkeycite%2Fnav%2F%3Fguid%3DI5b9cab20c43e11e79c8f8bb0457c507d%26ss%3D2022669341%26ds%3D2043119539&amp;listSource=RelatedInfo&amp;list=NegativeCitingReferences&amp;rank=0&amp;originationContext=docHeader&amp;transitionType=NegativeTreatment&amp;contextData=%28sc.CustomDigest%29&quot;,&quot;treatmentPhrase&quot;:&quot;Distinguished by&quot;},&quot;type&quot;:&quot;negative.indirect.history&quot;,&quot;value&quot;:&quot;mild&quot;}],&quot;metas&quot;:[{&quot;contentType&quot;:&quot;CASELAW&quot;,&quot;docCollection&quot;:&quot;w_cs_fed1&quot;,&quot;docFamilyGuid&quot;:&quot;I5549a5e19f0f11df896a9debfa48a185&quot;,&quot;legacyId&quot;:&quot;2022669341&quot;,&quot;sourcePubId&quot;:&quot;506&quot;}]}" type="hidden">




							</div>

				</div>
			</div>
		</div>
	</div>
	<!-- LEFT COLUMN -->  
	<div id="co_leftColumn">
		<div class="co_innertube">
			<div id="coid_website_folderingWidgetDiv"></div>
		</div>
	</div>
			<!-- RIGHT COLUMN -->
			<div id="co_rightColumn" class="co_addFocusCorrection">
				<div class="co_innertube">		
					<div id="coid_website_relatedInfoIPWidgetDiv" style="display: none;" aria-expanded="false">
					</div>




<div id="coid_website_documentToolWidgetDiv"></div>
		<div id="coid_website_relatedInfoWidgetDiv"> </div>
		<div id="coid_website_recommendedDocuments" class="co_recommendedDocumentContainer">
		</div>

<div id="downloadUserDocument"></div>
					<div id="downloadUserDocument"></div>
				</div>
			</div>

 <input class="hideTopTopics" id="hideTopTopics" name="hideTopTopics" type="hidden">
		<div class="co_clear"></div>
	</div>


	<!-- BEGIN FOOTER -->
	<div id="co_footerContainer"><div id="co_cookiePolicyContainer">
	<div class="co_cookiePolicyContent">
			<h3><b>Our policy towards the use of cookies</b></h3>
			<p>All Thomson Reuters websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.</p>
			<ul class="co_inlineList">
				<li>
					<a id="coid_website_cookiePolicyLinkOut" href="javascript:void(0)">Read cookie policy</a>
				</li>
				<li>
					<a id="coid_website_closeCookiePolicy" href="javascript:void(0)">Close</a>
				</li>
			<p></p>
			<button type="button" id="coid_website_cookiePolicyAcknowledged" title="Close message to acknowledge cookie policy" class="co_absolute">
				<span class="icon25 icon_close_x"></span>
			</button>
	</ul></div>
</div>


		
		<div class="co_innertube co_clearfix" id="co_footer" style="display: block;">







<div class="co_floatLeft">
	<div id="co_footerLinks">
		<ul class="co_inlineList">
					<li><a id="coid_websiteFooter_userSettings" href="javascript:void(0);"><span class="icon25 icon_gear_document"></span>Preferences</a></li>
				<li><a id="coid_websiteFooter_helplink" href="javascript:void(0);"><span class="icon25 icon_question_mark"></span>Training &amp; Support</a></li>
				
					<li><a id="coid_websiteFooter_signofflink" href="javascript:void(0);"><span class="icon25 icon_exit_door"></span>Sign Off</a></li>

		</ul>
	</div>
	<div id="co_footerCopyright">
		<ul class="co_inlineList">

			<li>Westlaw. <a href="/Copyright?transitionType=Default&amp;contextData=(sc.Default)"> © 2018</a> Thomson Reuters</li>
			<li><a id="coid_websiteFooter_privacyPolicyLink" href="javascript:void(0)">Privacy Statement</a></li>
			<li><a href="/Accessibility?transitionType=Default&amp;contextData=(sc.Default)">Accessibility</a></li>
				<li id="co_footer_supplier"><a id="coid_website_supplierTerms" href="javascript:void(0);">Supplier Terms</a></li>
				<li id="co_footerContactUs"><a href="/ContactUs?transitionType=Default&amp;contextData=(sc.Default)">Contact Us</a></li>
				<li id="co_footerCs">1-800-REF-ATTY (1-800-733-2889)</li>
				<li id="co_footer_improve"><strong><a id="coid_websiteFooter_pageSurvey" href="javascript:void(0);">Improve Westlaw</a></strong></li>
		</ul>


	</div>
</div>





<div id="co_trLogo" class="co_floatRight">

	<a id="co_trLogo_link" href="#">
		<img alt="Thomson Reuters" src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v2/co_logo_thomsonReuters.png" width="134" height="30">
	</a>
</div>



		</div>
	</div>
			<div id="coid_Trmr" style="display:none; visibility:hidden"></div>
		</div>
	</div>
	
	<!--static content version number-->
<script type="text/javascript">





	
		window['Server/Routing'] = {
			Search: 'search.int.next.westlaw.com',
			TypeAhead: 'typeahead.int.next.westlaw.com',
			Nlu: 'nlu.int.next.westlaw.com',
			Document: 'document.int.next.westlaw.com',
			Foldering: 'foldering.int.next.westlaw.com',
			CSS: 'ca.next.westlaw.com/StaticContent_40.1.1015',
			Images: 'ia.next.westlaw.com/StaticContent_40.1.1015',
			JavaScript: 'ja.next.westlaw.com/StaticContent_40.1.1015',
			RelatedInfo: 'relatedinfo.int.next.westlaw.com',
			Events: 'events.int.next.westlaw.com',
			KM: 'NONE',
			RequestDirector: 'www.westlaw.com',
			SocialPlatform: 'https://community-sso.thomsonreuters.com',
			Sync: 'sync.westlaw.com',
			Video: 'v1.next.westlaw.com',
			FormsAssembly: 'formsassembly.int.forms.westlaw.com',
			Publishing: 'publishing.int.next.westlaw.com',
			WebContent: 'webcontent.int.next.westlaw.com',
			Alert: 'alert.int.next.westlaw.com',
			Report: 'report.int.next.westlaw.com',
			ProductMetadata: 'pmd.int.next.westlaw.com/pmd',
			Website: '1.next.westlaw.com',
			WebsiteDefault: '1.next.westlaw.com',
			HistoryListener: 'historylistener.int.next.westlaw.com',
			FormsAssemblyTest: ''
		};
	
		
			if (window.location.host !== '1.next.westlaw.com') {
				window['Server/Routing'].ProxiedWebsite = '1.next.westlaw.com';
				window['Server/Routing'].Website = window.location.host;
				window['Server/Routing'].WebsiteDefault = window.location.host;
			}
		
</script>

<script type="text/javascript"></script>

	<script type="text/javascript" src="https://1.next.westlaw.com/v2/js/UrlRouting.40.1.1013.0.js"></script>
	
	<script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="https://ja.next.westlaw.com/StaticContent_40.1.1015/External/vendor/datejs@1.0/cultures/en-US.js"></script>
<script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="https://ja.next.westlaw.com/StaticContent_40.1.1015/v2/Products/WestlawNext/js/LocalizationResources/Localized/Messages.js"></script>

	
<script type="text/javascript">

	







</script>





















	
	














<script type="text/javascript">
window['Server/User'] = {
  "FirmName": "SEOUL NATIONAL UNIV (LV A)",
  "_AlertsIsAdmin": false,
  "_FeatureExposure": "Released",
  "ClientId": "SEOUL NU - WL NEXT",
  "_AlertsAccessFunctionalityTurnedOn": true,
  "_AlertsAccessCategoryApplied": false,
  "_ShowErrorDetails": false,
  "OnePassUserName": "5405685",
  "OnePassUserNameEncoded": "5405685",
  "ClientMatter": {
    "ClientId": "SEOUL NU - WL NEXT",
    "CompositeClientMatter": "SEOUL NU - WL NEXT",
    "DefaultClientId": "Seoul NU - WL Next",
    "ClientIdPromptText": "",
    "IsClientNonChargeable": "False",
    "NoClientId": "False",
    "TrackableCode": "D",
    "UserTurnedTrackingOn": false
  },
  "ClientReportingAttributes": {
    "PracticeArea": "",
    "ResearchReasonCode": "",
    "ResearchDescription": ""
  },
  "BillingMethodForDisplayOnly": "TRANSACTIONAL",
  "HasFlashPlayer": false,
  "IsUltra": true,
  "CustomerStorageKey": "E41F133AB8A01ED395E1D85D67D9406C",
  "SessionCreatedDateTime": "04/27/2018 11:43:14",
  "HasLoggedAggregateNotificationCount": false
};


window['Server/ViewModelData'] = {
  "DocumentGuid": "I5549a5e09f0f11df896a9debfa48a185",
  "DocumentCitation": "616 F.3d 1267",
  "DocumentTitle": "King Pharmaceuticals, Inc. v. Eon Labs, Inc.",
  "DocumentMetaDescription": "View on Westlaw or start a FREE TRIAL today, King Pharmaceuticals, Inc. v. Eon Labs, Inc., Cases",
  "ViewType": "FullText",
  "Rank": 142,
  "Grading": "na",
  "KMEnableTermNavigation": false,
  "KMEnableDocumentNavigation": false,
  "LegacyId": "2022669341",
  "DocumentSource": {
    "Key": "6e919702fa1e42df8fd85176577733c3",
    "NavigationPath": "Search/v1/results/navigation/i0ad62aef0000016306ea58342bf062c8?Nav=CUSTOMDIGEST&fragmentIdentifier=I5549a5e09f0f11df896a9debfa48a185&startIndex=1&contextData=%28sc.CustomDigest%29&transitionType=CustomDigestItem",
    "ListSource": "Search",
    "List": "CUSTOMDIGEST",
    "ListPageSourceKey": "b1be020b4aba9e28af6c04f62c735c28"
  },
  "HasDraftingNotes": false,
  "HasDocumentSections": false,
  "EnableBestPortion": true,
  "SubContentTypeId": "27",
  "DisableDocMetaInfoRetrievalOnWarningPage": false,
  "TermNavigationPreference": "AllTerms",
  "ShowMainToolbar": true,
  "ShowRelatedAnalysis": false,
  "ListSource": "Search",
  "IsRelatedFullTextView": false,
  "KeyCiteAlertWarning": "None",
  "DocketTrackWarning": "None",
  "DocumentSections": [],
  "RulebookMode": false,
  "RulebookModeContent": false,
  "NotesOfDecisionsCount": 0,
  "TocReportDocGuids": [],
  "TocReportViewMode": false,
  "IsMedLitStubDocument": false,
  "TrackableCode": "D",
  "NonTrackableCode": "H",
  "FullTocOnDoc": false,
  "ViewExpressions": []
};


window['Server/WidgetDomIds'] = {
  "DocToolbar": "co_docToolbar",
  "DocDisplay": "coid_website_documentWidgetDiv",
  "DocTools": "coid_website_documentToolWidgetDiv",
  "DocTopToolbar": "co_docTopToolbar",
  "DocRightToolbar": "co_newDocToolbar",
  "TopTopics": "coid_website_relatedInfoWidgetDiv",
  "DocBottomToolbar": "co_docFooterToolbar"
};


window['Server/PageData'] = {
  "DocumentTabView": {
    "IsSkipOutOfPlanChecked": false,
    "IsUserDocument": false,
    "UserDocumentData": {
      "documentGuid": "I5549a5e09f0f11df896a9debfa48a185"
    },
    "HasProfileSubTab": false,
    "DisplayOptions": {
      "showMainToolbar": true,
      "isNewDocumentView": false,
      "disableDocToolbar": false,
      "isAbstractView": false,
      "chunkSize": "L",
      "chunkableHeadnotes": false,
      "doCompleteSizeChecking": true,
      "ViewType": "FullText",
      "stickyHeader": true,
      "displayRelatedContentLink": true,
      "snippetRelocationInfo": {
        "contentType": "Cases",
        "subContentTypeId": "27"
      }
    },
    "ShowMainToolbar": true,
    "DocumentPersisted": false,
    "DocumentGuidNotFound": false,
    "ContentType": "Cases",
    "ExpandDocumentLevelTOC": true
  },
  "CobaltPageHeader": {
    "ShowPauseLink": false,
    "ShowCommunityContainer": false,
    "EnablePageHeaderV2": true,
    "ShowBetaFeedbackLink": false,
    "Notifications": {
      "HideNotificationToastAfterDuration": false,
      "NotificationClickGoDirectlyToAlerts": false
    }
  },
  "CompartmentStartPageId": "",
  "CobaltMasterFooterInSession": {
    "TRLogoImageLinkUrl": "http://www.thomsonreuters.com",
    "ShowWhatIsNewLink": false,
    "Unreleased": false,
    "IsAnonymousSession": false,
    "ShowMyContacts": false,
    "ShowPromotions": false,
    "ShowResetPromotions": false,
    "ShowCampusPolicy": false,
    "IsTransferContentAvailable": false,
    "ShowProductStartGuide": false,
    "HelpGuideDisplayName": "",
    "HelpGuideFileName": "",
    "HelpGuidePath": "",
    "CampusPolicyDisplayName": "",
    "CampusPolicyPath": "",
    "ShowAnalyticsLink": false,
    "AnalyticsPath": "Session/SignOn.html?transitionType=Default&contextData=(sc.Default)",
    "ShowMyAccountLink": false,
    "MyAccountPath": "WESTLAW/Common/Landing/MyAccountLanding",
    "LegalSolutionsLink": "http://legalsolutions.thomsonreuters.com/law-products/westlaw-legal-research/training-support",
    "SupplierTermsUrl": "http://legalsolutions.com/westlaw-additional-terms",
    "PrivacyPolicyPath": "https://www.thomsonreuters.com/en/privacy-statement.html"
  },
  "ActOnTracking": {
    "EnableActOnTracking": false,
    "ActOnTrackingInstanceId": ""
  },
  "CobaltPage": {
    "SetInCache": [
      {
        "Vertical": "Global",
        "Name": "ResultsPerPage",
        "Value": 20
      },
      {
        "Vertical": "Global",
        "Name": "ResultsPerPageAllowableValues",
        "Value": [
          "100",
          "20",
          "50"
        ]
      },
      {
        "Vertical": "Global",
        "Name": "Locale",
        "Value": ""
      },
      {
        "Vertical": "Global",
        "Name": "TimeZone",
        "Value": "Central Standard Time"
      },
      {
        "Vertical": "Global",
        "Name": "MultiFacetsEnabled",
        "Value": false
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_CASE",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_ANALYTICAL",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_PENDINGREG",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_PENDINGLEG",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_KNOWHOW",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "JurisdictionsContentType",
        "Value": "default"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_DOCKET",
        "Value": "CASE_TITLE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_BRIEF",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_TRIAL-TRANSCRIPTS",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_ADMINDECISION",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_FORM",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_NEWS",
        "Value": "DATE_DESCENDING"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_ORAL-ARGUMENTS",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "InstantSuggestions",
        "Value": true
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_TCO",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultNews_DuplicateIdentifier",
        "Value": false
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_REGULATION",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_EXPERTWITNESS",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "SliderDetail",
        "Value": "default"
      },
      {
        "Vertical": "Search",
        "Name": "ViewExpression",
        "Value": ""
      },
      {
        "Vertical": "Search",
        "Name": "DefaultPage",
        "Value": "ALL"
      },
      {
        "Vertical": "Search",
        "Name": "JurisdictionsGlobal",
        "Value": "CTAF"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_PMM",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_STATUTE",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_JURYVERDICT",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "SuppressRecentFiltersTooltip",
        "Value": false
      },
      {
        "Vertical": "Document",
        "Name": "HeadnotesDualColumnView",
        "Value": false
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorRulesSet",
        "Value": "standard"
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorItalicizeTitle",
        "Value": false
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorParallelCites",
        "Value": "CAFormat"
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorUseForCopyWithReference",
        "Value": true
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorCitationStyle",
        "Value": "LegalBriefs"
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorIncludeHistory",
        "Value": true
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorUnderlineTitle",
        "Value": true
      },
      {
        "Vertical": "Document",
        "Name": "HideHeadnotesBox",
        "Value": false
      },
      {
        "Vertical": "Foldering",
        "Name": "ShowAnnotationsPreferenceKey",
        "Value": "checked"
      },
      {
        "Vertical": "Website",
        "Name": "ShowKeyboardInstructions",
        "Value": true
      },
      {
        "Vertical": "Website",
        "Name": "DocumentFullscreenShowTerms",
        "Value": true
      },
      {
        "Vertical": "Website",
        "Name": "NewFeatureLightboxDisplayBlackList",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DocumentFullscreenTextSize",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DocumentFullscreenMargin",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DeliveryOptionSelected",
        "Value": "None"
      },
      {
        "Vertical": "Website",
        "Name": "DocumentFullscreenShowLinks",
        "Value": true
      },
      {
        "Vertical": "Website",
        "Name": "LastViewNotificationDate",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DocumentDisplayTextSize",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DisplaySearchTerms",
        "Value": true
      },
      {
        "Vertical": "Website",
        "Name": "KnowHowSpeedReadExpandAll",
        "Value": true
      },
      {
        "Vertical": "Website",
        "Name": "DocumentDisplayFont",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DocumentDisplayMargin",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DocumentFullscreenFont",
        "Value": ""
      },
      {
        "Vertical": "SAP",
        "Name": "PLAN ICONS",
        "Value": "NO"
      },
      {
        "Vertical": "SAP",
        "Name": "SKIP OUT OF PLAN",
        "Value": "NO"
      },
      {
        "Vertical": "SAP",
        "Name": "WARNING FLAG",
        "Value": "N"
      }
    ],
    "PingSync": "false",
    "ViewData": {
      "IsSponsorSession": true,
      "SearchWidgetParameters": {
        "search": {
          "renderCustomPageSearchWidget": false,
          "categoryPageTitle": "291 PATENTS",
          "isCategoryPageTopical": false,
          "topicKeyText": "291 PATENTS",
          "filters": {
            "jurisdiction": "CTAF",
            "sequence": 0,
            "content": "CUSTOMDIGEST",
            "index": false,
            "customDigest": true,
            "collectionSets": [
              "w_cs_cd_toc"
            ],
            "tocNode": "I4aee2539c6f64c1812a4c2f3395c2607",
            "keyNumber": "291",
            "displayJurisdictionSelector": true,
            "displayAdvancedSearchLink": false,
            "categoryPageUrl": "Home/WestKeyNumberSystem",
            "categoryPageContentType": "CUSTOMDIGEST",
            "categoryPageCheckboxLimit": 0,
            "resultsLimit": 0,
            "categoryPageAlertClippable": false,
            "isAdvancedSearchTemplatePage": false
          },
          "CustomPageSetForZone": false,
          "supportedFeatures": [],
          "skipSpellCheck": false,
          "browseHierarchyPathFromRoot": []
        },
        "SearchCompartmentName": "WestlawNext",
        "SearchDropDownItems": [],
        "grading": "na",
        "searchWidgetPosition": "Default",
        "hideSearchWidget": false,
        "makeSearchWidget": true,
        "prefersForceTnc": false,
        "prefersForceTncSingleQuote": true,
        "forceTncCounter": 0,
        "forceTncCounterThreshold": 5,
        "enableFavoriteSearch": false,
        "dynamicPage": false,
        "isAdvancedSearchTemplatePage": false
      },
      "ShowClientIdWidget": true,
      "OpenFindDropDown": false,
      "TimeoutInMinutes": 90,
      "FeatureConfigurations": {
        "FOLDERS": false,
        "HISTORY": true,
        "FOLDER_SHARING": false,
        "HIGHLIGHTS": false,
        "NOTES": false,
        "ANNOTATIONS": false,
        "BLOCK NOTES SHARING": false,
        "CONTACTS": false,
        "FAVORITES": false,
        "USER PROFILE": false,
        "KM": false,
        "FolderCachingDisabled": true,
        "KM IPAD": false,
        "SAO_INVITING": true,
        "SAO_SAMEEMAILDOMAIN": false,
        "CASENOTEBOOKEXPORT": false,
        "DOWNLOADDELIVERY": true,
        "DROPBOXDELIVERY": false,
        "EMAILDELIVERY": true,
        "EMAILWITHREFERENCEDELIVERY": false,
        "KINDLEDELIVERY": false,
        "PRINTDELIVERY": true,
        "KEYCITEALERTS": false,
        "LEGACYALERTACCESS": false,
        "BLOCKPERSISTENTINFO": true,
        "BLOCK100KANCILLARY": false,
        "DISPLAYMASHUPCHARGEWARNING": false,
        "SHOWCHARGEONWARNINGSCREEN": false,
        "SHOWCHARGELINKONWARNINGSCREEN": false,
        "USERISTRANSACTIONAL": true,
        "USER FORM UPLOAD": false,
        "MATTERUPLOADUSERDOC": false,
        "FOLDERUPLOADUSERDOC": false,
        "DISPLAY SESSION PAUSE LINK": false,
        "PASSTHRUPDFS": false,
        "processRIHistoryAsynchronously": true,
        "processDocumentHistoryAsynchronously": true,
        "PRINTBLANKFORMS": false,
        "WFBTRIALBLOCKSHARE": false,
        "ATTORNEY PORTAL": false,
        "SMALLLAWWORKBENCHMATTERTREE": false,
        "JUDICIALCHAMBERS": false,
        "CITATIONUS": false,
        "CITATIONCAN": false,
        "MYPLANSTATICDOC": true,
        "ALLOWFOLDERSHAREACROSSORGS": true,
        "BLOCKFOLDERSHAREFROMORGS": true,
        "ALLOWOFFLINEACCESS": false,
        "WEBHOSTEDCLIENTID": false,
        "WEBHOSTEDCLIENTIDIPAD": false,
        "WEBHOSTEDCLIENTIDSELECTION": false,
        "PRERELCONTENTFEAT": false,
        "ALERTS": false,
        "ALERTS ENHANCED": false,
        "ISEMULATEUSER": false,
        "WCLP": false,
        "NEWSLETTER": false,
        "KCALERT": false,
        "COINV ALERTS": false,
        "CITRANSITION": false,
        "BLCALERT": false,
        "DKTALERT": false,
        "DKTTRACK": true,
        "PUBALERT": false,
        "CWALERT": false,
        "POB ALERT": false,
        "POB WATCH": false,
        "CWALERTPremium": false,
        "CAPITOLWATCH": false,
        "ALERT SUMMARY REPORT": false,
        "WCLP CONTINUOUS": false,
        "KCALERT CONTINUOUS": false,
        "CWALERT CONTINUOUS": false,
        "POBA CONTINUOUS": false,
        "POBW CONTINUOUS": false,
        "NEWSLETTER DLY": false,
        "NEWSLETTER WKDY": false,
        "KCALERT DLY SINGLE": false,
        "KCALERT WKDY SINGLE": false,
        "BIALERT DLY SINGLE": false,
        "BLCALERT DAILY": false,
        "BLCALERT MULTI DAILY": false,
        "CWALERT DAILY": false,
        "BIALERT WKDY SINGLE": false,
        "BLCALERT BIWEEKLY": false,
        "BLCALERT CONTINUOUS": false,
        "WCLP WEEKLY": false,
        "NEWSLETTER WEEKLY": false,
        "KCALERT WEEKLY": false,
        "BIALERT WEEKLY": false,
        "BLCALERT WEEKLY": false,
        "DKTALERT WEEKLY": false,
        "DKTTRACK WEEKLY": true,
        "POBA WEEKLY": false,
        "POBW WEEKLY": false,
        "WCLP BIWEEKLY": false,
        "KCALERT BIWEEKLY": false,
        "BIALERT BIWEEKLY": false,
        "DKTALERT BIWEEKLY": false,
        "DKTTRACK BIWEEKLY": true,
        "NEWSLETTER BIWEEKLY": false,
        "POBA BIWEEKLY": false,
        "POBW BIWEEKLY": false,
        "WCLP MONTHLY": false,
        "NEWSLETTER MONTHLY": false,
        "KCALERT MONTHLY": false,
        "BIALERT MONTHLY": false,
        "BLCALERT MONTHLY": false,
        "DKTALERT MONTHLY": false,
        "DKTTRACK MONTHLY": true,
        "POBA MONTHLY": false,
        "POBW MONTHLY": false,
        "WCLP DLY SINGLE": false,
        "WCLP DLY MULT": false,
        "WCLP WKDY SINGLE": false,
        "WCLP WKDY MULT": false,
        "PUBALERT DLY SINGLE": false,
        "PUBALERT WKDY SINGLE": false,
        "DKTALERT WKDY SINGLE": false,
        "DKTALERT DLY SINGLE": false,
        "DKTTRACK WKDY SINGLE": true,
        "DKTTRACK DLY SINGLE": true,
        "CAPITOLWATCHTRACK DLY SINGLE": false,
        "CAPITOLWATCHTRACK DLY MULT": false,
        "CAPITOLWATCHTRACK WKDY SINGLE": false,
        "CAPITOLWATCHTRACK WKDY MULT": false,
        "CAPITOLWATCHTRACK WEEKLY": false,
        "CAPITOLWATCHTRACK BIWEEKLY": false,
        "CAPITOLWATCHTRACK MONTHLY": false,
        "POBA DLY SINGLE": false,
        "POBA DLY MULT": false,
        "POBA WKDY SINGLE": false,
        "POBA WKDY MULT": false,
        "POBW DLY SINGLE": false,
        "POBW DLY MULT": false,
        "POBW WKDY SINGLE": false,
        "POBW WKDY MULT": false,
        "showMatterTree": false,
        "WELCOME TO WLN BOX": false,
        "dataRoomReadSource": "Original",
        "dataRoomWriteDestination": "Single",
        "dataRoomFoldersWriteDestination": "SingleDataRoom",
        "showNapaContent": true,
        "PublicRecordsAccess": false,
        "PublicRecordsEnhancedSecurity": false,
        "PublicRecordsBlockRoaming": false,
        "PublicRecordsBlockHomeTrust": false,
        "PublicRecordsAllowRoamTrust": false,
        "PublicRecordsBypassCountry": false,
        "PublicRecordsBlockIPUndefined": false,
        "PublicRecordsBlockUndefinedTrust": false,
        "PublicRecordsDowngradeEmailIPRoaming": false,
        "PublicRecordsDowngradeEmailIPUndefined": false,
        "PublicRecordsUnmaskRoam": false,
        "DISABLE PR ANC MASK": false,
        "PublicRecordsSsnOnlyOK": false,
        "ReversePhoneGateway": false,
        "QSentReport": false,
        "CreditHeaderContentDatabaseGroup": false,
        "PolkGateway": false,
        "PolkReport": false,
        "DriversLicenseRecordsContentDatabaseGroup": false,
        "UCC COLUMN RESULTS": false,
        "matterTreeType": "None",
        "ISCAMPUSUSER": false,
        "ISCAMPUSNEWSUSER": false,
        "ISCAMPUSBUSINESSUSER": false,
        "isUnreleasedFeatureExposure": false,
        "WLANALYTICS ACCESS": false,
        "NEWSALERTAUTHOR": false,
        "NEWSALERTEDITOR": false,
        "UNRELEASED CAT PAGES": false,
        "INTERNAL ADMIN LIMITS": false,
        "DATAROOMALERTS": false,
        "DLVRY SESSION LIMIT": false,
        "DLVRY DAILY LIMIT": false,
        "DLVRY SESSION LIMIT PRAC LAW": false,
        "DLVRY DAILY LIMIT PRAC LAW": false,
        "DLVRY SESSN LIMIT PRAC LAW TRL": false,
        "DLVRY DAILY LIMIT PRAC LAW TRL": false,
        "CONTENT DLVRY RSTRCT": true,
        "BLOCKAUWLN": false,
        "BLOCKCANWLN": false,
        "BLOCKHKWLN": false,
        "BLOCKUKWLN": false,
        "ALERTS ADDRESS BOOK": true,
        "ALERTS BATCH PROCESSING": false,
        "ALERTS CALENDARING": true,
        "ALERTS FUNCTIONALITY": true,
        "ECHACCESS": false,
        "PMD VERSION": "5207",
        "USER ACADEMIC": true,
        "USER CORPORATE": false,
        "USER DEVELOPER": false,
        "USER GOVERNMENT": false,
        "USER INTERNAL": false,
        "USER LARGE LAW": false,
        "USER MEDIUM LAW": false,
        "USER SMALL LAW": false,
        "SIGNOFF SURVEY": false,
        "INLINE KC CASES BRIEF": false,
        "BYPASS WARN INLINE KC": false,
        "BLOCK PL ITEMS": false,
        "PRACTICAL LAW": false,
        "PRDCT PLCUK": false,
        "PRDCT PLCAU": false,
        "DISABLE PL REL CONTENT CACHE": false,
        "HISTORY UI": true,
        "EDSECTIONALLOW": false,
        "TAPSELECTED": false,
        "REDLINING": false,
        "WLNBYPASSBLOCK": false,
        "BLOCK NATIVE SIGNIN": false,
        "BLC ZONE": false,
        "CUSTOM PAGES": false,
        "CUSTOM PAGES READ": false,
        "CUSTOM PAGE ADMIN": false,
        "ELIBRARIES CP ZONE": false,
        "TYPE AHEAD": false,
        "PATRONHELP": false,
        "HISTORY RETENTION 1": false,
        "HISTORY RETENTION 180": false,
        "BLC POWERSEARCH": false,
        "PRDCT CORRECTIONAL": false,
        "EASY EDIT": false,
        "ENHANCED RB": false,
        "ENHANCED RB STICKY": false,
        "WMGRAPHICAL": false,
        "PRPTSUBSCRIBER": false,
        "BLOCK PRPT BLC": false,
        "PLCT DISPLAY LEGAL ANALYTICS": false,
        "PRPT SMALL": false,
        "PRPT CORPCOUNSEL": false,
        "PRPT LARGE": false,
        "BLOCK PRPT LARGE PAGES": false,
        "PRPT GOVT": false,
        "PRPT NONTRACKABLE": false,
        "PRPT KM LITIGATION": false,
        "PRPT KM TRANSACTIONAL": false,
        "WAYWO": false,
        "AnonymousSession": false,
        "AnonymousSessionBlock": false,
        "SOCIAL PLATFORM": false,
        "BLOCK TNP PLUS": false,
        "TNP TEPC CALC": false,
        "TNP CORTC CALC": false,
        "APFF ACCESS": false,
        "TDRC": false,
        "FPC": false,
        "FPP": false,
        "TAXHYPERION NLTR": false,
        "WCO ACCESS": false,
        "BLOCKMYSTARTPAGELINK": false,
        "TNP CEC CALC": false,
        "TNPNATLANG": false,
        "TAXNEWSCATEGORIES": false,
        "TNPDIGMCMECHAN": false,
        "TNPDIGBROWN": false,
        "TNPDIGNIKOLAKAKIS": false,
        "TNPDIGHAYHOETAXATION": false,
        "TNPDIGKERZNER": false,
        "TNPDIGSCHWARTZ": false,
        "TNPDIGINNES": false,
        "TNPDIGARON": false,
        "TNPDIGCARR": false,
        "TNPDIGGAMBLE": false,
        "TNPDIGTAXATIONOFREALESTATE": false,
        "TNPDIGBROOKS": false,
        "TNPDIGMUNRO": false,
        "TNPDIGTHAW": false,
        "TNPDIGVINER": false,
        "TNPDIGFRIEDLANDER": false,
        "TNPDIGBUTCHER": false,
        "TNPDIGALEXANDER": false,
        "TNPDIGHAYHOECASELAW": false,
        "TNPDIGHAYHOEFEDPROVLEGIS": false,
        "TNPDIGHAYHOEGOVPUBLICATIONS": false,
        "TNPDIGJOLIN": false,
        "TNPDIGSTILLABOWER": false,
        "TNPDIGCASESINDEXCITATOR": false,
        "TNPDIGSEGUIN": false,
        "TNPDIGWISE": false,
        "TNPDIGBOWEN": false,
        "TNPDIGBISCOTT": false,
        "TNPDIGEDMUNDS": false,
        "TNPDIGMANNGUIDETOREVIEW": false,
        "TNPDIGCOMPILATIONENGAGEMENTS": false,
        "TNPDIGGUIDETOESTATEANDTRUSTS": false,
        "TNPDIGITIZATION": false,
        "TNPLITIGATOR": false,
        "TNPCROSSREFFILTER": false,
        "RESULTLISTEASYEDIT": false,
        "RESULTLISTQDRAFT": false,
        "DISPLAY TEST PREF TAB": false,
        "BlindLog": false,
        "EncryptLog": false,
        "MASS EMAILER": false,
        "ADCVERREDLININGTOGGLE": false,
        "ENVHEALTHSAFETYPRACPG": false,
        "INSURCOMPLIANCEPRACPG": false,
        "BLOCK WLN PATRON": false,
        "DSP INT HEADNOTE INFO": false,
        "PRDCT WLNLINKS": false,
        "GAO LH PDFS OPEN IN LINKS": false,
        "WLNLINKS UK": false,
        "BLOCK WLNLINKS EMBEDDED LINKS": false,
        "BLOCK LICENSE AGREEMENT": false,
        "FIRMSTYLE": false,
        "SMART BREADCRUMB DISPLAY": false,
        "IRS WLN PAGE": false,
        "FORMSAUTOSHAREOFF": false,
        "WLNPLTRACK": false,
        "WLNPL GOVTHOMEPAGE": false,
        "WLNPL CORPHOMEPAGE": false,
        "WLNPL DEFAULTHOMEPAGE": true,
        "ENABLE-LEGI-GOV-LINKS": false,
        "ENABLE BAILII LINKS": false,
        "BLOCK SHARE NOTE LINK": false,
        "BLCCAN ZONE": false,
        "BLCCAN SUBSCRIBER": false,
        "BLOCKBLCCAN": true,
        "BLOCKBLC": false,
        "WM SEARCH RESULTS": false,
        "WMHK SEARCH RESULTS": false,
        "WMAU SEARCH RESULTS": false,
        "TAX PWC USER": false,
        "TAX KPMG USER": false,
        "COPY USER DATA": false,
        "ASSIGNCLIENTFILE": false,
        "RESEARCH REPORT": false,
        "FOLDER ANALYSIS": false,
        "FOLDER ANALYSIS ADDL CONTENT": false,
        "TIME ZONE AUSTRALIA": false,
        "TIME ZONE NEW ZEALAND": false,
        "EY WLN PAGE": false,
        "FOLDER DESCRIPTION": false,
        "ENABLE CONTRACT EXPRESS": false,
        "CONTRACT EXPRESS PL AU": false,
        "CONTRACT EXPRESS PL US": false,
        "ASK-EDITOR": false,
        "BLOCK OPEN WEB": false,
        "PLUK SUBSCRIBER": false,
        "WLUK SUBSCRIBER": false,
        "LIBRARY SUBSCRIBER": false,
        "CHECKPOINTDIRECTLINK": false,
        "BLOCKCHECKPOINTLINKS": false,
        "LINK BUILDER": false,
        "BCICALCULATOR": false,
        "PLUK-ENAB-ALLCONTACTS": false,
        "ALLOW ICLR": true,
        "BLOCK PROVIEW FEDERATED SEARCH": false,
        "DOC ANALYSIS": false,
        "DT DocAnalysis": false,
        "GENERATE WLUK TRANSTOKEN": false,
        "WFB USEMOCKFORMS": false,
        "BLOCKSESSIONPAUSEDISPLAY": false,
        "PWC WLN PAGE": false,
        "KPMG WLN PAGE": false,
        "CROSSBORDER DASHBOARD": false,
        "TR DISCOVER SEARCH": false,
        "VIRTUAL ASSISTANT": false,
        "BLCDEALTRACKALERT": false,
        "BLCDEALTRACKALERT BIWEEKLY": false,
        "BLCDEALTRACKALERT CONTINUOUS": false,
        "BLCDEALTRACKALERT DAILY": false,
        "BLCDEALTRACKALERT MONTHLY": false,
        "BLCDEALTRACKALERT MULTIDAY": false,
        "BLCDEALTRACKALERT WEEKLY": false,
        "EY MIGRATION POP UP": false,
        "KPMG MIGRATION POP UP": false,
        "PWC MIGRATION POP UP": false,
        "IRS MIGRATION POP UP": false,
        "TAX MIGRATE": false,
        "SEARCH TABS": false,
        "JOURNAL PURCHASE FORM": false,
        "WLUK EDITORS PICKS TAB": false,
        "LEGAL LIT ANALYTICS": false,
        "UKMATTERMAPS": false,
        "USMATTERMAPS": false,
        "DISPLAY PL MESSAGE 1": false,
        "DISPLAY PL MESSAGE 2": false,
        "GRADING TOOL": false,
        "MODERN DOC DISPLAY": false,
        "INDIGO SEARCH": false,
        "INDIGO DISPLAY": false,
        "PSEUDO BLOCK INDIGO DISPLAY": true,
        "INDIGO DISPLAY PREF": false,
        "INDIGO HOT DOCS": false,
        "INDIGO RESEARCH REPORT": false,
        "COMPARE BLACKLINING": false,
        "NOTIFICATION CENTER": false,
        "PRIOR USER INTERACTIONS": false,
        "COLD START": false,
        "TOC FOR CASES": false,
        "MATERIAL KEY FACT FILTER": false,
        "PROCEDURAL POSTURE FILTER": false,
        "FAVORITE SEARCHES": false,
        "FOLDER KEYCITE CHANGE": false,
        "FOLDER RECOMMEND CHANGE": false,
        "FOLDER RECOMMEND ALERT": false,
        "RECENT FILTERS": false,
        "SEARCH RESULT CITING REFS": false,
        "SEARCH RESULT NEG HISTORY": false,
        "QUESTIONANSWERING": false,
        "ITDEPENDS": false,
        "ITDEPENDSQUESTIONANSWER": false,
        "WLUK DOC ALERTS": false,
        "WLUK JCL ALERTS": false,
        "PA REGULATIONS STATUS FILTER": false,
        "ALWAYS CLIENT ID PROMPT": false,
        "PL US BANNER": false,
        "ANSWERS FEEDBACK": false,
        "KC IMPLIED OVERRULINGS": false,
        "ENHANCED THEME": false,
        "DOC ANALYZER TOUR": false,
        "LIT ANALYTICS TOUR": false,
        "HOME PAGE TOUR": false,
        "BUSINESS DEVELOPMENT PL US": false,
        "WLNPL SLF HOMEPAGE": false
      },
      "IsUserMigrated": false,
      "SupportedFeatures": [
        "PRACTICALLAW",
        "ALERTS",
        "BROWSE",
        "BROWSEPREVIEW",
        "CASEEVALUATORWLN",
        "CDN",
        "CLIENTID",
        "CONTACTS",
        "CONTENTTYPEDELIVERYLIMIT",
        "COREUI",
        "CUSTOMPAGES",
        "DELIVERY",
        "DOCKETS",
        "DOCUMENTORDERING",
        "DOCUMENTS",
        "DROPBOX",
        "ERRORS",
        "FAVORITESORGANIZER",
        "FINDANDPRINT",
        "FOLDERS",
        "FOLDERSEXTERNALSHARING",
        "GLOSSARY",
        "WAYWO",
        "IOS",
        "IPAD",
        "FACTORANALYSIS",
        "KEYNUMBERSEARCH",
        "KM",
        "LINKIN",
        "LINKOUT",
        "LIVECHAT",
        "MOBILE",
        "MYPLAN",
        "NYOFFICALDIGEST",
        "PRICINGGUIDE",
        "PROMOTIONS",
        "PUBLICATIONFAVORITES",
        "RELATEDINFORMATION",
        "RELATEDTOPICS",
        "REPORTSHARED",
        "REVERSEPROXY",
        "SEARCH",
        "SHAREPOINTSEARCH",
        "SHAREPOINTWIDGETS",
        "SOCIALPLATFORM",
        "SURVEY",
        "USERAGREEMENT",
        "USERDOCUMENTS",
        "USEREMULATION",
        "USERSETTINGS",
        "BANKRUPTCYEXPLORER",
        "BUSINESSINVESTIGATOR",
        "BUSINESSLAWCENTER",
        "CASENOTEBOOK",
        "DUNANDBRADSTREETBUSINESS",
        "EXPERIANBUSINESSCREDIT",
        "EXPERTDUEDILIGENCE",
        "EXPERTEVALUATOR",
        "MATTERBENCHMARKING",
        "RECENTHISTORY",
        "WEB2MASHUP",
        "AUTHORITYCOMPILER",
        "SEARCHTEMPLATEPREVIEW",
        "PEOPLEMAP",
        "PUBLICRECORDS",
        "DOCKETGATEWAY",
        "WEBCONTENT",
        "PROFESSIONAL",
        "SUGGESTEDDOCUMENTS",
        "EMBEDDEDTEXT",
        "PRODUCTVIEW",
        "PRIVATEFILES",
        "STATEQACOMPARE",
        "SOURCELINK",
        "PMDPROTECTEDCONTENT",
        "ROADRUNNER",
        "REDLINE",
        "SUPERBROWSE",
        "TOCREPORTVIEW",
        "DATACOMPARISONREPORT",
        "GRAPHICALFACETS",
        "COPYUSERDATA",
        "SHAREDNOTES",
        "RESEARCHACCELERATOR",
        "WEBINARS",
        "READINGMODE",
        "ANALYTICS",
        "HIDESEARCHTERMHIGHLIGHTINGPREFERENCE",
        "MONETIZATION",
        "SHOWDOCUMENTANALYZEROVERVIEWPREFERENCE",
        "SHOWLITANALYTICSOVERVIEWPREFERENCE",
        "SHOWHOMEPAGEOVERVIEWPREFERENCE",
        "FOUNDATION"
      ],
      "ActiveBrowserPingInitialWaitInMinutes": 3,
      "ActiveBrowserPingFrequencyInMinutes": 3,
      "ShowClientIdToast": false,
      "DataRoomFeatures": [],
      "SocialPlatformProductId": "140",
      "MaxFileUploadSize": 157286400,
      "SnapEngageScriptUrl": "",
      "DeliveryQueueQueried": false,
      "DeliveryQueueTotal": 0,
      "DeliveryQueueInProgress": 0,
      "DeliveryQueueDocketsInProgress": 0,
      "DeliveryQueueInError": 0,
      "DeliveryQueueNotification": 0
    },
    "WidgetDomIds": {
      "FooterDivId": "co_footer",
      "ErrorSummaryWidget": "coid_website_errorsSummaryPlaceHolder",
      "DockWidget": "co_dockContainer",
      "RecentFoldersWidget": "co_recentFoldersContainer",
      "RecentHistoryWidget": "co_recentHistoryContainer",
      "FrequentFavoritesWidget": "co_frequentFavoritesContainer",
      "AlertsCenter": "co_alertsCenterContainer",
      "ClientIdWidget": "co_clientIdContainer",
      "SignOff": "co_signOffContainer",
      "WhatIsNext": "co_whatIsNextContainer",
      "SearchWidget": "coid_website_searchWidget"
    },
    "RedirectError": {
      "Show": false
    },
    "DomStorageHasBeenCleared": false,
    "LiveChat": {
      "Show": false,
      "Options": {
        "QueueNumber": 0
      }
    },
    "WelcomeLightbox": {
      "Show": false
    },
    "SyncInitiated": false,
    "SyncCapable": false,
    "SubscriptionRenewalBanner": {
      "Show": false
    },
    "IsBusinessLawCenter": false
  },
  "TabScripts": {
    "DocSource": "6e919702fa1e42df8fd85176577733c3",
    "DocGuid": "I5549a5e09f0f11df896a9debfa48a185",
    "NavigationPath": "Search/v1/results/navigation/i0ad62aef0000016306ea58342bf062c8?Nav=CUSTOMDIGEST&fragmentIdentifier=I5549a5e09f0f11df896a9debfa48a185&startIndex=1&contextData=%28sc.CustomDigest%29&transitionType=CustomDigestItem",
    "ListSource": "Search",
    "List": "CUSTOMDIGEST",
    "Rank": 142,
    "DocumentVersionNumber": 0
  }
};


window['Server/KM'] = {
  "SessionId": "",
  "FirmName": "",
  "FirmLogoUri": "",
  "FirmWelcomeUri": "",
  "Protocol": "http"
};


window['Server/Configuration'] = {
  "CompartmentName": "WestlawNext",
  "CookieDomain": "next.westlaw.com",
  "EnableIpad": false,
  "EnableIphone": false,
  "IsIPadAppRenderingMode": false,
  "IsIPhoneAppRenderingMode": false,
  "IOSNativeVersion": "0.0.0",
  "EnableSync": false,
  "EnableDeliveryQueue": true,
  "EnableDeliveryWidget": true,
  "ProductName": "WestlawNext",
  "ProductDisplayName": "Westlaw",
  "ProductDisplayDelimiter": "|",
  "ProductViewName": "none",
  "DailyDeliveryLimit": -1,
  "DailyDeliveryCount": -1,
  "SessionDeliveryLimit": 20,
  "SupportedAlertTypes": [
    "WestClip",
    "KeyCite",
    "DocketAlert",
    "DocketTrack",
    "DealTrack",
    "PublicationAlert",
    "Newsletter",
    "BusinessInvestigator",
    "CourtWire",
    "BusinessLawCenterAlert",
    "PeopleMap",
    "CapitolWatchTrack"
  ],
  "EnableDataRoomAlerts": true,
  "GlobalizationKeyMode": "Default",
  "IsAnonymousSession": false,
  "EnableAccessibleLightbox": true,
  "EnableContactsPaging": true,
  "IsCrawlerSession": false,
  "IsGlobalizationI18NLocaleEnabled": false,
  "IsGlobalizationI18NLibraryLookupEnabled": true,
  "IsProcessCategoryPagesWithDifferentLocalesOn": false,
  "OverrideResultsPerPage": 0,
  "UseExpandableToc": true,
  "Locale": "en-US",
  "IsSmartFoldersEnabled": true,
  "IsFeatureOverlayEnabled": true,
  "IsTRDiscoverEnabled": true,
  "IsVideoTourEnabled": true,
  "IsBestPortionNavigationEnabled": true,
  "UsePageHeaderV2": true,
  "UseTypeAhead": true,
  "UseSnapshots": true,
  "IsBriefAnalyzerEnabled": true,
  "IsChargeableByDefaultForSession": true,
  "IsIssueFinderEnabled": true,
  "IsWestlawAnswersEnabled": true,
  "IsSharedHighlightsEnabled": true,
  "IsRealTimeNotificationEnabled": true,
  "EnableA11YLightboxKeyboardScroll": true,
  "IsA11YRedesignedHeaderEnabled": true,
  "IsA11YPreferencesLightboxEnabled": true,
  "SpeechToTextCustomizationIdOverride": "default",
  "InfrastructureAccessControls": [
    "iac-a11y-asbuilder-tmpl",
    "iac-a11y-header-redesign",
    "iac-accessible-clientid-widget",
    "iac-add-timezone",
    "iac-alert-admin-settings",
    "iac-alert-ny-sct-hourly",
    "iac-alerts-cal",
    "iac-alerts-customerinfo-olc",
    "iac-alerts-cw",
    "iac-alerts-docket-guid",
    "iac-alerts-productaware-history",
    "iac-alerts-standart-email-format",
    "iac-all-citations",
    "iac-allow-robots-indexing-sitemap-wln",
    "iac-analyticsclientidfeaturesenabled",
    "iac-analytics-related-filings",
    "iac-annotation-filtering",
    "iac-anonymous-cdn",
    "iac-appcommand",
    "iac-asm-policy",
    "iac-au-compartments",
    "iac-au-seo",
    "iac-autosuggest-au",
    "iac-batch-getsynopsis",
    "iac-bestlaw-tracking",
    "iac-blc-filersearch",
    "iac-blc-fs-next",
    "iac-blc-redlining",
    "iac-blc-ri-agreementsenh",
    "iac-blc-ri-newpathway",
    "iac-blc-ri-privateequity",
    "iac-blind-encrypted",
    "iac-blind-encrypted-header-enabled",
    "iac-block-uk-westlaw",
    "iac-blt-alertfulltext",
    "iac-blt-alert-type-mna-trans",
    "iac-blt-alert-type-sec-insider",
    "iac-blt-alert-type-sec-noninsider",
    "iac-blt-feature18",
    "iac-blt-feature3",
    "iac-blt-hoovers",
    "iac-blt-incorporationdata",
    "iac-blt-news",
    "iac-blt-oct2014-release",
    "iac-blt-officerlinks",
    "iac-blt-report-advisors",
    "iac-blt-securities",
    "iac-blt-securities-alerts",
    "iac-blt-subsidiaries",
    "iac-blt-table-sections",
    "iac-blt-tagged-sections",
    "iac-blt-tickercik",
    "iac-blt-webkitpdf",
    "iac-blt-xmlmindrtf",
    "iac-businesslawcenter-tdr",
    "iac-canadian-content",
    "iac-casetracking",
    "iac-change-uk-ntz-clientid",
    "iac-cig-addfoldereditem",
    "iac-cig-facet-orphan",
    "iac-cig-group-orphan",
    "iac-cig-orphan",
    "iac-cig-orphan-ind",
    "iac-cig-report-orphan",
    "iac-ci-resultlist",
    "iac-citation-reordering",
    "iac-client-chargeable-by-default",
    "iac-clientid-new-validation",
    "iac-concourselibrary-wln",
    "iac-content-finder",
    "iac-correct-dock-user-property-value",
    "iac-courtexpress",
    "iac-cpet-browseparts-novus",
    "iac-cr-effective-date-display",
    "iac-crossborder-dashboard",
    "iac-crossborder-itg",
    "iac-display-applied-filter-names-on-ssp",
    "iac-display-recent-items",
    "iac-docanalyzer-caselc-atlaslc",
    "iac-docanalyzer-cited-statutes",
    "iac-docanalyzer-filter",
    "iac-docanalyzer-footnotes",
    "iac-docanalyzer-rdintegration",
    "iac-docanalyzer-relevantportion",
    "iac-docanalyzer-secondarysources",
    "iac-docanalyzer-statutes",
    "iac-docanalyzer-ui-march-release",
    "iac-doc-medical-entities-link-out",
    "iac-docversioning-wln",
    "iac-dpa-browse-juris-landing-pg",
    "iac-dpa-curated",
    "iac-dpa-delivery-watson-answer",
    "iac-dpa-enforcementmap",
    "iac-dpa-featured-content",
    "iac-dpa-keyword-newjurs",
    "iac-dpa-keyword-novus",
    "iac-dpa-knowledgegraph",
    "iac-dpa-related-concepts",
    "iac-dpa-usabilla",
    "iac-dpa-watson-v11",
    "iac-dpa-watson-v12",
    "iac-dr-client-missed",
    "iac-dtp-bankruptcy-claims",
    "iac-dtp-dktptynmtbl",
    "iac-dtp-experts",
    "iac-dtp-openweb",
    "iac-dyn-stem-exceptions",
    "iac-enable-news-summary-alerts-delivery",
    "iac-enacted-legislation-link",
    "iac-enhanced-search-term-tooltip",
    "iac-factoranalysis-history",
    "iac-fa-searchbilling",
    "iac-fastdom-standarddocument",
    "iac-feature-overlay",
    "iac-findandprint",
    "iac-firmlibrary-wln",
    "iac-foldering-get-descendants-new",
    "iac-folderingshareacrossorgs",
    "iac-forcesignon-orphansession",
    "iac-gateway-do",
    "iac-get-renewalandtrialdata",
    "iac-grantonlyfacsinsessionbindings",
    "iac-guid-chasing-disable",
    "iac-hide-docket-monthly-frequency",
    "iac-hide-territorial-options",
    "iac-historical-datacorrections",
    "iac-image-module",
    "iac-improved-navigation",
    "iac-indigo-coldstart",
    "iac-indigo-cpet-browseparts",
    "iac-indigo-display-pref",
    "iac-indigo-fav-searches",
    "iac-indigo-folder-kc-change",
    "iac-indigo-folder-recommend-change",
    "iac-indigo-hot-docs",
    "iac-indigo-notification-center",
    "iac-indigo-paymenttype",
    "iac-indigo-pui",
    "iac-indigo-recent-filters",
    "iac-indigo-research-report",
    "iac-indigo-statutes-compare",
    "iac-indigo-typeahead",
    "iac-inlinehtmldelivery-dockettrackalert",
    "iac-internationalfind",
    "iac-ios-newadvancedsearch",
    "iac-ip2-markman",
    "iac-ip-trademark-viennacode-facet",
    "iac-itdepends",
    "iac-itg-tab",
    "iac-kc-alerts-patents",
    "iac-kc-citing-references",
    "iac-kc-citing-refs-enhanced-sw",
    "iac-kc-flags",
    "iac-kc-flags-green-c-by-boolean",
    "iac-kc-judicial-history",
    "iac-kc-negative-treatment",
    "iac-kc-rules-affected-by",
    "iac-kc-statutes-affected-by",
    "iac-kc-table-of-authorities",
    "iac-kc-validity",
    "iac-kc-wave-the-white-flag",
    "iac-keycite-nod-redesign-old-rels",
    "iac-keycite-sort-by-court-level",
    "iac-keynumber-facets",
    "iac-km-aliveserverconnection",
    "iac-km-fiacctprefs",
    "iac-la-case-outcomes",
    "iac-la-case-types",
    "iac-la-courts",
    "iac-la-delivery",
    "iac-la-law-firms",
    "iac-linkbuilder-docandcatpages",
    "iac-linkbuilder-searchresultspages",
    "iac-linkbuilder-topic-search",
    "iac-linkouturl-pubandserial",
    "iac-log-prdct-wlus-deny",
    "iac-lt-dpa-watson-integration",
    "iac-master-page",
    "iac-mattermaps-deliver-image",
    "iac-mattermaps-editmap",
    "iac-matters-by-number-wln",
    "iac-medlit",
    "iac-modal-footnotes",
    "iac-modernization-wln-ios-doc",
    "iac-most-cited-sort",
    "iac-move-menus-down",
    "iac-multipart-pdf",
    "iac-new-newsletter-template",
    "iac-newsroom-images",
    "iac-non-unique-cites",
    "iac-novustimezone",
    "iac-nyofficial-digestlink",
    "iac-oversized-and-error-email-delivery",
    "iac-pa-regulations-status-facets",
    "iac-partytype-checkbox",
    "iac-patron-category-page",
    "iac-pdf-multipart-check",
    "iac-planz-application-enabled",
    "iac-plconnect-tasks-and-synonyms",
    "iac-plconnect-tasks-ux-redesign",
    "iac-plc-rss-feeds",
    "iac-plct-crossclientid",
    "iac-plct-crossproductclientid",
    "iac-plct-globalsearch",
    "iac-plct-linkbuilder",
    "iac-plct-smalllawfirmmgmt",
    "iac-plct-ssrulebooks",
    "iac-plct-startupssmallbus",
    "iac-plct-viewalltasks",
    "iac-plc-viewonlydraftingnotes",
    "iac-plc-waywo",
    "iac-plplus-application-enabled",
    "iac-plplus-calendar",
    "iac-pl-scrollissues",
    "iac-pluk-asset-page-enable-wln-links",
    "iac-pluk-cdn-available-for-ip",
    "iac-plus-clientidinsession",
    "iac-plus-clientidpromptpltowl",
    "iac-plus-documentononepage",
    "iac-plus-feedback",
    "iac-plus-homebanner",
    "iac-plus-knowhowbooleanquery",
    "iac-plus-linkbuilder",
    "iac-plus-notesformating",
    "iac-plus-searchcontext",
    "iac-plus-truncatejurinsearch",
    "iac-plus-unhideannotations",
    "iac-plus-viewmorelessdetails",
    "iac-portalmanager-combined",
    "iac-portalmanager-contentlinks",
    "iac-portalmanager-findbypartyname",
    "iac-portalmanager-search",
    "iac-practical-law-display-changes",
    "iac-practicallaw-itg-dropdown",
    "iac-practical-law-subheadings",
    "iac-practiceareas-asterisknote",
    "iac-practicepoint-smartsearch-onesynonym",
    "iac-practicepoint-smartsearch-synonyms",
    "iac-practicepoint-smartsearch-treatises",
    "iac-practitioner-insights-alerts-no-logo",
    "iac-pr-add-bing",
    "iac-pr-addfoldereditem",
    "iac-pr-entity-extraction",
    "iac-pr-fein-plus3",
    "iac-price-guide-link",
    "iac-pricing-guide-redirect",
    "iac-privacy-policy",
    "iac-pr-polkrpt",
    "iac-pr-qsentrpt",
    "iac-pr-section-delivery",
    "iac-pr-ssn-only-search",
    "iac-pr-use-pipl-v5",
    "iac-public-record-prod-gateway",
    "iac-public-records",
    "iac-public-records-alerts",
    "iac-public-records-firstamerican",
    "iac-public-records-report-excel-delivery",
    "iac-public-records-report-filtering",
    "iac-pubrec-real-time-monitor",
    "iac-qanda",
    "iac-qanda-pinpoint",
    "iac-qanda-typeahead",
    "iac-raise-document-limit",
    "iac-ra-no-rank1docs-cache",
    "iac-remove-nyor-hard-coded-collections",
    "iac-remove-securedatatoken",
    "iac-research-accel",
    "iac-research-accel-synopsis",
    "iac-ri-bill-activity",
    "iac-ri-bill-tracking",
    "iac-ri-capitol-watch",
    "iac-ri-category-delivery",
    "iac-ri-citestyles-endpoint-v2-enable",
    "iac-ri-context-analysis",
    "iac-ri-editorial-materials",
    "iac-ri-filings",
    "iac-ri-fnd-newpathway",
    "iac-ri-form-families",
    "iac-ri-legislative-timeline",
    "iac-ri-no-single-rn-uds-post",
    "iac-ri-notes-of-decisions",
    "iac-ri-opinions",
    "iac-ri-professional-references",
    "iac-ri-reduce-uds-rn-data",
    "iac-ri-topics",
    "iac-ri-versions",
    "iac-sb-list-items-delivery",
    "iac-search-como-group1",
    "iac-search-como-group2",
    "iac-search-como-group3",
    "iac-search-como-group4",
    "iac-search-como-group6",
    "iac-search-como-group7",
    "iac-search-como-group8",
    "iac-search-como-public-records",
    "iac-search-como-recodocs",
    "iac-search-como-reghist",
    "iac-search-custom-nyor-reranking",
    "iac-search-delivery-group1",
    "iac-search-delivery-group2",
    "iac-search-delivery-group3",
    "iac-search-delivery-group4",
    "iac-search-delivery-group5",
    "iac-search-firmcentral",
    "iac-search-knowhowrankoption",
    "iac-search-matterroom",
    "iac-search-nl-thresholding-option",
    "iac-search-pmd-result-types",
    "iac-search-result-duplicate-identifier",
    "iac-search-suggestions",
    "iac-search-within-favourites-plcuk",
    "iac-searchwithin-ios",
    "iac-shared-highlights",
    "iac-share-folders-with-cobalt-contacts",
    "iac-sharing-with-the-same-domain",
    "iac-show50statesurvey-inlineflags",
    "iac-small-law-survey-redirect",
    "iac-smartbreadcrumb-add-navid",
    "iac-smartbreadcrumbs-au",
    "iac-smartfolders-ss",
    "iac-snapshots-state",
    "iac-snowdonia-beta",
    "iac-sortoption-courtlevel-pref",
    "iac-starpages-plcuk",
    "iac-staticqa",
    "iac-staticqa-history",
    "iac-staticqa-searchbilling",
    "iac-statutes-new-ast-pdfs",
    "iac-superbrowse-mult-gradeheads",
    "iac-superbrowse-paging",
    "iac-taxpage-eylogo",
    "iac-term-frequency-sorting",
    "iac-transfer-content",
    "iac-trd-alternate-search",
    "iac-trd-juris-facet",
    "iac-trd-legalanalytics",
    "iac-trd-lpafacet-subsearch",
    "iac-trillium-crsw-doc-enhance",
    "iac-trillium-link",
    "iac-uk-a11y-clientid-lightbox",
    "iac-uk-clientid",
    "iac-uk-compartments",
    "iac-uk-fd-and-fs",
    "iac-uk-keywordfinder",
    "iac-uk-linkbuilder",
    "iac-uk-linkbuilder-copy",
    "iac-uk-nonpltracking",
    "iac-uk-performance-new-static-content-or",
    "iac-unlink-unmigrated",
    "iac-use-new-training-user",
    "iac-userdoclink-wln",
    "iac-us-knowhow-algorithm",
    "iac-v3inapplibrary",
    "iac-validity-highlighting",
    "iac-verify-eaddress-against-existance",
    "iac-webinars",
    "iac-website-throttle",
    "iac-westsearch-cases-keynumberfacet",
    "iac-westsearch-cases-partyfacet",
    "iac-westsearch-cases-synopsis",
    "iac-westsearch-cases-topicfacet",
    "iac-westsearch-enhancements",
    "iac-without-flash-dependencies",
    "iac-wln-cig-linkedreport",
    "iac-wlndoc-sharednotes",
    "iac-wln-global-search-judicial-chambers",
    "iac-wln-historicalheader",
    "iac-wln-ios-display-toa",
    "iac-wln-newfiletype",
    "iac-wlnopenweb-serverbrowsepage",
    "iac-wln-ri-tabs",
    "iac-wln-save-snippet",
    "iac-wln-strong-downgrade-email",
    "iac-wlntax-blue-flag",
    "iac-wln-toc-keyciteflag",
    "iac-wl-startpage",
    "iac-wl-striphash",
    "iac-wordsphrases-snippet-support"
  ],
  "IsTypeAheadNewUiEnabled": true,
  "ContactsPageSize": 300,
  "ShowPrivacyPolicy": true,
  "ShowCookiePolicy": true,
  "ResearchReportDocumentLimit": 1000,
  "IsSaveSnippetEnabled": true,
  "IsHideAnnotationsSharedByInactiveUsersEnabled": true,
  "AllowPauseOnLinkOut": true,
  "IsMaintainDocumentPositionRIEnabled": true,
  "IsFormsEngine2Enabled": false,
  "IsFormsEngine2DownloadEnabled": false,
  "IsIndigoDisplayEnabled": false
};


window['Server/Mobile'] = {
  "IsNativeIPad": false,
  "IsNativeIPhone": false
};


window['Server/Messages'] = {
  "ProductName": "Westlaw",
  "ProductSupportNumber": "1-800-WESTLAW (1-800-937-8529)"
};


window['Server/Net'] = {
  "PageContextData": "(sc.CustomDigest)",
  "CacheScopeList": [
    "^/RelatedInfo/v[3456]/keycite/content/",
    "^/RelatedInfo/v3/content/json/",
    "^/RelatedInfo/v1/wlncCaselawHistory\\\\?",
    "^/RelatedInfo/v1/wlncCitingReferences\\\\?",
    "^/RelatedInfo/v1/wlncCourtDocs\\\\?",
    "^/RelatedInfo/v1/wlncLegalMemos\\\\?",
    "^/RelatedInfo/v1/kcJudicialHistory\\\\?",
    "^/RelatedInfo/v1/kcCitingReferences\\\\?",
    "^/RelatedInfo/v1/riFilings\\\\?",
    "^/RelatedInfo/v1/kcNegativeTreatment\\\\?",
    "^/RelatedInfo/v1/kcTableOfAuthorities\\\\?",
    "^/RelatedInfo/v1/kcBillDrafts\\\\?",
    "^/RelatedInfo/v1/kcLegislativeMaterials\\\\?",
    "^/RelatedInfo/v1/kcRegulatoryHistory\\\\?",
    "^/RelatedInfo/v1/kcValidity\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnAgreements\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnAgreementsTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnSecCommentLetters\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnSecCommentLettersTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingsAndDisclosures\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingsAndDisclosuresTwoStepViaMA\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingsAndDisclosuresExhibits\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingsAndDisclosuresExhibitsTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingsAndDisclosuresExhibitsTwoStepViaMAAndFD\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnMergersAndAcquisitions\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnMergersAndAcquisitionsEnhanced\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnMergersAndAcquisitionsEnhancedTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnMergersAndAcquisitionsRelated\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnRandPTransactionFullTextCategory\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnRandPTransactionFullTextCategoryTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingFullTextCategory\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFundsInvestments\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFundsInvestmentsV2\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFundsInvestmentsTwoStepViaMA\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFundsInvestmentsTwoStepViaFDAndMA\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnPefundsFundsFirms\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnAgreementsEnh\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnAgreementsEnhTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnAgreementsEnhTwoStepViaMA\\\\?",
    "^/RelatedInfo/v1/tnpCases\\\\?",
    "^/RelatedInfo/v1/tnpCommentary\\\\?",
    "^/RelatedInfo/v1/tnpCompliance\\\\?",
    "^/RelatedInfo/v1/tnpGovernmentDocuments\\\\?",
    "^/RelatedInfo/v1/tnpHistory\\\\?",
    "^/RelatedInfo/v1/tnpHistoryAndTreatments\\\\?",
    "^/RelatedInfo/v1/tnpLegislation\\\\?",
    "^/Search/v1/search/external/results",
    "^/Search/v3/search/results",
    "^/Search/v1/results",
    "^/Document/v1/fulltext/",
    "^/Document/v1/list/fulltext/",
    "^/Document/v1/Mobile/FullText/",
    "^/Document/v1/fixedheader/",
    "^/Document/v1/list/fixedheader/",
    "^/Document/v1/list/Mobile/Fulltext/",
    "^/Document/v[12]/MetaInfo/"
  ],
  "SessionScope": "8ddfa247da5ec522372afb44cc5a905f27604688c70f518919c93bafe2056482",
  "UserScope": "5405685",
  "CacheScope": "05596002fe07413917f7c9c83340799e"
};


window['Server/Events'] = {
  "PageEventIdentifier": "73391a8d4dae4b459f58115bd209aca6",
  "PageName": "Cobalt.Website.ServerPage.Document",
  "ResourceToken": "v1|86e4b35ab09b20248bf874536f0736cdbc954dd91a0d8ec8bc90b5160326c724"
};

</script>


	
	

<!-- View Path: ~/Document/Views/DocumentTabView.cshtml -->
<script type="text/javascript">
window.__viewName = '~/Document/Views/DocumentTabView.cshtml';
</script>
<script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="https://ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/webpack-loader.js"></script>

	

<div id="co_searchDisableDiv" class="co_screenOverlay co_hideState"></div></body></html>